<SEC-DOCUMENT>0001213900-25-069378.txt : 20250730
<SEC-HEADER>0001213900-25-069378.hdr.sgml : 20250730
<ACCEPTANCE-DATETIME>20250730171605
ACCESSION NUMBER:		0001213900-25-069378
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20250724
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250730
DATE AS OF CHANGE:		20250730

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brag House Holdings, Inc.
		CENTRAL INDEX KEY:			0001903595
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISCELLANEOUS AMUSEMENT & RECREATION [7990]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42525
		FILM NUMBER:		251168158

	BUSINESS ADDRESS:	
		STREET 1:		45 PARK STREET
		CITY:			MONTCLAIR
		STATE:			NJ
		ZIP:			07042
		BUSINESS PHONE:		413-398-2845

	MAIL ADDRESS:	
		STREET 1:		45 PARK STREET
		CITY:			MONTCLAIR
		STATE:			NJ
		ZIP:			07042
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0250726-8k_brag.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:TBH="http://braghouse.com/20250724">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03C_TBH_braghouse.com_20250724 -->
<!-- Field: Set; Name: xdx; ID: xdx_04E_20250724_20250724 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityCentralIndexKey_0001903595 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-07-24" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-07-24" id="Fact000004" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-07-24" id="Fact000005" name="dei:EntityCentralIndexKey">0001903595</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="tbh-20250724.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-07-24">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903595</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-07-24</xbrli:startDate>
        <xbrli:endDate>2025-07-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_907_edei--DocumentType_c20250724__20250724_z2XgekIVtXQi"><ix:nonNumeric contextRef="AsOf2025-07-24" id="Fact000010" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PURSUANT TO SECTION 13 OR 15(d) OF</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_903_edei--DocumentPeriodEndDate_c20250724__20250724_zeV1N7j1bath"><ix:nonNumeric contextRef="AsOf2025-07-24" format="ixt:datemonthdayyearen" id="Fact000011" name="dei:DocumentPeriodEndDate">July 24, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_907_edei--EntityRegistrantName_c20250724__20250724_zNfaCvsh95V6"><ix:nonNumeric contextRef="AsOf2025-07-24" id="Fact000012" name="dei:EntityRegistrantName">Brag House Holdings, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20250724__20250724_z9fPTtla8imk"><ix:nonNumeric contextRef="AsOf2025-07-24" format="ixt-sec:stateprovnameen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b><span id="xdx_90E_edei--EntityFileNumber_c20250724__20250724_znzWwWZHGGXl"><ix:nonNumeric contextRef="AsOf2025-07-24" id="Fact000014" name="dei:EntityFileNumber">001-42525</ix:nonNumeric></span></b></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20250724__20250724_zyJb70wnvEO1"><ix:nonNumeric contextRef="AsOf2025-07-24" id="Fact000015" name="dei:EntityTaxIdentificationNumber">87-4032622</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">of incorporation)</p></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(Commission File Number)</td>
    <td style="text-align: center">&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(I.R.S. Employer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification No.)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90D_edei--EntityAddressAddressLine1_c20250724__20250724_zRsHyQmaYut9"><ix:nonNumeric contextRef="AsOf2025-07-24" id="Fact000016" name="dei:EntityAddressAddressLine1">45 Park Street</ix:nonNumeric></span>,<br/>
<span id="xdx_909_edei--EntityAddressCityOrTown_c20250724__20250724_zIdc9te9plha"><ix:nonNumeric contextRef="AsOf2025-07-24" id="Fact000017" name="dei:EntityAddressCityOrTown">Montclair</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressStateOrProvince_c20250724__20250724_zQSU3OCm37Kb"><ix:nonNumeric contextRef="AsOf2025-07-24" id="Fact000018" name="dei:EntityAddressStateOrProvince">NJ</ix:nonNumeric></span> <span id="xdx_902_edei--EntityAddressPostalZipCode_c20250724__20250724_zsJkPvAeEBV8"><ix:nonNumeric contextRef="AsOf2025-07-24" id="Fact000019" name="dei:EntityAddressPostalZipCode">07042</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code: <b>(<span id="xdx_90C_edei--CityAreaCode_c20250724__20250724_zBLuJ6S8PeRg"><ix:nonNumeric contextRef="AsOf2025-07-24" id="Fact000020" name="dei:CityAreaCode">413</ix:nonNumeric></span>) <span id="xdx_90B_edei--LocalPhoneNumber_c20250724__20250724_zzmMdf4cFhzf"><ix:nonNumeric contextRef="AsOf2025-07-24" id="Fact000021" name="dei:LocalPhoneNumber">398-2845</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_edei--WrittenCommunications_c20250724__20250724_zGmc0laqUV02"><ix:nonNumeric contextRef="AsOf2025-07-24" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_edei--SolicitingMaterial_c20250724__20250724_zaxovrJFPpF9"><ix:nonNumeric contextRef="AsOf2025-07-24" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_edei--PreCommencementTenderOffer_c20250724__20250724_ze1iWilEdlp"><ix:nonNumeric contextRef="AsOf2025-07-24" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_edei--PreCommencementIssuerTenderOffer_c20250724__20250724_zwtFOqpxm6Fi"><ix:nonNumeric contextRef="AsOf2025-07-24" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b>Title of each class</b></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b>Trading Symbol(s)</b></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b>Name of each exchange on which registered</b></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span id="xdx_903_edei--Security12bTitle_c20250724__20250724_zRxLIP32kW7k"><ix:nonNumeric contextRef="AsOf2025-07-24" id="Fact000026" name="dei:Security12bTitle">Common Stock, $0.0001 par value</ix:nonNumeric></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span id="xdx_906_edei--TradingSymbol_c20250724__20250724_zI40X4qh7gT9"><ix:nonNumeric contextRef="AsOf2025-07-24" id="Fact000027" name="dei:TradingSymbol">TBH</ix:nonNumeric></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">The <span id="xdx_903_edei--SecurityExchangeName_c20250724__20250724_zWluVkCb72Jj"><ix:nonNumeric contextRef="AsOf2025-07-24" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_edei--EntityEmergingGrowthCompany_c20250724__20250724_zlgh2OTqx1K5"><ix:nonNumeric contextRef="AsOf2025-07-24" format="ixt:booleantrue" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_edei--EntityExTransitionPeriod_c20250724__20250724_z4bVGV8wmqZg"><ix:nonNumeric contextRef="AsOf2025-07-24" format="ixt:booleanfalse" id="Fact000030" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1.01 Entry into a Material Definitive Agreement.</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 24, 2025, Brag House Holdings, Inc. (the
&#8220;<b>Company</b>&#8221;) entered into a Securities Purchase Agreement (the &#8220;<b>Securities Purchase Agreement</b>&#8221;) with
twelve accredited investors (the &#8220;<b>Investors</b>&#8221;) for a private investment in public equity (the &#8220;<b>PIPE Offering</b>&#8221;)
of 15,000 shares of its Series B Convertible Preferred Stock par value $0.0001 per share (the &#8220;<b>Series B Preferred Stock</b>&#8221;)
convertible into 15,923,567 shares of common stock, par value $0.0001 (the &#8220;<b>Common Stock</b>&#8221;), at a conversion price of
$0.942 per share of Series B Convertible Stock, and an aggregate of 15,923,567 warrants (the &#8220;<b>PIPE Warrants</b>&#8221;) to acquire
up to 15,923,567 shares of Common Stock. The purchase price of the securities was $1,000 per share of Series B Convertible Stock and accompanying
1,061.5711 PIPE Warrants to acquire up to 1,061.5711 shares of Common Stock, subject to beneficial ownership limitations set by the holder.
The PIPE Warrants issued in the PIPE Offering are exercisable immediately upon issuance at an exercise price of $0.817 per share and will
expire five years from the date of issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The PIPE Offering closed
on July 30, 2025, with aggregate gross proceeds totaling approximately $15 million, before deducting placement agent fees and other expenses.
The Company intends to use the proceeds from the PIPE Offering for general corporate and working capital purposes.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise price and number of shares of Common
Stock issuable upon exercise of the PIPE Warrants is subject to appropriate adjustment in the event of stock dividends, stock splits,
reorganizations or similar events affecting the Common Stock and the exercise price. Subject to limited exceptions, the Investors may
not exercise any portion of the PIPE Warrants to the extent that the Investors would beneficially own more than 4.99% (or, at the election
of the holder prior to the date of issuance, 9.99%) of the outstanding Common Stock after exercise. In the event of certain fundamental
transactions, the holder of the PIPE Warrants will have the right to receive the Black Scholes Value (as defined in the PIPE Warrants)
of its PIPE Warrants calculated pursuant to a formula set forth in the PIPE Warrants, payable in cash. There is no trading market available
for the PIPE Warrants on any securities exchange or nationally recognized trading system. The Company does not intend to list the PIPE
Warrants on any securities exchange or nationally recognized trading system.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revere Securities, LLC acted as placement agent (the
&#8220;<b>Placement Agent</b>&#8221;) in connection with the PIPE Offering, pursuant to that certain Placement Agency Agreement, dated
as of July 24, 2025, between the Company and the Placement Agent, pursuant to which the Company paid the Placement Agent (i) a cash fee
equal to 8.00% of the aggregate gross proceeds from the sale of the shares of the Series B Preferred Stock in the PIPE Offering, provided,
however, that the cash fee for the proceeds that were not sourced by the Placement Agent was 6.00% and (ii) reimbursement for certain
of out-of-pocket expenses, including (a) legal fees of $150,000 and (b) up to $50,000 in documented out-of-pocket expenses incurred in
connection with the PIPE Offering, excluding legal fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities being offered and sold by the Company
in the PIPE Offering have not been registered under the Securities Act of 1933, as amended (the &#8220;<b>Securities Act</b>&#8221;),
and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission (the &#8220;<b>SEC</b>&#8221;)
or an applicable exemption from such registration requirements. The securities were offered only to accredited investors. The Company
has agreed to file one or more registration statements with the SEC covering the resale of the unregistered shares issuable upon the conversion
of the Series B Preferred Stock and the shares issuable upon exercise of the unregistered warrants pursuant to a Registration Rights Agreement
entered into between the Company and the Investors (the &#8220;<b>Registration Rights Agreement</b>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the closing of the PIPE Offering, the
Company believes its pro forma stockholders&#8217; equity is above $2.5 million, in compliance with Nasdaq Listing Rule 5550(b)(1).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing descriptions of the PIPE Warrants,
Securities Purchase Agreement, Placement Agency Agreement, and Registration Rights Agreement (collectively, the &#8220;<b>Transaction
Documents</b>&#8221;), do not purport to be a complete description and are qualified in its entirety by reference to the full text of
the Transaction Documents, copies of which are filed herewith as Exhibits 4.1, 10.1, 10.2, 10.3, respectively, and incorporated by reference
herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 3.02 Unregistered Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information set forth in Item 1.01 of this
Current Report on Form 8-K with regard to the offer and sale of the shares of Series B Preferred Stock and the PIPE Warrants to the Investors
pursuant to the Securities Purchase Agreement is incorporated herein by reference. The shares of Series B Preferred Stock and the PIPE
Warrants issued and sold under the Securities Purchase Agreement as described in Item 1.01 were offered and sold by the Company in reliance
upon an exemption from registration pursuant to Rule 506 promulgated pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 3.03 Material Modification to Rights of
Security Holders.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the PIPE Offering, on July 25, 2025, as
amended on July 30, 2025, the Company filed a Certificate of Designation of Series B Convertible Preferred Stock with the Secretary of
State of the State of Delaware (collectively, the &#8220;<b>Certificate of Designation</b>&#8221;). Prior to the issuance of any Series
B Preferred Stock shares, the Company filed an amendment to the Certificate of Designation on July 30<sup>th</sup> to amend the voting
rights to state that holders of Series B Preferred Stock shares are not entitled to any voting rights other than any vote required by
law or the Company&#8217;s Certificate of Incorporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The stated value of the Series B Preferred Stock is
$1,000 per share. The conversion price of the Series B Preferred Stock is $0.942 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing description of the Certificate of
Designation does not purport to be a complete description and is qualified in its entirety by reference to the Certificate of Designation,
which is filed herewith as Exhibit 3.1 and incorporated by reference into this Item 3.03.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 5.03. Amendments to Articles of Incorporation
or Bylaws; Change in Fiscal Year.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The disclosures set forth in Item 3.03 above are
incorporated by reference into this Item 5.03.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 8.01 Other Events</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 24, 2025, the Company issued a press release
announcing the pricing of the PIPE Offering. A copy of the pricing press release is filed as Exhibit 99.1 to this Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 30, 2025, the Company issued a press release
announcing the closing of the PIPE Offering. A copy of the closing press release is filed as Exhibit 99.2 to this Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01 Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1.5pt solid; width: 9%"><b>Exhibit No.</b></td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: justify; width: 90%"><b>Description</b></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td>3.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea025072601ex3-1_brag.htm">Certificate of Designation of Series B Preferred Stock</a></td></tr>
  <tr style="background-color: White">
    <td>4.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea025072601ex4-1_brag.htm">Common Stock Purchase Warrant</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td>10.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea025072601ex10-1_brag.htm">Securities Purchase Agreement</a></td></tr>
  <tr style="background-color: White">
    <td>10.2</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea025072601ex10-2_brag.htm">Placement Agency Agreement</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td>10.3</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea025072601ex10-3_brag.htm">Registration Rights Agreement</a></td></tr>
  <tr style="background-color: White">
    <td>99.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea025072601ex99-1_brag.htm">Pricing Press Release dated July 24, 2025</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td>99.2</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea025072601ex99-2_brag.htm">Closing Press Release dated July 30, 2025</a></td></tr>
  <tr style="background-color: White">
    <td>104</td>
    <td>&#160;</td>
    <td style="text-align: justify">Cover Page Interactive Data File (embedded with the Inline XBRL document)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>Date: July 30, 2025</td>
    <td colspan="2"><b>BRAG HOUSE HOLDINGS, INC. </b></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 36%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>By: </td>
    <td style="border-bottom: black 1.5pt solid"><i>/s/ Lavell Juan Malloy, II</i></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Name:&#160; </td>
    <td>Lavell Juan Malloy, II</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Title: </td>
    <td>Chief Executive Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">3</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6PbQbOHGXjjnEKTJEvC0uk+LWjLT+PZJvad0QQyAk53w5QoSioJVukeG0rEo4YNe3yiFU2CCjOaN3ZOtNCn5WeNHWsTJuWH9gRp5BzySTSPn74Lxri3UKcj6NF9N4BnKRygT2WxF89YxMo2s0TqsWlKlhz9SzRqf4NX44qCcZ6l5D0hHZajIpRBM5ym+IZRTDju7qQXy1UJaZCMKhAlEw3Xrvyp8OzZeEvMXOx9mR/nfwAdKRSmg= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ea025072601ex3-1_brag.htm
<DESCRIPTION>CERTIFICATE OF DESIGNATION OF SERIES B PREFERRED STOCK
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 3.1</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>BRAG HOUSE HOLDINGS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CERTIFICATE OF AMENDMENT TO </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CERTIFICATE OF DESIGNATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SERIES B CONVERTIBLE PREFERRED STOCK </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Brag House Holdings, Inc.,
a Delaware corporation (the &ldquo;<U>Corporation</U>&rdquo;), does hereby certify, in accordance with Section 151 of Title 8 of the Delaware
General Corporation Law, that the following resolutions were duly adopted pursuant to the authority of the Board of Directors (the &ldquo;<U>Board</U>&rdquo;)
of the Corporation under the Certificate of Incorporation of the Corporation, as amended (the &ldquo;<U>Certificate of Incorporation</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><B>WHEREAS</B>, on July 24, 2025, the Board previously
authorized and approved, (i) the issuance of a series of preferred stock designated as &ldquo;Series B Convertible Preferred Stock&rdquo;
and (ii) the designation, number of shares, powers, preferences, rights, qualifications, limitations and restrictions thereof (in addition
to any provisions set forth in the Certificate of Incorporation that are applicable to the preferred stock of all classes and series);
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><B>WHEREAS</B>, as of July 30, 2025, no shares of
Series B Convertible Preferred Stock have been issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><B>NOW THEREFORE</B>, in consideration of the mutual
promises and obligations contained herein, the Corporation, intending to be legally bound, and incorporating the recitals set forth herein,
hereby agrees to the foregoing recitals and as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>RESOLVED</B>, pursuant to
authority expressly set forth in the Certificate of Incorporation, the Board hereby approves of the following amendment to the Certificate
of Designation of the Series B Convertible Preferred Stock (the &ldquo;<U>Certificate of Designation</U>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">FIRST: Section 4 of the Corporation&rsquo;s
Certificate of Designation of the Series B Convertible Preferred Stock is hereby amended to read in its entirety as set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;The holders of the shares of Series B Preferred
Stock (each a &ldquo;<U>Holder</U>,&rdquo; and collectively, the &ldquo;<U>Holders</U>&rdquo;) shall not be entitled to any voting rights,
other than any vote required by law or the Certificate of Incorporation. However, for as long as any shares of Series B Preferred Stock
are outstanding, the Corporation shall not, without the affirmative vote of the Holders of a majority of the then outstanding shares of
the Series B Preferred Stock, (i) alter or change adversely the powers, preferences or rights given to the Series B Preferred Stock or
alter or amend this Certificate of Designation, (ii) amend its certificate of incorporation or other charter documents in any manner that
adversely affects any rights of the Holders of Series B Preferred Stock, or (iii) enter into any agreement with respect to any of the
foregoing.&rdquo;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">SECOND: The foregoing amendment
was duly adopted in accordance with Section 151 of Title 8 of the Delaware General Corporation Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature page follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, Brag House
Holdings, Inc. has caused this Certificate of Amendment to be duly executed in its corporate name this 30<SUP>th</SUP> day of July, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-variant: small-caps"><B>BRAG HOUSE HOLDINGS, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">By:</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify"><I>/s/ Lavell Juan Malloy II</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:&nbsp;</TD>
    <TD STYLE="text-align: justify">Lavell Juan Malloy II</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD STYLE="text-align: justify">Chief Executive Officer</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page to Certificate of Designation
Amendment</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Brag House Holdings, Inc., a Delaware corporation (the &#8220;<U>Corporation</U>&#8221;),
does hereby certify, in accordance with Section 151 of Title 8 of the Delaware General Corporation Law, that the following resolutions
were duly adopted pursuant to the authority of the Board of Directors (the &#8220;<U>Board</U>&#8221;) of the Corporation under the Certificate
of Incorporation of the Corporation, as amended (the &#8220;<U>Certificate of Incorporation</U>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">RESOLVED, that the Corporation
hereby designates and creates a series of authorized shares of preferred stock (the &#8220;<U>Preferred Shares</U>&#8221;) of the Corporation,
designated as Series B Convertible Preferred Stock, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FIRST: that, of the 25,000,000
Preferred Shares, having a par value of one-tenth of a cent ($0.0001) per share (&#8220;<U>Preferred Stock</U>&#8221;) authorized to be
issued by the Corporation, 15,000 shares are hereby designated as &#8220;<U>Series B Convertible Preferred Stock</U>.&#8221; The rights,
preferences and limitations granted to and imposed upon the Series B Convertible Preferred Stock are as set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1. <U>Definitions</U>.
For the purposes hereof, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Common Stock</U>&#8221;
means the Corporation&#8217;s common stock, par value $0.0001 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Conversion</U>&#8221;
shall have the meaning set forth in Section 6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Conversion Date</U>&#8221;
shall have the meaning set forth in Section 6(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Conversion Period
Commencement Date</U>&#8221; means July 25, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Conversion Shares</U>&#8221;
means, collectively, the shares of Common Stock issuable upon conversion of the shares of the Series B Preferred Stock in accordance with
the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Notice of Conversion</U>&#8221;
shall have the meaning set forth in Section 6(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Options</U>&#8221;
means any rights, warrants or options to subscribe for or purchase (i) Common Stock or (ii) Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Option Value</U>&#8221;
means the value of an Option based on the Black and Scholes Option Pricing Model obtained from the &#8220;OV&#8221; function on Bloomberg
determined as of (A) the Trading Day prior to the public announcement of the issuance of the applicable Option, if the issuance of such
Option is publicly announced or (B) the Trading Day immediately following the issuance of the applicable Option if the issuance of such
Option is not publicly announced, for pricing purposes and reflecting (i) a risk-free interest rate corresponding to the U.S. Treasury
rate for a period equal to the remaining term of the applicable Option as of the applicable date of determination, (ii) an expected volatility
equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg as of (A) the Trading Day immediately
following the public announcement of the applicable Option if the issuance of such Option is publicly announced or (B) the Trading Day
immediately following the issuance of the applicable Option if the issuance of such Option is not publicly announced, (iii) the underlying
price per share used in such calculation shall be the highest VWAP of the Common Stock during the period beginning on the Trading Day prior to the
execution of definitive documentation relating to the issuance of the applicable Option and ending on (A) the Trading Day immediately
following the public announcement of such issuance, if the issuance of such Option is publicly announced or (B) the Trading Day immediately
following the issuance of the applicable Option if the issuance of such Option is not publicly announced, (iv) a zero cost of borrow and
(v) a 360 day annualization factor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.8pt 0pt 44pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.8pt 0pt 44pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Original Issue Date</U>&#8221;
means the date of the first issuance of any shares of the Series B Preferred Stock under the terms of the Exchange Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Series B Preferred
Stock</U>&#8221; means the Corporation&#8217;s Series B Convertible Preferred Stock, par value $0.0001 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Stated Value</U>&#8221;
means the stated value of the Series B Convertible Preferred Stock, which shall be $1,000 per share, subject to adjustment for stock splits,
dividends, combinations and related transactions as set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.8pt 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Subscription
Date</U>&#8221; means the date of the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2. <U>Designation
and Amount</U>. Fifteen Thousand (15,000) shares of Preferred Stock of the Corporation are hereby designated as &#8220;Series B Convertible
Preferred Stock.&#8221;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3. <U>No Dividends</U>.
Holders shall be entitled to receive, and the Corporation shall pay, dividends on shares of Series B Preferred Stock equal (on an as-if-converted-to-Common-Stock
basis) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares
of the Common Stock. No other dividends shall be paid on shares of Series B Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4. <U>Voting Rights</U>.
Except as required by law, the listing rules of any applicable exchange, or the Bylaws of the Company, holders of Series B Preferred Stock
(each, a &#8220;<U>Holder</U>,&#8221; and collectively, the &#8220;<U>Holders</U>&#8221;) shall be entitled to cast the number of votes
equal to the number of whole shares of Common Stock into which the shares of Series B Preferred Stock are convertible on the basis of
a conversion price of $0.942. Except as provided by law, the listing rules of any applicable exchange, or by the other provisions of this
Certificate of Designation, the Holders shall vote together with the holders of shares of Common Stock as a single class. However, for
as long as any shares of Series B Preferred Stock are outstanding, the Corporation shall not, without the affirmative vote of the Holders
of a majority of the then outstanding shares of the Series B Preferred Stock, (i) alter or change adversely the powers, preferences or
rights given to the Series B Preferred Stock or alter or amend this Certificate of Designation, (ii) amend its certificate of incorporation
or other charter documents in any manner that adversely affects any rights of the Holders of Series B Preferred Stock, or (iii) enter
into any agreement with respect to any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 5. <U>Liquidation</U>.
Upon any liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary (a &#8220;<U>Liquidation</U>&#8221;),
the entire remaining assets and funds of the Corporation legally available for distribution, if any, shall be distributed among the holders
of Common Stock and the Series B Preferred Stock in proportion to the shares of Common Stock then held by them and the shares of Common
Stock which they then have the right to acquire upon conversion of the shares of Series B Preferred Stock then held by them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6. <U>Conversion</U><B>.</B>
Holders of Series B Preferred Stock shall have the following rights with respect to the conversion (&#8220;<U>Conversion</U>&#8221;) of
the Series B Preferred Stock into shares of Common Stock:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <U>Conversions at Option
of Holder</U>. Subject to and in compliance with the provisions of this Section 6, upon the Conversion Period Commencement Date, each
share of Series B Preferred Stock may, at the option of the Holder, be converted into fully paid and non-assessable shares of Common Stock,
as set forth in this Section 6, upon notice (a &#8220;<U>Notice of Conversion</U>&#8221;) to the Corporation. The Holders shall effect
conversions by providing the Corporation with a Notice of Conversion that shall specify the Conversion Price, the number of shares of
Series B Preferred Stock to be converted, the number of shares of Series B Preferred Stock owned prior to the conversion at issue, the
number of shares of Series B Preferred Stock owned subsequent to the conversion at issue and the date on which such conversion is to be effected, which
date may not be prior to the date the Holder delivers such Notice of Conversion to the Corporation (the &#8220;<U>Conversion Date</U>&#8221;).
If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion to
the Corporation is deemed delivered hereunder. To effect conversions, as the case may be, of shares of Series B Preferred Stock, a Holder
shall not be required to surrender the certificate(s) representing such shares of Series B Preferred Stock to the Corporation unless all
of the shares of Series B Preferred Stock represented thereby are so converted, in which case the Holder shall deliver the certificate
representing such shares of Series B Preferred Stock promptly following the Conversion Date at issue. The Corporation shall issue certificates
representing the Conversion Shares promptly, but in no event more than five (5) business days following surrender by a Holder of the certificate(s)
representing the converted shares of Series B Preferred Stock to the Corporation (such date that the Corporation is required to deliver
such certificate(s), the &#8220;<U>Delivery Date</U>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <U>Conversion Price; Conversion
Share</U><I>s</I>. The &#8220;<U>Conversion Price</U>&#8221; of the Series B Preferred Stock shall be $0.942. Each share of Series B Preferred
Stock shall be convertible into such number of Conversion Shares that results from dividing the Stated Value by the Conversion Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <U>Limitations of Conversion</U>.
Notwithstanding anything to the contrary contained herein, the number of Conversion Shares that may be acquired by the Holder upon conversion
of the Series B Preferred Stock (or otherwise in respect hereof) shall be limited to the extent necessary to ensure that, following such
conversion (or other issuance), the total number of shares of Common Stock then beneficially owned by such Holder and its affiliates and
any other persons whose beneficial ownership of Common Stock would be aggregated with the Holder&#8217;s for purposes of Section 13(d)
of the Securities and Exchange Act of 1934, as amended (the &#8220;<U>Exchange Act</U>&#8221;), does not exceed 4.99% of the total number
of issued and outstanding shares of Common Stock (including for such purpose the shares of Common Stock issuable upon such conversion)
(the &#8220;<U>Beneficial Ownership Limitation</U>&#8221;), and such Conversion Shares that may otherwise be acquired by the Holder upon
such conversion (or other issuance) shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not
result in the Holder exceeding the Beneficial Ownership Limitation). For such purposes, beneficial ownership shall be determined in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. The Holder, upon not less than 61 days&#8217;
prior notice to the Corporation, may increase or decrease the beneficial ownership limitations provision of this Section, provided that
the beneficial ownership limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after
giving effect to the issuance of shares of Common Stock upon conversion of the Series B Preferred Stock held by the Holder and the provisions
of this Section shall continue to apply. Any such increase or decrease will not be effective until the 61st day after such notice is delivered
to the Corporation. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity
with the terms of this Section to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such
limitation. The limitations contained in this paragraph shall apply to a successor Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <U>Stock Splits</U>. If
the Corporation, at any time after the Original Issue Date and while at least one share of Series B Preferred Stock is outstanding: (i)
subdivides outstanding shares of Common Stock into a larger number of shares, (ii) combines (including by way of reverse stock split)
outstanding shares of Common Stock into a smaller number of shares or (iii) issues by reclassification of shares of Common Stock any shares
of capital stock of the Corporation, then in each case the Conversion Price shall be multiplied by a fraction of which (x) the numerator
shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and (y) the
denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this
Section shall become effective immediately after the effective date of the applicable event described in subsections (i) through (iii)
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <U>Subsequent Rights Offering</U><I>s</I>.
In addition to any adjustments pursuant to Section 6(d) above, if at any time the Corporation grants, issues or sells any Common Stock
Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares
of Common Stock (the &#8220;<U>Purchase Rights</U>&#8221;), then the Holder will be entitled to acquire, upon the terms applicable to
such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of
Common Stock acquirable upon complete conversion of such Holder&#8217;s Series B Preferred Stock (without regard to any limitations on
exercise hereof) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date
as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided,
however, that, to the extent that the Holder&#8217;s right to participate in any such Purchase Right would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial
ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall
be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial
Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) <U>Calculations</U>. All
calculations under this Section 6 shall be made to the nearest cent or the nearest 1/100<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT>
of a share, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) <U>Reservation of Shares.</U>
The Corporation covenants and agrees that any Conversion Shares issued upon the conversion of the Series B Preferred Stock will, upon
issuance, be validly issued and outstanding, fully paid and non-assessable, and free from all taxes, liens and charges with respect to
the issuance thereof. The Corporation further covenants and agrees that the Corporation will at all times have authorized and reserved
a sufficient number of shares of its Common Stock to provide for issuance of the Conversion Shares upon the conversion of the Series B
Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) <U>Payment of Taxes</U>.
The Corporation and its paying agent shall be entitled to withhold taxes on all payments on the Series B Preferred Stock and Conversion
Shares to the extent required by law. Prior to the date of any such payment, each Holder shall deliver to the Corporation or its paying
agent a duly executed, valid, accurate and properly completed Internal Revenue Service Form W-9 or an appropriate Internal Revenue Service
Form W-8, as applicable. The Corporation shall pay any and all documentary, stamp and similar issue or transfer tax due on (A) the issue
of the Series B Preferred Stock and (B) the issue of Conversion Shares; provided, however, in the case of any conversion of Series B Preferred
Stock, the Corporation shall not be required to pay any tax or duty that may be payable in respect of any transfer involved in the issue
and delivery of Conversion Shares in a name other than that of the Holder of the shares to be converted, and no such issue or delivery
shall be made unless and until the person requesting such issue has paid to the Corporation the amount of any such tax or duty, or has
established to the satisfaction of the Corporation that such tax or duty has been paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) <U>Buy-In</U>. If the Corporation
fails, prior to the applicable Delivery Date, to, at its option, (i) deliver to such Holder the applicable certificate or certificates
or (ii) cause its transfer agent to credit the account of such Holder or such Holder&#8217;s broker with the Depository Trust Company
through its Deposit Withdrawal Agent Commission system, and if after such Delivery Date such Holder is required by its brokerage firm
to purchase (in an open market transaction or otherwise), or the Holder&#8217;s brokerage firm is required to purchase, shares of Common
Stock to deliver in satisfaction of a sale by such Holder of the Conversion Shares which such Holder was entitled to receive upon the
conversion relating to such Delivery Date (a &#8220;<U>Buy-In</U>&#8221;), then the Corporation shall (A) pay in cash to such Holder the
amount by which (x) such Holder&#8217;s total purchase price (including any brokerage commissions) for the shares of Common Stock so purchased
exceeds (y) the product of (1) the aggregate number of shares of Common Stock that such Holder was entitled to receive from the conversion
at issue (or, if less, the number of shares actually delivered in satisfaction of such sale) multiplied by (2) the actual sale price at
which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions) and (B) at the option
of such Holder, either reissue (if surrendered) the shares of Series B Preferred Stock equal to the number of shares of Series B Preferred
Stock submitted for conversion or deliver to such Holder the number of shares of Common Stock that would have been issued if the Corporation
had timely complied with its delivery requirements. For example, if a Holder purchases shares of Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted conversion of shares of Series B Preferred Stock with respect to which
the actual sale price (including any brokerage commissions) giving rise to such purchase obligation was a total of $10,000 under clause
(A) of the immediately preceding sentence, the Corporation shall be required to pay such Holder $1,000. The Holder shall provide the Corporation
written notice indicating the amounts payable to such Holder in respect of the Buy-In and, upon request of the Corporation, evidence of
the amount of such loss. Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at
law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Corporation&#8217;s
failure to timely deliver certificates representing shares of Common Stock upon conversion of the shares of Series B Preferred Stock as
required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Partial Liquidated Damages</U><I>.</I>
If the Corporation fails to deliver to a Holder shares of Common Stock by the Delivery Date, the Corporation shall pay to such Holder,
in cash, as liquidated damages and not as a penalty, for each $1,000 of Stated Value of Series B Preferred Stock being converted, $50
per business day (increasing to $100 per business day on the third business day and increasing to $200 per business day on the sixth business
day after such damages begin to accrue) for each business day after the Delivery Date until such shares are delivered or Holder rescinds
such conversion. Nothing herein shall limit a Holder&#8217;s right to pursue actual damages for the Corporation&#8217;s failure to deliver
the shares or pay the cash within the period specified herein and such Holder shall have the right to pursue all remedies available to
it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. The exercise
of any such rights shall not prohibit a Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><U>(j) </U>Adjustment <U>Upon
Issuance of Common Stock</U>. If and whenever on or after the Subscription Date, as long as the <U>Series B Preferred Stock</U> is outstanding,
the Company issues or sells, or in accordance with this Section 6 (j) is deemed to have issued or sold, any Common Stock (including the
issuance or sale of Common Stock owned or held by or for the account of the Company, but excluding Common Stock deemed to have been issued
or sold by the Company in connection with any Excluded Securities) for a consideration per share (the &#8220;<U>New Issuance Price</U>&#8221;)
less than a price (the &#8220;<U>Applicable Price</U>&#8221;) equal to the Conversion Price in effect immediately prior to such issue
or sale or deemed issuance or sale (the foregoing a &#8220;<U>Dilutive Issuance</U>&#8221;), then immediately after such Dilutive Issuance,
the Conversion Price then in effect shall be reduced to an amount equal to the New Issuance Price; provided that if the New Issuance Price
is less than the Floor Price, the New Issuance Price shall be deemed to be the Floor Price (such adjusted price, the &#8220;<U>Base Share
Price</U>&#8221;) and the number of shares of Common Stock issuable upon conversion of the <U>Series B Convertible Stock</U> shall be
proportionately adjusted such that the aggregate Conversion Price of the <U>Series B Preferred Stock</U> on the Issuance Date for the
Warrant Shares then outstanding shall remain unchanged. For the avoidance of doubt, (x) for the purposes of this Section 6(j), pre-funded
warrants to purchase Common Stock shall be treated as Common Stock with the aggregate consideration received or receivable by the Company
upon the issuance and the exercise of such pre-funded warrants deemed the consideration per share and (y) if any sale or issuance, or
deemed issuance, if determined to be for a consideration per share less than the par value of a share of Common Stock, the New Issuance
Price shall be deemed to equal the par value of a share of Common Stock. For purposes of determining the adjusted Conversion Price under
this Section 6(j), the following shall be applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Issuance of </U>Options.
If the Company in any manner grants or sells any Options and the lowest price per share for which one share of Common Stock is issuable
upon the exercise of any such Option or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of
any such Option is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and to have been
issued and sold by the Company at the time of the granting or sale of such Option for such price per share. For purposes of this Section
6(j) (i), the &#8220;lowest price per share for which one share of Common Stock is issuable upon the exercise of any such Option or upon
conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option&#8221; shall be equal to the
sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to any one share of Common Stock
upon the granting or sale of the Option, upon exercise of the Option and upon conversion, exercise or exchange of any Convertible Security
issuable upon exercise of such Option less any consideration paid or payable by the Company with respect to one share of Common Stock
upon the granting or sale of such Option, upon exercise of such Option and upon conversion, exercise or exchange of any Convertible Security
issuable upon exercise of such Option. No further adjustment of the Conversion Price shall be made upon the actual issuance of such Common
Stock or of such Convertible Securities upon the exercise of such Options or upon the actual issuance of such Common Stock upon conversion,
exercise or exchange of such Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.85pt 0pt 116pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.85pt 0pt 116pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) <U>Issuance of Convertible
Securities</U>. If the Company in any manner issues or sells any Convertible Securities and the lowest price per share for which one share
of Common Stock is issuable upon the conversion, exercise or exchange thereof is less than the Applicable Price, then such share of Common
Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale of such Convertible
Securities for such price per share. For the purposes of this Section 6(j)(ii), the &#8220;lowest price per share for which one share
of Common Stock is issuable upon the conversion, exercise or exchange thereof&#8221; shall be equal to the sum of the lowest amounts of
consideration (if any) received or receivable by the Company with respect to any one share of Common Stock upon the issuance or sale of
the Convertible Security and upon conversion, exercise or exchange of such Convertible Security less any consideration paid or payable
by the Company with respect to such one share of Common Stock upon the issuance or sale of such Convertible Security and upon conversion,
exercise or exchange of such Convertible Security. No further adjustment of the Exercise Price shall be made upon the actual issuance
of such Common Stock upon conversion, exercise or exchange of such Convertible Securities, and if any such issue or sale of such Convertible
Securities is made upon exercise of any Options for which adjustment of the <U>Series B Convertible Preferred Stock</U> has been or is
to be made pursuant to other provisions of this Section 6(j), no further adjustment of the Conversion Price shall be made by reason of
such issue or sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.85pt 0pt 116pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii) <U>Change in Option Price
or Rate of Conversion.</U> If the purchase price provided for in any Options, the additional consideration, if any, payable upon the issue,
conversion, exercise or exchange of any Convertible Securities, or the rate at which any Convertible Securities are convertible into or
exercisable or exchangeable for Common Stock increases or decreases at any time, the Conversion Price in effect at the time of such increase
or decrease shall be adjusted to the Conversion Price, which would have been in effect at such time had such Options or Convertible Securities
provided for such increased or decreased purchase price, additional consideration or increased or decreased conversion rate, as the case
may be, at the time initially granted, issued or sold. For purposes of this Section 6(j)(iii), if the terms of any Option or Convertible
Security that was outstanding as of the Issue Date are increased or decreased in the manner described in the immediately preceding sentence,
then such Option or Convertible Security and the Common Stock deemed issuable upon exercise, conversion or exchange thereof shall be deemed
to have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section 6(j) shall be made if such adjustment
would result in an increase of the Conversion Price then in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.8pt 0pt 80pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iv) Calculation of Consideration
Received. In case any Option is issued in connection with the issue or sale of other securities of the Company, together comprising one
integrated transaction, (x) the Options will be deemed to have been issued for the Option Value of the Options and (y) the other securities
issued or sold in such integrated transaction shall be deemed to have been issued or sold for the difference of (I) the aggregate consideration
received by the Company less any consideration paid or payable by the Company pursuant to the terms of such other securities of the Company,
less (II) the Option Value of such Options. If any Common Stock, Options or Convertible Securities are issued or sold or deemed to have
been issued or sold for cash, the consideration other than cash received therefore will be deemed to be the net amount received by the
Company therefor. If any Common Stock, Options or Convertible Securities are issued or sold for a consideration other than cash, the amount
of such consideration received by the Company will be the fair value of such
consideration, except where such consideration consists of publicly traded securities, in which case the amount of consideration received
by the Company will be the Closing Sale Price of such publicly traded securities on the date of receipt of such publicly traded securities.
If any Common Stock, Options or Convertible Securities are issued to the owners of the non-surviving entity in connection with any merger
in which the Company is the surviving entity, the amount of consideration therefor will be deemed to be the fair value of such portion
of the net assets and business of the non-surviving entity as is attributable to such Common Stock, Options or Convertible Securities,
as the case may be. The fair value of any consideration other than cash or publicly traded securities will be determined jointly by the
Company and the holders of a majority of the Warrant Shares underlying the Warrants at such time of determination. If such parties are
unable to reach agreement within ten (10) days after the occurrence of an event requiring valuation (the &#8220;Valuation Event&#8221;),
the fair value of such consideration will be determined within five (5) Business Days after the tenth (10<SUP>th</SUP>) day following
the Valuation Event by an independent, reputable appraiser jointly selected by the Company and the holders of a majority of the Warrant
Shares underlying the Warrants at such time of determination. The determination of such appraiser shall be final and binding upon all
parties absent manifest error and the fees and expenses of such appraiser shall be borne by the Company. Notwithstanding anything to the
contrary contained herein, if a calculation pursuant to this Section 6(j) (iv) would result in an Conversion Price that is lower than
the par value of the Common Stock, then the Conversion Price shall be deemed to equal the par value of the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.8pt 0pt 117pt; text-align: justify; text-indent: -1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v) <U>Record Date</U>. If the
Company takes a record of the holders of Common Stock for the purpose of entitling them (A) to receive a dividend or other distribution
payable in Common Stock, Options or in Convertible Securities or (B) to subscribe for or purchase Common Stock, Options or Convertible
Securities, then such record date will be deemed to be the date of the issue or sale of the Common Stock deemed to have been issued or
sold upon the declaration of such dividend or the making of such other distribution or the date of the granting of such right of subscription
or purchase, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(vi) <U>No Readjustment</U>.
For the avoidance of doubt, in the event that following the consummation of a Dilutive Issuance and the Conversion Price has been adjusted
pursuant to this Section 6(j) and the Dilutive Issuance that triggered such adjustment is unwound, cancelled or expires after the fact
for any reason, the Conversion Price will not be readjusted to the Conversion Price that would have been in effect if such Dilutive Issuance
had not occurred or been consummated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 7. <U>Reacquired Shares</U>.
Any shares of Series B Preferred Stock purchased or otherwise acquired by the Corporation in any manner whatsoever shall be retired and
cancelled promptly after the acquisition thereof. All such shares shall upon their cancellation become authorized but unissued shares
of Preferred Stock and may be reissued as part of a new series of preferred stock to be created by resolution or resolutions of the Board
of Directors, subject to the conditions and restrictions on issuance set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECOND: That such determination
of the designation, rights, preferences and limitations relating to the Series B Preferred Stock, was duly made by the Board of Directors
pursuant to the provisions of the Certificate of the Incorporation, and in accordance with Section 151 of Title 8 of the Delaware General
Corporation Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Corporation
has caused this Designation to be duly executed to be effective July 25, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">Brag House Holdings, Inc., a Delaware corporation</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 60%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; width: 37%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap"><I>/s/ Lavell Juan Malloy II</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lavell Juan Malloy II</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">President and Chief Executive Officer</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp; </P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>ea025072601ex4-1_brag.htm
<DESCRIPTION>COMMON STOCK PURCHASE WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: -72.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BRAG
HOUSE HOLDINGS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares:</FONT></TD>
    <TD STYLE="text-align: right; width: 50%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: July 30, 2025</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
Exercise Date: July 30, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date set forth herein (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on July
30, 2030 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Brag House Holdings, Inc.,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to _________ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant
Shares</U>&rdquo;) of the Company&rsquo;s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal
to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated July 24, 2025, among the Company and the purchasers
signatory thereto and that certain Registration Rights Agreement dated July 24, 2025, among the Company and the purchasers signatory
thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company which would entitle the holder thereof to acquire at any time Common
Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible
into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Convertible
Securities</U>&rdquo; means any stock or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable
for Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Excluded
Securities</U>&rdquo; means (a) shares of Common Stock or options to employees, officers or directors of the Company pursuant to any
stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority
of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities
upon the exercise or exchange of or conversion of any Securities issued hereunder, warrants to the Placement Agent in connection with
the transactions pursuant to this Agreement and/or other securities exercisable or exchangeable for or convertible into shares of Common
Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended since the date of this
Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities
(other than in connection with stock splits or combinations) or to extend the term of such securities, and (c) securities issued pursuant
to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, provided that such securities
are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the
filing of any registration statement in connection therewith, and provided that any such issuance shall only be to a Person (or to the
equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic
with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall
not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose
primary business is investing in securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Floor
Price</U>&rdquo; means $0.471 per share (subject to adjustment for reverse and forward stock splits, recapitalizations and similar transactions
following the date of the Purchase Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Options</U>&rdquo;
means any rights, warrants or options to subscribe for or purchase (i) Common Stock or (ii) Convertible Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Option
Value</U>&rdquo; means the value of an Option based on the Black and Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo;
function on Bloomberg determined as of (A) the Trading Day prior to the public announcement of the issuance of the applicable Option,
if the issuance of such Option is publicly announced or (B) the Trading Day immediately following the issuance of the applicable Option
if the issuance of such Option is not publicly announced, for pricing purposes and reflecting (i) a risk-free interest rate corresponding
to the U.S. Treasury rate for a period equal to the remaining term of the applicable Option as of the applicable date of determination,
(ii) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg as of
(A) the Trading Day immediately following the public announcement of the applicable Option if the issuance of such Option is publicly
announced or (B) the Trading Day immediately following the issuance of the applicable Option if the issuance of such Option is not publicly
announced, (iii) the underlying price per share used in such calculation shall be the highest VWAP of the Common Stock during the period
beginning on the Trading Day prior to the execution of definitive documentation relating to the issuance of the applicable Option and
ending on (A) the Trading Day immediately following the public announcement of such issuance, if the issuance of such Option is publicly
announced or (B) the Trading Day immediately following the issuance of the applicable Option if the issuance of such Option is not publicly
announced, (iv) a zero cost of borrow and (v) a 360 day annualization factor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Date</U>&rdquo; means the date of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank
unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink- original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable, but
in no event later than three (3) Trading Days, following the date on which the final Notice of Exercise is delivered to the Company.
Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall
have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number
of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the
date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such
notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this
paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder
at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $0.817, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Cashless
Exercise</U>. The Company will use its best efforts to maintain an effective registration statement after the Effectiveness Date of the
Initial Registration Statement. If, after the six month anniversary of the Issue Date, at the time of exercise hereof there is no effective
registration statement registering, or the prospectus contained therein is not available for the resale of the Warrant Shares by the
Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which
the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
= as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and
delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in
Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the VWAP on the Trading Day
immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading
hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular
trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise
if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section
2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
= the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant
Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this
Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 1in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such
system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the
Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of- sale limitations
pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in
the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is
entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest
of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the
aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery
to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice
of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect
to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date. The Company agrees to
maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used
herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days,
on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of
Exercise.</FONT></P>

<P STYLE="margin-left: 1in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 1in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></P>

<P STYLE="margin-left: 1in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 1in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="margin-left: 1in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 1in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy- In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="margin-left: 1in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 1in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="margin-left: 1in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 1in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="margin-left: 1in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 1in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of
this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete
exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership
Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the
time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder
has exercised this Warrant.</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person (excluding mergers effected solely to change the Company&rsquo;s
name), (ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment,
transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii)
any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant
to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has
been accepted by the holders of more than 50% of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more
related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange
pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company,
directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination
(including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or
group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any
shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons
making or party to, such stock or share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have
been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section 2(e) on the exercise of this Warrant) and to the extent it is within the Company&rsquo;s control
to cause the successor or acquiring corporation to deliver to the Holder the foregoing, the number of shares of Common Stock of the successor
or acquiring corporation or of the Company, if it is the surviving corporation. The Company shall cause any successor entity in a Fundamental
Transaction that is within the Company&rsquo;s control and in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with
the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved
by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the
Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form
and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or
its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to
any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity),
and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the
other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Adjustment
Upon Issuance of Common Stock</U>. If and whenever on or after the Subscription Date, as long as this Warrant is outstanding, the Company
issues or sells, or in accordance with this Section 3 is deemed to have issued or sold, any Common Stock (including the issuance or sale
of Common Stock owned or held by or for the account of the Company, but excluding Common Stock deemed to have been issued or sold by
the Company in connection with any Excluded Securities) for a consideration per share (the &ldquo;<U>New Issuance Price</U>&rdquo;) less
than a price (the &ldquo;<U>Applicable Price</U>&rdquo;) equal to the Exercise Price in effect immediately prior to such issue or sale
or deemed issuance or sale (the foregoing a &ldquo;<U>Dilutive Issuance</U>&rdquo;), then immediately after such Dilutive Issuance, the
Exercise Price then in effect shall be reduced to an amount equal to the New Issuance Price; provided that if the New Issuance Price
is less than the Floor Price, the New Issuance Price shall be deemed to be the Floor Price (such adjusted price, the &ldquo;<U>Base Share
Price</U>&rdquo;) and the number of shares of Common Stock issuable upon exercise of this Warrant shall be proportionately adjusted such
that the aggregate Exercise Price of this Warrant on the Issuance Date for the Warrant Shares then outstanding shall remain unchanged.
For the avoidance of doubt, (x) for the purposes of this Section 3(e), pre-funded warrants to purchase Common Stock shall be treated
as Common Stock with the aggregate consideration received or receivable by the Company upon the issuance and the exercise of such pre-funded
warrants deemed the consideration per share and (y) if any sale or issuance, or deemed issuance, if determined to be for a consideration
per share less than the par value of a share of Common Stock, the New Issuance Price shall be deemed to equal the par value of a share
of Common Stock. For purposes of determining the adjusted Exercise Price under this Section 3(e), the following shall be applicable:</FONT>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Issuance of Options</U>. If the Company in any manner grants or sells any Options and the lowest price per share for which one share
of Common Stock is issuable upon the exercise of any such Option or upon conversion, exercise or exchange of any Convertible Securities
issuable upon exercise of any such Option is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding
and to have been issued and sold by the Company at the time of the granting or sale of such Option for such price per share. For purposes
of this Section 3(e)(i), the &ldquo;lowest price per share for which one share of Common Stock is issuable upon the exercise of any such
Option or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option&rdquo; shall
be equal to the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to any one share
of Common Stock upon the granting or sale of the Option, upon exercise of the Option and upon conversion, exercise or exchange of any
Convertible Security issuable upon exercise of such Option less any consideration paid or payable by the Company with respect to one
share of Common Stock upon the granting or sale of such Option, upon exercise of such Option and upon conversion, exercise or exchange
of any Convertible Security issuable upon exercise of such Option. No further adjustment of the Exercise Price shall be made upon the
actual issuance of such Common Stock or of such Convertible Securities upon the exercise of such Options or upon the actual issuance
of such Common Stock upon conversion, exercise or exchange of such Convertible Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Issuance of Convertible Securities</U>. If the Company in any manner issues or sells any Convertible Securities and the lowest price
per share for which one share of Common Stock is issuable upon the conversion, exercise or exchange thereof is less than the Applicable
Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time
of the issuance or sale of such Convertible Securities for such price per share. For the purposes of this Section 3(e)(ii), the &ldquo;lowest
price per share for which one share of Common Stock is issuable upon the conversion, exercise or exchange thereof&rdquo; shall be equal
to the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to any one share of Common
Stock upon the issuance or sale of the Convertible Security and upon conversion, exercise or exchange of such Convertible Security less
any consideration paid or payable by the Company with respect to such one share of Common Stock upon the issuance or sale of such Convertible
Security and upon conversion, exercise or exchange of such Convertible Security. No further adjustment of the Exercise Price shall be
made upon the actual issuance of such Common Stock upon conversion, exercise or exchange of such Convertible Securities, and if any such
issue or sale of such Convertible Securities is made upon exercise of any Options for which adjustment of this Warrant has been or is
to be made pursuant to other provisions of this Section 3(e), no further adjustment of the Exercise Price shall be made by reason of
such issue or sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<U>Change in Option Price or Rate of Conversion.</U> If the purchase price provided for in any Options, the additional consideration,
if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which any Convertible
Securities are convertible into or exercisable or exchangeable for Common Stock increases or decreases at any time, the Exercise Price
in effect at the time of such increase or decrease shall be adjusted to the Exercise Price, which would have been in effect at such time
had such Options or Convertible Securities provided for such increased or decreased purchase price, additional consideration or increased
or decreased conversion rate, as the case may be, at the time initially granted, issued or sold. For purposes of this Section 3(e)(iii),
if the terms of any Option or Convertible Security that was outstanding as of the Issue Date are increased or decreased in the manner
described in the immediately preceding sentence, then such Option or Convertible Security and the Common Stock deemed issuable upon exercise,
conversion or exchange thereof shall be deemed to have been issued as of the date of such increase or decrease. No adjustment pursuant
to this Section 3(e) shall be made if such adjustment would result in an increase of the Exercise Price then in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Calculation of Consideration Received. In case any Option is issued in connection with the issue or sale of other securities of the Company,
together comprising one integrated transaction, (x) the Options will be deemed to have been issued for the Option Value of the Options
and (y) the other securities issued or sold in such integrated transaction shall be deemed to have been issued or sold for the difference
of (I) the aggregate consideration received by the Company less any consideration paid or payable by the Company pursuant to the terms
of such other securities of the Company, less (II) the Option Value of such Options. If any Common Stock, Options or Convertible Securities
are issued or sold or deemed to have been issued or sold for cash, the consideration other than cash received therefore will be deemed
to be the net amount received by the Company therefor. If any Common Stock, Options or Convertible Securities are issued or sold for
a consideration other than cash, the amount of such consideration received by the Company will be the fair value of such consideration,
except where such consideration consists of publicly traded securities, in which case the amount of consideration received by the Company
will be the Closing Sale Price of such publicly traded securities on the date of receipt of such publicly traded securities. If any Common
Stock, Options or Convertible Securities are issued to the owners of the non-surviving entity in connection with any merger in which
the Company is the surviving entity, the amount of consideration therefor will be deemed to be the fair value of such portion of the
net assets and business of the non-surviving entity as is attributable to such Common Stock, Options or Convertible Securities, as the
case may be. The fair value of any consideration other than cash or publicly traded securities will be determined jointly by the Company
and the holders of a majority of the Warrant Shares underlying the Warrants at such time of determination. If such parties are unable
to reach agreement within ten (10) days after the occurrence of an event requiring valuation (the &ldquo;Valuation Event&rdquo;), the
fair value of such consideration will be determined within five (5) Business Days after the tenth (10<SUP>th</SUP>) day following the
Valuation Event by an independent, reputable appraiser jointly selected by the Company and the holders of a majority of the Warrant Shares
underlying the Warrants at such time of determination. The determination of such appraiser shall be final and binding upon all parties
absent manifest error and the fees and expenses of such appraiser shall be borne by the Company. Notwithstanding anything to the contrary
contained herein, if a calculation pursuant to this Section 3(e)(iv) would result in an Exercise Price that is lower than the par value
of the Common Stock, then the Exercise Price shall be deemed to equal the par value of the Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Record Date</U>. If the Company takes a record of the holders of Common Stock for the purpose of entitling them (A) to receive a dividend
or other distribution payable in Common Stock, Options or in Convertible Securities or (B) to subscribe for or purchase Common Stock,
Options or Convertible Securities, then such record date will be deemed to be the date of the issue or sale of the Common Stock deemed
to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting
of such right of subscription or purchase, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
<U>No Readjustment</U>. For the avoidance of doubt, in the event that following the consummation of a Dilutive Issuance and the Exercise
Price has been adjusted pursuant to this Section 3(e) and the Dilutive Issuance that triggered such adjustment is unwound, cancelled
or expires after the fact for any reason, the Exercise Price will not be readjusted to the Exercise Price that would have been in effect
if such Dilutive Issuance had not occurred or been consummated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of
the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property,
or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company,
then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall appear upon
the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified,
a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or
warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend,
distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger,
sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the
Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice
or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such
notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non- public information regarding
the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Voluntary
Adjustment by Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights)
are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent,
together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent
or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required,
such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting the rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise,&rdquo; and to
receive the cash payments contemplated pursuant to Sections 2(d)(i) and 2(d)(iv), in no event will the Company be required to net cash
settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt
by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate
relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which,
in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock
certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation,
in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-indent: 0.5in; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-indent: 0.5in; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except and to the extent as waived or consented
to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through
any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist
in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights
of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not
increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase
in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully
paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such
authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the
Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that the right
to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the Purchase Agreement,
if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the
Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited
to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due
pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered
in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder of this Warrant, on the other hand.</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BRAG HOUSE HOLDINGS, INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Lavell Juan Malloy, II</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lavell Juan Malloy, II</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BRAG
HOUSE HOLDINGS, INC.</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase Warrant Shares of the Company</FONT> pursuant to the terms of the attached Warrant (only if
exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box): [ ] in lawful</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">money
of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; margin-left: 1.5in; text-indent: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744; if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the
formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant
to the cashless exercise procedure set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 1.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 1.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">____________________________<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 1.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 1.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 1.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">____________________________<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 1.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 1.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 1.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">____________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4) <U>Accredited
Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act
of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>:</FONT> _____________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory:</FONT> _______________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of Authorized
Signatory:</FONT> ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT> ___________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)</I></FONT></P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR VALUE RECEIVED, the foregoing Warrant
and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Email Address:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: ___________________, </FONT>_____________</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:
    </FONT>____________________________</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:
    </FONT>_____________________________</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ea025072601ex10-1_brag.htm
<DESCRIPTION>SECURITIES PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of July 24, 2025, between Brag House Holdings, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo;
and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;), and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally
and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE I.<BR>
DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1 <U>Definitions</U>.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings
set forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Certificate
of Designation</U>&rdquo; means the certificate of designation of the Series B Convertible Preferred Stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
Counsel</U>&rdquo; means Lucosky Brookman LLP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof,
unless otherwise instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effective
Date</U>&rdquo; means the earliest of the date that (a) the initial Registration Statement registering for resale all Shares and Warrant
Shares has been declared effective by the Commission, (b) all of the Shares and Warrant Shares have been sold pursuant to Rule 144 or
may be sold pursuant to Rule 144 without the requirement for the Company to be in compliance with the current public information required
under Rule 144 and without volume or manner-of-sale restrictions, (c) following the one year anniversary of the Closing Date provided
that a holder of Shares or Warrant Shares is not an Affiliate of the Company, or (d) all of the Shares and Warrant Shares may be sold
pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act without volume or manner-of-sale restrictions and
Company Counsel has delivered to such holders a standing written unqualified opinion that resales may then be made by such holders of
the Shares and Warrant Shares pursuant to such exemption which opinion shall be in form and substance reasonably acceptable to such holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Escrow
Agent</U>&rdquo; means Continental Stock Transfer &amp; Trust Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Escrow
Agreement</U>&rdquo; means the escrow agreement entered into, by and among the Company, the Escrow Agent and the Placement Agent pursuant
to which the Purchasers shall deposit Subscription Amounts with the Escrow Agent to be applied to the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(bb).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legend
Removal Date</U>&rdquo; shall have the meaning ascribed to such term in Section 4.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share
Purchase Price</U>&rdquo; equals $0.942, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Series B&nbsp;Preferred Stock or the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agent</U>&rdquo; means Revere Securities LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public
Information Failure</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public
Information Failure Payments</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Rights Agreement</U>&rdquo; means the Registration Rights Agreement, dated on or about the date hereof, among the Company and the Purchasers,
in the form of <U>Exhibit A</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering
the resale by the Purchasers of the Shares and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Series
B&nbsp;Preferred Stock</U>&rdquo; means the Series B convertible preferred stock of the Company, par value $0.0001 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Series B&nbsp;Preferred Stock issued or issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified
below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in
United States dollars and in immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth in the SEC Reports and shall, where applicable, also include any direct or indirect subsidiary
of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, the OTCQB, OTCQX, Pink Open Market (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants, the Certificate of Designation, the Registration Rights Agreement, and all exhibits
and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means VStock Transfer, LLC, the current transfer agent of the Company, with a mailing address of 18 Lafayette Pl, #2Woodmere,
NY 11598, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof, which such
Common Warrants shall be exercisable immediately upon issuance and have a term equal to five and one-half (5.5) years, in the form of
<U>Exhibit B-2</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE II.</B><BR>
<B>PURCHASE AND SALE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1 <U>Closing</U>.
On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery
of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase,
up to an aggregate of approximately $15 million of Shares and Warrants Each Purchaser shall deliver to the Escrow Agent, via wire transfer,
immediately available funds equal to such Purchaser&rsquo;s Subscription Amount as set forth on the signature page hereto executed by
such Purchaser, and the Company shall deliver to each Purchaser its respective Shares and Warrants, as determined pursuant to Section
2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction
of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of the Placement Agent or such
other location as the parties shall mutually agree. For purposes hereof, beneficial ownership shall be calculated in accordance with Section
13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Purchaser that the Company
is not representing to the Purchaser that such calculation is in compliance with Section 13(d) of the Exchange Act and the Purchaser is
solely responsible for any schedules required to be filed in accordance therewith. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes hereof, in determining the number of outstanding shares of Common Stock, a Purchaser may rely on the number of
outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission,
as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer
Agent setting forth the number of shares of Common Stock outstanding. In any case, the number of outstanding shares of Common Stock shall
be determined after giving effect to the conversion or exercise of securities of the Company, including the Warrants, by the Purchaser
or its Affiliates or Attribution Parties (as defined below) since the date as of which such number of outstanding shares of Common Stock
was reported. Notwithstanding anything to the contrary herein and the Purchaser&rsquo;s Subscription Amount set forth on the signature
pages attached hereto, the number of Shares purchased by a Purchaser (and such Purchaser&rsquo;s Affiliates, and any other Persons acting
as a group together with the Purchaser or any of the Purchaser&rsquo;s Affiliates (such Persons, &ldquo;Attribution Parties&rdquo;)) hereunder
shall not, when aggregated with all other shares of Common Stock beneficially owned by such Purchaser (and its Affiliates and Attribution
Parties) at such time, result in such Purchaser (and its Affiliates and Attribution Parties) beneficially owning (as determined in accordance
with Section 13(d) of the Exchange Act) in excess of the Beneficial Ownership Limitation, and such Purchaser&rsquo;s Subscription Amount,
to the extent it would otherwise exceed the Beneficial Ownership Limitation immediately prior to the Closing, shall be conditioned upon
the issuance of Shares at the Closing to the other Purchasers signatory hereto. To the extent that a Purchaser&rsquo;s beneficial ownership
of the Shares would otherwise be deemed to exceed the Beneficial Ownership Limitation, such Purchasers&rsquo; Subscription Amount shall
automatically be reduced as necessary in order to comply with this paragraph. The &ldquo;Beneficial Ownership Limitation&rdquo; shall
be 4.99% (or at the election of Purchaser, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect
to the issuance of the Securities on the Closing Date, including shares of Common Stock issuable upon exercise of the Warrants, provided
that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of such Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2.2 <U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) On
or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) this
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) a
legal opinion of Company Counsel, in a form reasonably acceptable to the Placement Agent and Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) a
copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis, a certificate
evidencing a number of Shares equal to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price, registered
in the name of such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv) [Reserved];</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v) a
Common Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 100% of the initial
number of such Purchaser&rsquo;s Conversion Shares, with an exercise price equal to $0.817, subject to adjustment therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vi) [Reserved];
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vii) the
Registration Rights Agreement duly executed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b) On or
prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company or the Escrow Agent, as applicable, the
following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) to
the Company, this Agreement duly executed by such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) to
the Escrow Agent, such Purchaser&rsquo;s Subscription Amount by wire transfer to the account specified in the Escrow Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) to
the Company, the Registration Rights Agreement duly executed by such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2.3 <U>Closing
Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific
date therein in which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified
by materiality, in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) the
delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of
a specific date therein in which case they shall be accurate in all material respects or, to the extent representations or warranties
are qualified by materiality or Material Adverse Effect, in all respects as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) the
delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv) there
shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v) from
the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude
in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Securities at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE III.<BR>
REPRESENTATIONS AND WARRANTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1 <U>Representations
and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part
hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section
of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) <U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company are set forth in <U>Schedule 3.1(a)</U>. The Company owns, directly or indirectly,
all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding
shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights
to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in
the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) <U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to
own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in
violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected
to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse
effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries,
taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis
its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;); provided,
however, that &ldquo;<U>Material Adverse Effect</U>&rdquo; shall not include any event, occurrence, fact, condition or change, directly
or indirectly, arising out of or attributable to: (i) the announcement, pendency or completion of the transactions contemplated by the
Transaction Documents, or (ii) any action required or permitted by the Transaction Documents or any action taken (or omitted to be taken)
with the written consent of or at the written request of Purchaser). As to all Company and Subsidiary power, authority and qualification,
no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such
power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) <U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith other
than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or
upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute
the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by
general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting
enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive
relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) <U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it
is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do
not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with
notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets
of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration
or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing
a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property
or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in
a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority
to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property
or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not
have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) <U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection
with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant
to Section 4.4 of this Agreement, (ii) the filing with the Commission pursuant to the Registration Rights Agreement, (iii) the notice
and/or application(s) to each applicable Trading Market for the issuance and sale of the Securities and the listing of the Shares and
Warrant Shares for trading thereon in the time and manner required thereby,(iv) the filing of Form D with the Commission and such filings
as are required to be made under applicable state securities laws and (vi) the filing of the Certificate of Designation with the Secretary
of State in the state of Delaware to designate the shares of Series B Preferred Stock (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f) <U>Issuance
of the Securities</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction
Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than
restrictions on transfer provided for in the Transaction Documents. The Warrant Shares, when issued in accordance with the terms of the
Transaction Documents, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other
than restrictions on transfer provided for in the Transaction Documents. The Company has reserved from its duly authorized capital stock
the maximum number of shares of Common Stock issuable pursuant to this Agreement, the Series B Preferred Stock and the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g) <U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)(i)</U>, which <U>Schedule 3.1(g)(i)</U>
shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date
hereof. The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than
pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans, the issuance of shares of Common Stock
to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock
Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first
refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction
Documents. Except as set forth in <U>Schedule 3.1(g)(ii)</U> or as a result of the purchase and sale of the Securities, there are no outstanding
options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or
obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares
of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company
or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any
Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or
other securities to any Person (other than the Purchasers). There are no outstanding securities or instruments of the Company or any Subsidiary
with any provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities
by the Company or any Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any
redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any
Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation
rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock
of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and
state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe
for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for
the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect
to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the
Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h) <U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two
years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing
materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the
&ldquo;<U>SEC Reports</U>&rdquo;). As of their respective dates, the SEC Reports complied in all material respects with the requirements
of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of
a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. The Company has never been an issuer subject to Rule 144(i)
under the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable
accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such
financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent
basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial statements or the
notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all
material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results
of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end
audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) <U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports, except as set forth on <U>Schedule 3.1(i)</U>, (i) there has been no event, occurrence or development that has had or
that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent
or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice
and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings
made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant
to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment
of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth on <U>Schedule 3.1(i)</U>, no
event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with
respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition
that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed
made that has not been publicly disclosed at least one (1) Trading Day prior to the date that this representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j) <U>Litigation</U>.
Except as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending
or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(each, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on <U>Schedule 3.1(j)</U> (i) adversely affects or challenges the
legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director
or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities
laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated,
any investigation by the Commission involving the Company or any current or former director or officer of the Company, except for routine
examinations or investigations conducted by the Commission in the ordinary course of business that would not have a Material Adverse Effect.
The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company
or any Subsidiary under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k) <U>Labor
Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company,
which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees
is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company
nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships
with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary is, or is now expected
to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement
or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued
employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any
of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and
regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the
failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l) <U>Compliance</U>.
Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived
that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or
any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement
or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default
or violation has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator or other governmental authority
or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality
and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)&#9;<U>Environmental
Laws</U>.&#9;The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution
or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata),
including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or
hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to
the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as
all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits,
plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have received
all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and
(iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii),
the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n) <U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except
where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification
of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o) <U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good
and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each
case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere
with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal,
state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and the payment of which is neither
delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by
them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(p) <U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to
so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither
the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired,
terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement.
Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC
Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the
rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the
Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual
Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and
value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(q) <U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited
to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company nor any Subsidiary
has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(r) <U>Transactions
with Affiliates and Employees</U>. Except as set forth on <U>Schedule 3.1(r)</U>, during the past three fiscal years and the subsequent
interim period through the date of this Agreement, none of the officers or directors of the Company or any Subsidiary and, to the knowledge
of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any
Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing
for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of
money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge
of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director,
trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for
services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock
option agreements under any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(s) <U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance in all material respects with any and all applicable
requirements of the Sarbanes-Oxley Act of 2002, as amended, that are effective as of the date hereof, and any and all applicable rules
and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. Except as
set forth in the SEC Reports, the Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide
reasonable assurance that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations, (ii)
transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability,
(iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to
any differences. Except as set forth in the SEC Reports, the Company and the Subsidiaries have established disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls
and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange
Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The
Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the
Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation
Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying
officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since
the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange
Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control
over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(t) <U>Certain
Fees</U>. Except for the fees and expenses of the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are or will be payable
by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other
Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect
to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may
be due in connection with the transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(u) <U>Private
Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no registration
under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby.
The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v) <U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be
or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company
shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the
Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(w) <U>Registration
Rights</U>. Other than to each of the Purchasers pursuant to the Registration Rights Agreement or as set forth in the SEC Reports, no
Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the
Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(x) <U>Listing
and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company
has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common
Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.
Except as set forth in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received notice from any Trading
Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing
or maintenance requirements of such Trading Market. Other than with regard to compliance with Nasdaq Listing Rule 5550(a)(2) (a minimum
bid price of at least $1 per share), the Company is, and has no reason to believe that it will not in the foreseeable future continue
to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer
through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to
the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(y) <U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state
of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations
or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s issuance of
the Securities and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(z) <U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information. The Company understands and confirms that the Purchasers
will rely on the foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by or
on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions
contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct and does not contain any untrue statement
of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances
under which they were made, not misleading. The press releases disseminated by the Company during the twelve (12) months preceding the
date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made
and when made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties
with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(aa)&#9;<U>No Integrated
Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither the Company,
nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security
or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with
prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of any such securities under
the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of the securities of the
Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(bb)&#9;<U>Solvency</U>.
Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company
of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds the amount
that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known contingent
liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its business as
now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the
business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current
cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into
account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts
are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account
the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances
which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction
within one year from the Closing Date. <U>Schedule 3.1(bb)</U> sets forth as of the date hereof all outstanding secured and unsecured
Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement,
&ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade
accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect
of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the
notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary
course of business; and (z) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in
accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(cc)&#9;<U>Tax Status</U>.
Except as set forth in <U>Schedule 3.1(cc)</U>, the Company and its Subsidiaries each (i) has made or filed all United States federal,
state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which
it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined
to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment
of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid
taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any
Subsidiary know of no basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(dd)&#9;<U>No General
Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities by any
form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and certain
other &ldquo;accredited investors&rdquo; within the meaning of Rule 501 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ee)&#9;<U>Foreign
Corrupt Practices.</U> Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other
person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts,
entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign
or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii)
failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the
Company is aware) which is in violation of law or (iv) violated in any material respect any provision of FCPA or any applicable anti-corruption
or anti-bribery laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ff)&#9;<U>Accountants</U>.
The Company&rsquo;s accounting firm is set forth in the SEC Reports. To the knowledge and belief of the Company, such accounting firm
(i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial
statements to be included in the Company&rsquo;s Annual Report for the fiscal year ended December 31, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(gg)&#9;<U>No Disagreements
with Accountants and Lawyers.</U> There are no disagreements of any kind presently existing, or reasonably anticipated by the Company
to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company is current
with respect to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any of its obligations
under any of the Transaction Documents. &#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(hh)&#9; <U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely
in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby.
The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their
respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely
incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions
contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) <FONT STYLE="text-decoration: underline solid">Acknowledgment
Regarding Purchaser&rsquo;s Trading Activity</FONT>.<FONT STYLE="text-decoration-style: double"> Anything in this Agreement or
elsewhere herein to the contrary notwithstanding (except for Sections 3.2(g) and 4.14 hereof), it is understood and acknowledged by
the Company that: (i) none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from
purchasing or selling, long and/or short, securities of the Company, or &ldquo;derivative&rdquo; securities based on securities
issued by the Company or to hold the Securities for any specified term, (ii) past or future open market or other transactions by any
Purchaser, specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo; transactions, before or after the
closing of this or future private placement transactions, may negatively impact the market price of the Company&rsquo;s
publicly-traded securities, (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to which any such
Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock and (iv) each
Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party in any
&ldquo;derivative&rdquo; transaction. </FONT>The Company further understands and acknowledges that (y) one or more Purchasers may
engage in hedging activities at various times during the period that the Securities are outstanding, including, without limitation,
during the periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z) such
hedging activities (if any) could reduce the value of the existing stockholders' equity interests in the Company at and after the
time that the hedging activities are being conducted.&nbsp; The Company acknowledges that such aforementioned hedging activities do
not constitute a breach of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(jj)&#9;<U>Regulation
M Compliance.</U>&nbsp; The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement
of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(kk)&#9;<U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ll)&#9;<U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(mm)&#9;<U>Stock
Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance with
the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common
Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company&rsquo;s
stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice
to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public
announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(nn)&#9;<U>Office
of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company's knowledge, any director, officer, agent, employee
or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(oo) <U>U.S.
Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning
of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(pp)&#9;<U>Bank
Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956,
as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal
Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent
(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank
or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or
Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to
regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(qq)&#9;<U>Money
Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable
financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable
money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or
any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(rr)&#9;<U>No Disqualification
Events</U>. &nbsp;With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities Act, none
of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating
in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity securities, calculated
on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company
in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and, together, &ldquo;<U>Issuer Covered Persons</U>&rdquo;)
is subject to any of the &quot;Bad Actor&quot; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a
&ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has
exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied,
to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy of any disclosures
provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ss)&#9;<U>Other
Covered Persons</U>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that
has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(tt)&#9;<U>Notice
of Disqualification Events</U>. The Company will notify the Purchasers and the Placement Agent in writing prior to the Closing Date of
(i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, reasonably
be expected to become a Disqualification Event relating to any Issuer Covered Person, in each case of which it is aware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2 <U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the
date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) <U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company
or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise
to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such
Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership,
limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a
party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except (i) as limited
by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) <U>Own
Account</U>. Such Purchaser understands that the Securities are &ldquo;restricted securities&rdquo; and have not been registered under
the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account and not with
a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state
securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state
securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution
of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting
such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable
federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) <U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which
it exercises any Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7)
or (a)(8) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo; as defined in Rule 144A(a) under the Securities
Act. Such Purchaser hereby represents that neither such Purchaser nor any of its Rule 506(d) Related Parties (as defined below) is a &ldquo;bad
actor&rdquo; within the meaning of Rule 506(d) promulgated under the Securities Act. For purposes of this Agreement, &ldquo;Rule 506(d)
Related Party&rdquo; shall mean a person or entity covered by the &ldquo;Bad Actor disqualification&rdquo; provision of Rule 506(d) of
the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) <U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) <U>General
Solicitation</U>. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication
regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any
seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f) <U>Access
to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed necessary
of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results
of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity
to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment.&nbsp; Such Purchaser acknowledges and agrees that neither the
Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the
Securities nor is such information or advice necessary or desired.&nbsp; Neither the Placement Agent nor any Affiliate has made or makes
any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public
information with respect to the Company which such Purchaser agrees need not be and has not been provided to it.&nbsp; In connection with
the issuance of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor
or fiduciary to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g) <U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has
any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or
sales, including Short Sales,&nbsp;of the securities of the Company during the period commencing as of the time that such Purchaser first
received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms
of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the
case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s
assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion of assets managed by
the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons
party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners,
legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made
to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for
the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect
to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Company acknowledges and
agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on
the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties contained in any
other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation
of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute
a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or
similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE IV.<BR>
OTHER AGREEMENTS OF THE PARTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1 <U>Transfer
Restrictions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) The
Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities
other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection
with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of
counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities
Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and the Registration
Rights Agreement and shall have the rights and obligations of a Purchaser under this Agreement and the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) The
Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in substantially
the following form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">[NEITHER] THIS SECURITY [NOR THE SECURITIES
INTO WHICH THIS SECURITY IS EXERCISABLE] [HAS BEEN] REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION
OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY [AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY] MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &ldquo;ACCREDITED
INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The Company acknowledges
and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant
a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo; as defined
in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured
Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal
opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall
be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable documentation
as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities, including,
if the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of any required
prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately
amend the list of Selling Stockholders (as defined in the Registration Rights Agreement) thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) Certificates
evidencing the Shares and Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof), (i) while
a registration statement (including the Registration Statement) covering the resale of such security is effective under the Securities
Act, (ii) following any sale of such Shares or Warrant Shares pursuant to Rule 144 and the Company is then in compliance with the current
public information required under Rule 144 (assuming cashless exercise of the Warrants), (iii) if such Shares or Warrant Shares are eligible
for sale under Rule 144 (assuming cashless exercise of the Warrants), without the requirement for the Company to be in compliance with
the current public information required under Rule 144 as to such Shares and/or Warrant Shares and without volume or manner-of-sale restrictions,
or (iv) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser
promptly after the Effective Date if required by the Transfer Agent to effect the removal of the legend hereunder, or if requested by
a Purchaser, respectively. If all or any portion of the Series B Preferred Stock in converted or a Warrant is exercised at a time when
there is an effective registration statement to cover the resale of the Warrant Shares, or if such s or Warrant Shares may be sold under
Rule 144 (assuming in the case of the Warrants, cashless exercise of the Warrants) or if such legend is not otherwise required under applicable
requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then
such Warrant Shares shall be issued free of all legends. The Company shall cause its counsel to issue a legal opinion to the Transfer
Agent promptly after the Effective Date if required by the Transfer Agent to effect the removal of the legend hereunder or if required
by a Purchaser. The Company agrees that following the Effective Date or at such time as such legend is no longer required under this Section
4.1(c), it will, no later than the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement
Period (as defined below) following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing Shares
or Warrant Shares, as the case may be, issued with a restrictive legend (such date, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver
or cause to be delivered to such Purchaser a certificate representing such shares that is free from all restrictive and other legends.
The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer
set forth in this Section 4. Certificates for Securities subject to legend removal hereunder shall be transmitted by the Transfer Agent
to the Purchaser by crediting the account of the Purchaser&rsquo;s prime broker with the Depository Trust Company System as directed by
such Purchaser. As used herein, &ldquo;Standard Settlement Period&rdquo; means the standard settlement period, expressed in a number of
Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of a
certificate representing Shares or Warrants Shares, as the case may be, issued with a restrictive legend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) In
addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated
damages and not as a penalty, for each $1,000 of Shares or Warrant Shares (based on the VWAP of the Common Stock on the date such Securities
are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day
(increasing to $20 per Trading Day five (5) Trading Days after the Legend Removal Date) for each Trading Day after the Legend Removal
Date until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to be delivered)
to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such Purchaser that
is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases (in an open market transaction
or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion of the number of shares
of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock that
such Purchaser anticipated receiving from the Company without any restrictive legend, then, an amount equal to the excess of such Purchaser&rsquo;s
total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased
(including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<B><U>Buy-In Price</U></B>&rdquo;) over the product
of (A) such number of Shares or Warrant Shares that the Company was required to deliver to such Purchaser by the Legend Removal Date multiplied
by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the date of the delivery by
such Purchaser to the Company of the applicable Shares or Warrant Shares (as the case may be) and ending on the date of such delivery
and payment under this clause (ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) Each
Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities pursuant
to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption
therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution
set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities as set forth
in this Section 4.1 is predicated upon the Company&rsquo;s reliance upon this understanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2 <U>Furnishing
of Information</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) Until
the earlier of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired, the Company covenants to maintain the
registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions in respect
thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to
the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3 <U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section
2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration
under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the Securities for purposes
of the rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other
transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4 <U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the
transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto,
with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company represents
to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the
Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents in connection with the transactions
contemplated by the Transaction Documents. In addition, effective upon the issuance of such press release, the Company acknowledges and
agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any
of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and any of the Purchasers
or any of their Affiliates on the other hand, shall terminate. The Company and each Purchaser shall consult with each other in issuing
any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any
such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release
of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall
not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly
provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall
not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory
agency or Trading Market, without the prior written consent of such Purchaser, except (a) as required by federal securities law in connection
with (i) any registration statement contemplated by the Registration Rights Agreement and (ii) the filing of final Transaction Documents
with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the Company
shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5 <U>Shareholder
Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser
is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6 <U>Non-Public
Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its
behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes,
material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information and agreed
with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be relying on the
foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company delivers any material, non-public
information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not
have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees
or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or
Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable
law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information
regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current
Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions
in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7 <U>Use
of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder for general corporate purposes and working
capital purposes and shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s debt (other than (i)
payment of trade payables in the ordinary course of the Company&rsquo;s business and prior practices and (ii) payment, in the ordinary
course of business, of amounts then currently due and payable on existing indebtedness owed to commercial banks), (b) for the redemption
of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC
regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8 <U>Indemnification
of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors,
officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning
of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners
or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such
title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any and all losses,
liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court
costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of
or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement
or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their
respective Affiliates, by the Company or any stockholder of the Company who is not an Affiliate of such Purchaser Party, arising out of
or relating to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach
of such Purchaser Party&rsquo;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings
such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws
or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct).
If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such
Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with
counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate
counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of
such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing,
(ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there
is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position
of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such
separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party
effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent,
but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations,
warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification
required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course of the investigation or defense,
as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action
or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9 <U>Reservation
of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all
times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares
pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10 <U>Listing
of Common Stock</U>. The Company hereby agrees to use its best efforts to maintain the listing or quotation of the Common Stock on the
Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the
Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Warrant Shares on such Trading
Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include
in such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of the Shares and
Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably
necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s
reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility
of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including,
without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection
with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11 <U>Equal
Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is
also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right
granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers
as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition
or voting of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12 <U>Reserved.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.13 <U>Reserved.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.14 <U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it,
nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales,
of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time that
the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section
4.4.&nbsp; Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated
by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser
will maintain the confidentiality of the existence and terms of this transaction and the information included in the Disclosure Schedules.&nbsp;
Notwithstanding the foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges
and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions
in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant
to the initial press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions
in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated
by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser
shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its Subsidiaries after
the issuance of the initial press release as described in Section 4.4.&nbsp; Notwithstanding the foregoing, in the case of a Purchaser
that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets
and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio
manager that made the investment decision to purchase the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.15 <U>Form
D; Blue Sky Filings</U>. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D and
to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under
applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall provide evidence of such actions promptly
upon request of any Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.16 <U>Reserved.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.17 <U>Acknowledgment
of Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares of Common
Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its obligations under
the Transaction Documents, including, without limitation, its obligation to issue the Shares and Warrant Shares pursuant to the Transaction
Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the
effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect that such issuance
may have on the ownership of the other stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE V.</B><BR>
<B>MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1 <U>Termination</U>.&nbsp;
This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated
on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>, that no such termination
will affect the right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2 <U>Fees
and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses
of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without
limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered
by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3 <U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties
with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect
to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4 <U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via email
attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a
Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email attachment
at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address
for such notices and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice provided
pursuant to any Transaction Document constitutes, or contains material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5 <U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in
the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares based on the initial
Subscription Amounts hereunder (or, prior to the Closing Date, the Company and each Purchaser) or, in the case of a waiver, by the party
against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately
and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers)
shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed
to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.
Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser
relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected
Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6 <U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7 <U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other
than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or
transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by
the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8 <U>No
Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations and warranties of the Company
in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of
the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be
enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9 <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action
or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section
4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10 <U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.11 <U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a &ldquo;.pdf&rdquo;
format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.12 <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.13 <U>Rescission
and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of
the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and
the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw,
in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part
without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission of an exercise
of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise notice
concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration
of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance of a replacement
warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.14 <U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of
and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of
such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.15 <U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby
agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would
be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.16 <U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser
enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part
thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required
to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without
limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration
the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such
payment had not been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.17 <U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and
not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For
reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through
the legal counsel to the Placement Agent. The legal counsel of the Placement Agent does not represent any of the Purchasers and only represents
the Placement Agent. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience
of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that
each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and
not between the Company and the Purchasers collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.18 <U>Liquidated
Damages</U>.&nbsp; The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.19&#9;<U>Saturdays, Sundays,
Holidays, etc.</U>&#9;If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.20 <U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and shares of <U>Series B&nbsp;Preferred</U> Stock or Common Stock in any Transaction Document shall be subject to adjustment
for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the <U>Series B&nbsp;Preferred</U>
Stock or Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.21 <B><U>WAIVER
OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES
EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>Brag House Holdings,
Inc.</B></FONT></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><U>Address for Notice:</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">By<FONT STYLE="text-decoration: none">: </FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; layout-grid-mode: line"><FONT STYLE="text-decoration: none"><I>/s/ Lavell Juan Malloy, II</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">45 Park Street</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line; width: 3%">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line; width: 5%">Name:</TD>
    <TD STYLE="layout-grid-mode: line; width: 32%">Lavell Juan Malloy, II</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line; width: 50%">Montclair, NJ 07042</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">Title:</TD>
    <TD STYLE="layout-grid-mode: line"> Chief Executive Officer</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: right; layout-grid-mode: line">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="layout-grid-mode: line">With a copy to (which shall not constitute notice):</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Daniel Leibovich</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">45 Park Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Montclair, NJ 07042</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">BRAG
HOUSE HOLDINGS, INC.</FONT> SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Purchaser: ____________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Purchaser</I>:
_____________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ___________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address of Authorized Signatory: ____________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Delivery of Securities to Purchaser (if not same as address
for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subscription Amount: $_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shares of Preferred Stock: __________________ Beneficial Ownership
Blocker &#9744; 4.99% or &#9744; 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Warrants: __________________ Beneficial Ownership Blocker &#9744;&nbsp;4.99% or
&#9744; 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">EIN Number: __________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 37; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>ea025072601ex10-2_brag.htm
<DESCRIPTION>PLACEMENT AGENCY AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">July 24, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lavell Juan Malloy, II</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Brag House Holdings, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">45 Park Street,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Montclair, NJ 07042</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>Re:</B></TD><TD STYLE="text-align: justify"><B><U>TBH | PIPE Offering | Placement Agent Agreement</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Mr. Malloy:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purpose of this Placement
Agent Agreement is to outline our agreement pursuant to which Revere Securities LLC (&ldquo;<B><U>Revere</U></B>&rdquo;) will act as the
placement agent on a &ldquo;best efforts&rdquo; basis in connection with the proposed PIPE Offering (the &ldquo;<B><U>Placement</U></B>&rdquo;)
by Brag House Holdings, Inc. (collectively, with its subsidiaries and affiliates, the &ldquo;<B><U>Company</U></B>&rdquo;) of its shares
of Series B Preferred Stock, par value $0.0001 per share (the &ldquo;<B><U>Preferred Stock</U></B>&rdquo;) having the rights, preferences,
and privileges set forth in the Certificate of Designation (as defined below) and convertible into shares of common stock, $0.0001 par
value per share of the Company (&ldquo;<B>Common Stock</B>&rdquo;) and warrants (&ldquo;<B><U>Warrants</U></B>&rdquo;) to purchase shares
of Common Stock (collectively, the &ldquo;<B><U>Securities</U></B>&rdquo;). This Placement Agent Agreement sets forth certain conditions
and assumptions upon which the Placement is premised. The Company expressly acknowledges and agrees that Revere&rsquo;s obligations hereunder
are on a reasonable &ldquo;best efforts&rdquo; basis only and that the execution of this Agreement does not constitute a commitment by
Revere to purchase the Securities and does not ensure the successful placement of the Securities or any portion thereof or the success
of Revere with respect to securing any other financing on behalf of the Company. The Company confirms that entry into this Placement Agent
Agreement and completion of the Placement with Revere will not breach or otherwise violate the Company&rsquo;s obligations to any other
party or require any payments to such other party. For the sake of clarity, such obligations may include but not be limited to obligations
under an engagement letter, placement agency agreement, underwriting agreement, advisory agreement, right of first refusal, tail fee obligation
or other agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The terms of the Preferred
Stock will be set forth in the Certificate of Designation (the &ldquo;<B><U>Certificate of Designation</U></B>&rdquo;) to be filed by
the Company with the Secretary of State of the State of Delaware as an amendment to the Company&rsquo;s Certificate of Incorporation.
The Securities will be offered and sold to accredited investors in the Placement pursuant to the exemption from the registration requirements
of the Securities Act of 1933, as amended, and the rules and regulations of the Securities and Exchange Commission (the &ldquo;<B><U>Commission</U></B>&rdquo;)
thereunder (collectively, the &ldquo;<B><U>Securities Act</U></B>&rdquo;), in reliance upon Section 4(a)(2) of the Securities Act and
Rule 506(b) of Regulation D promulgated by the Commission under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The terms of our agreement
are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify"><B><U>Engagement</U></B>. The Company hereby engages Revere, for the period beginning on the date hereof
and ending two (2) business days thereafter or upon the completion of the Placement, whichever is sooner (the &ldquo;<B><U>Engagement
Period</U></B>&rdquo;), to act as the Company&rsquo;s exclusive placement agent and investment bank in connection with the proposed Placement.
During the Engagement Period or until the consummation of the Placement, and as long as Revere is proceeding in good faith with preparations
for the Placement, the Company agrees not to solicit, negotiate with or enter into any agreement with any other source of financing (whether
equity, debt or otherwise), any underwriter, potential underwriter, placement agent, financial advisor, investment banking firm or any
other person or entity in connection with an offering of the Company&rsquo;s debt or equity securities or any other financing by the Company.
Revere will use its reasonable &ldquo;best efforts&rdquo; to solicit offers to purchase the Securities from the Company on the terms,
and subject to the conditions, set forth in the Prospectus (as defined below). Revere shall use commercially reasonable efforts to assist
the Company in obtaining performance by each Purchaser (as defined in the Securities Purchase Agreement)) whose offer to purchase Securities
has been solicited by Revere, but Revere shall not, except as otherwise provided in this Agreement, be obligated to disclose the identity
of any potential purchaser or have any liability to the Company in the event any such purchase is not consummated for any reason. The
Company acknowledges that under no circumstances will Revere be obligated to underwrite or purchase any Securities for its own account
and, in soliciting purchases of the Securities, Revere shall act solely as an agent of the Company. The services provided pursuant to
this Placement Agent Agreement shall be on an &ldquo;agency&rdquo; basis and not on a &ldquo;principal&rdquo; basis.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify"><B><U>The Placement</U></B>. The Placement is expected to consist of a sale of approximately $15 million
of the Company&rsquo;s Securities. The Placement will be a private placement of units, with each unit consisting of one share of Preferred
Stock and one Warrant, each Warrant to purchase one share of Common Stock. Revere will act as placement agent for the Placement subject
to, among other matters referred to herein and additional customary conditions, completion of Revere&rsquo;s due diligence examination
of the Company and its affiliates, listing approval by the Nasdaq Capital Market LLC (&ldquo;<B><U>Exchange</U></B>&rdquo;) of the Securities
to be issued, and the execution of a definitive Securities Purchase Agreement in connection with the Placement (the &ldquo;<B><U>Securities
Purchase Agreement</U></B>&rdquo;). The actual size of the Placement, the precise number of Securities to be offered by the Company and
the offering price will be the subject of continuing negotiations between the Company and the investors thereto.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify"><B><U>Placement Compensation</U></B>. The placement commission will be 8.0% for the Placement; provided
that the placement commission for any proceeds that are not sourced by Revere shall be 6.0%.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify"><B><U>Registration Statement</U></B>. To the extent the Company decides to proceed with the Placement,
the Company will, as soon as practicable and in no event later than the times set forth in the registration rights agreement to be entered
into with the investors in the Placement, prepare and file with the Commission a Registration Statement on Form S-1 or Form S-3 (the &ldquo;<B><U>Registration
Statement</U></B>&rdquo;) under the Securities Act and a prospectus included therein (the &ldquo;<B><U>Prospectus</U></B>&rdquo;) covering
the resale of the Securities to be offered and sold in the Placement. The Registration Statement (including the Prospectus therein), and
all amendments and supplements thereto, will be in form reasonably satisfactory to the investors, Revere and counsel to the investors
and Revere. Other than any information provided by the investors or Revere in writing specifically for inclusion in the Registration Statement
or the Prospectus, the Company will be solely responsible for the contents of its Registration Statement and Prospectus and any and all
other written or oral communications provided by or on behalf of the Company to any actual or prospective investor of the Securities,
and the Company represents and warrants that such materials and such other communications will not, as of the date of each filing of the
Registration Statement and any amendments or as of the date of effectiveness, contain any untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading. If at any time prior to the completion of the resale of the Securities by the investors an
event occurs that would cause the Registration Statement or Prospectus (as supplemented or amended) to contain an untrue statement of
a material fact or to omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under
which they were made, not misleading, the Company will notify Revere and the investors immediately of such event and the Company shall
prepare a supplement or amendment to the Registration Statement or Prospectus that corrects such statement or omission.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify">[Reserved].</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify"><B><U>Company Standstill</U></B>. In connection with the Placement, without the prior written consent
of the investors, the Company will not, for a period of sixty (60) days after the later of the Closing of the Placement and the effectiveness
of the Registration Statement (the &ldquo;<B><U>Standstill Period</U></B>&rdquo;), (a) offer, sell, issue, or otherwise transfer or dispose
of, directly or indirectly, any equity of the Company or any securities convertible into or exercisable or exchangeable for equity of
the Company; (b) file or caused to be filed any registration statement with the Commission relating to the offering of any equity of the
Company or any securities convertible into or exercisable or exchangeable for equity of the Company; or (c) enter into any agreement or
announce the intention to effect any of the actions described in subsections (a) or (b) hereof (all of such matters, the &ldquo;<B><U>Standstill
Restrictions</U></B>&rdquo;). So long as none of such equity securities shall be saleable in the public market until the expiration of
the Standstill Period, the following matters shall not be prohibited by the Standstill Restrictions: (i) the adoption of an equity incentive
plan and the grant of awards or equity pursuant to any equity incentive plan, and the filing of a registration statement on Form S-8;
(ii) securities issued pursuant to agreements, options, restricted share units or convertible securities existing as of the date hereof
provided the terms are not modified; and (iii) securities issued pursuant to acquisitions or strategic transactions (whether by merger,
consolidation, purchase of equity, purchase of assets, reorganization or otherwise) approved by a majority of the disinterested directors
of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no
registration rights that require or permit the filing of any registration statement in connection therewith during the Standstill Period,
and provided that any such issuance shall only be to a person or entity (or to the equityholders of an entity) which is, itself or through
its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide
to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is
issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities. In
no event should any equity transaction during the Standstill Period result in the sale of equity at an offering price to the public less
than that of the Placement referred herein.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify"><B><U>Expenses</U></B>. The Company also agrees to pay Revere (a) $150,000 for fees and expenses of legal
counsel and other out-of-pocket expenses; plus documented out-of-pocket expenses incurred in connection with the Offering, excluding legal
fees, up to a cap of $50,000.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify"><B><U>Termination</U></B>. Notwithstanding anything to the contrary contained herein, the Company agrees
that the provisions relating to the payment of fees, reimbursement of expenses, indemnification and contribution, confidentiality, conflicts,
independent contractor and waiver of the right to trial by jury will survive any termination or expiration of this Placement Agent Agreement.
Notwithstanding anything to the contrary contained herein, the Company has the right to terminate this Agreement for cause in compliance
with FINRA Rule 5110(g)(5)(B)(i). Notwithstanding anything to the contrary contained in this Agreement, in the event that no Placement
is completed for any reason whatsoever during the Engagement Period, the Company shall be obligated to pay to Revere its actual and accountable
out-of-pocket expenses related to the Placement (including the fees and disbursements of Placement Agent&rsquo;s legal counsel) and if
applicable, for electronic road show service used in connection with the Placement. During the engagement hereunder: (i) the Company will
not, and will not permit its representatives to, other than in coordination with Revere, contact or solicit institutions, corporations
or other entities or individuals as potential purchasers of the Securities and (ii) the Company will not pursue any financing transaction
which would be in lieu of the Placement. Furthermore, the Company agrees that during Revere&rsquo;s engagement hereunder, all inquiries
from prospective investors will be referred to Revere.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify"><B><U>Closing; Closing Deliverables</U></B>. Unless otherwise directed by the Placement Agent, settlement
of the Securities shall occur via &ldquo;Delivery Versus Payment&rdquo; (&ldquo;<B><U>DVP</U></B>&rdquo;) (i.e., on the Closing Date,
the Company shall cause the Depositary to issue the Securities directly to the clearing firm designated by the Placement Agent; upon receipt
of such Securities, the Placement Agent shall promptly electronically deliver such Securities to the applicable Purchaser, and payment
therefor shall be made by the Placement Agent (or its clearing firm) by wire transfer to the Company).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">9.1.</TD><TD STYLE="text-align: justify"><B><U>Company Deliveries</U></B>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">9.1.1.</TD><TD STYLE="text-align: justify">On the date hereof, the Company shall deliver each of the following:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">9.1.1.1</TD><TD STYLE="text-align: justify">This Agreement duly executed by the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">9.1.1.2</TD><TD STYLE="text-align: justify">A duly executed and delivered Officers&rsquo; Certificate, in
customary form reasonably satisfactory to the Placement Agent and its counsel.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">9.1.2.</TD><TD STYLE="text-align: justify">On or prior to the Closing Date, the Company shall deliver each
of the following:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">9.1.2.1</TD><TD STYLE="text-align: justify">A legal opinion of counsel to the Company, addressed to the
Placement Agent and the Purchasers, in form and substance reasonably acceptable to the Placement Agent and Purchasers.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">9.1.2.2</TD><TD STYLE="text-align: justify">[Reserved].</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">9.1.2.3</TD><TD STYLE="text-align: justify">A copy of the irrevocable instructions to the Transfer Agent
instructing the Transfer Agent to deliver, on an expedited basis, a certificate (or at the request of the Purchaser, book entry statement)
evidencing a number of shares of Preferred Stock equal to such Purchaser&rsquo;s Subscription Amount (as defined in the Securities Purchase
Agreement) divided by the Per Share Purchase Price (as defined in the Securities Purchase Agreement), registered in the name of such
Purchaser.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">9.1.2.4</TD><TD STYLE="text-align: justify">A certified copy of the Certificate of Designation, as certified
by the Secretary of State of the Company&rsquo;s jurisdiction of incorporation.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">9.1.2.5</TD><TD STYLE="text-align: justify">The Warrants, registered in the name of such Purchaser, to purchase
up to a number of shares of Common Stock equal to the sum of 100.0% of the number of shares of Common Stock stated on such Purchaser&rsquo;s
signature page to the Securities Purchase Agreement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">9.1.2.6</TD><TD STYLE="text-align: justify">The Company shall have provided each Purchaser with the Company&rsquo;s
wire instructions, on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.</TD><TD STYLE="text-align: justify"><B><U>Publicity</U></B>. The Company agrees that it will not issue press releases or engage in any other
publicity, without Revere&rsquo;s prior written consent, commencing on the date hereof and continuing until the final Closing of the Placement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.</TD><TD STYLE="text-align: justify"><B><U>Information</U></B>. During the Engagement Period or until the Closing, the Company agrees to cooperate
with Revere and to furnish, or cause to be furnished, to Revere, any and all information and data concerning the Company, and the Placement
that Revere deems appropriate (the &ldquo;<B><U>Information</U></B>&rdquo;). The Company will provide Revere reasonable access during
normal business hours from and after the date of execution of this Placement Agent Agreement until the Closing to all of the Company&rsquo;s
assets, properties, books, contracts, commitments and records and to the Company&rsquo;s officers, directors, employees, appraisers, independent
accountants, legal counsel and other consultants and advisors. Except as contemplated by the terms hereof or as required by applicable
law, Revere will keep strictly confidential all non-public Information concerning the Company provided to Revere. No obligation of confidentiality
will apply to Information that: (a) is in the public domain as of the date hereof or hereafter enters the public domain without a breach
by Revere, (b) was known or became known by Revere prior to the Company&rsquo;s disclosure thereof to Revere as demonstrated by the existence
of its written records, (c) becomes known to Revere from a source other than the Company which information is not provided by the breach
of an obligation of confidentiality owed to the Company, (d) is disclosed by the Company to a third party without restrictions on its
disclosure or (e) is independently developed by Revere as demonstrated by its written records. For the avoidance of doubt, except as otherwise
provided herein, all information which is not publicly available relating to the Company&rsquo;s proprietary technology is proprietary
and confidential.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.</TD><TD STYLE="text-align: justify"><B><U>No Third Party Beneficiaries; No Fiduciary Obligations</U></B>. This Placement Agent Agreement does
not create, and shall not be construed as creating, rights enforceable by any person or entity not a party hereto, except those entitled
hereto by virtue of the indemnification provisions hereof. The Company acknowledges and agrees that: (i) Revere is not and shall not be
construed as a fiduciary of the Company and shall have no duties or liabilities to the equity holders or the creditors of the Company
or any other person or entity by virtue of this Placement Agent Agreement or the retention of Revere hereunder, all of which are hereby
expressly waived; and (ii) Revere is a full service securities firm engaged in a wide range of businesses and from time to time, in the
ordinary course of its business, Revere or its affiliates may hold long or short positions and trade or otherwise effect transactions
for its own account or the account of its customers in debt or equity securities or loans of the companies which may be the subject of
the transactions contemplated by this Placement Agent Agreement. During the course of Revere&rsquo;s engagement with the Company, Revere
may have in its possession material, non-public information regarding other companies that could potentially be relevant to the Company
or the transactions contemplated herein but which cannot be shared due to an obligation of confidence to such other companies.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.</TD><TD STYLE="text-align: justify"><B><U>Indemnification, Advancement &amp; Contribution</U></B>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">13.1.</TD><TD STYLE="text-align: justify"><B><U>Indemnification</U></B>. The Company agrees to indemnify
and hold harmless Revere, its affiliates and each person controlling Revere (within the meaning of Section 15 of the Securities Act),
and the directors, officers, agents and employees of Revere, its affiliates and each such controlling person (Revere, and each such entity
or person hereafter is referred to as an &ldquo;<B><U>Indemnified Person</U></B>&rdquo;) from and against any losses, claims, damages,
judgments, assessments, costs and other liabilities (collectively, the &ldquo;<B><U>Liabilities</U></B>&rdquo;), and shall reimburse
each Indemnified Person for all fees and expenses (including the reasonable fees and expenses of counsel for the Indemnified Persons)
(collectively, the &ldquo;<B><U>Expenses</U></B>&rdquo;) and agrees to advance payment of such Expenses as they are incurred by an Indemnified
Person in investigating, preparing, pursuing or defending any actions, whether or not any Indemnified Person is a party thereto, arising
out of or based upon (i) any untrue statement or alleged untrue statement of a material fact contained in (A) the Registration Statement,
Prospectus or any other offering documents (as from time to time each may be amended and supplemented), (B) any materials or information
provided to investors by, or with the approval of, the Company in connection with the marketing of the Placement, including any &ldquo;road
show&rdquo; or investor presentations made to investors by the Company (whether in person or electronically), or (C) any application
or other document or written communication (collectively called &ldquo;application&rdquo;) executed by the Company or based upon written
information furnished by the Company in any jurisdiction in order to qualify the Securities under the securities laws thereof or to file
for an exemption from such requirement or filed with the Commission, any state securities commission or agency, any national securities
exchange; or (ii) the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading, unless such statement or omission was
made in reliance upon, and in conformity with, information provided to the Company by Revere in writing specifically for use in the Registration
Statement, Prospectus or any other offering documents with respect which or resulting from conduct by Revere or another Indemnified Party,
as to which Revere shall indemnify and hold harmless the Company, its officers, directors and controlling parties in the manner set forth
in this Section 13. The Company also agrees to reimburse and advance each Indemnified Person for all Expenses as they are incurred in
connection with such Indemnified Person&rsquo;s enforcement of his or its rights under this Section 13.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">13.2.</TD><TD STYLE="text-align: justify"><B><U>Procedure</U></B>. Upon receipt by an Indemnified Person
of actual notice of an action against such Indemnified Person with respect to which indemnity may reasonably be expected to be sought
under this Section 13, such Indemnified Person shall promptly notify the Company in writing; provided that failure by any Indemnified
Person so to notify the Company shall not relieve the Company from any obligation or liability which the Company may have on account
of this Section 13 or otherwise to such Indemnified Person. The Company shall, if requested by Revere, assume the defense of any such
action (including the employment of counsel designated by Revere and reasonably satisfactory to the Company). Any Indemnified Person
shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Indemnified Person unless: (i) the Company has failed promptly to assume the defense
and employ separate counsel reasonably acceptable to Revere for the benefit of Revere and the other Indemnified Persons or (ii) such
Indemnified Person shall have been advised that in the opinion of counsel that there is an actual or potential conflict of interest that
prevents (or makes it imprudent for) the counsel designated by and engaged by the Company for the purpose of representing the Indemnified
Person, to represent both such Indemnified Person and any other person represented or proposed to be represented by such counsel, in
which event the Company shall pay the reasonable fees and expenses of one counsel, plus local counsel, for all Indemnified Parties, which
counsel shall, if Revere is a defendant, be designated by Revere. The Company shall not be liable for any settlement of any action effected
without its written consent (which shall not be unreasonably withheld). In addition, the Company shall not, without the prior written
consent of Revere, settle, compromise or consent to the entry of any judgment in or otherwise seek to terminate any pending or threatened
action in respect of which advancement, reimbursement, indemnification or contribution may be sought hereunder (whether or not such Indemnified
Person is a party thereto) unless such settlement, compromise, consent or termination (i) includes an unconditional release of each Indemnified
Person, acceptable to such Indemnified Party, from all Liabilities arising out of such action for which indemnification or contribution
may be sought hereunder and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act, by or
on behalf of any Indemnified Person. The advancement, reimbursement, indemnification and contribution obligations of the Company required
hereby shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as every Liability
and Expense is incurred and is due and payable, and in such amounts as fully satisfy each and every Liability and Expense as it is incurred
(and in no event later than 30 Calendar Days following the date of any invoice therefore).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">13.3.</TD><TD STYLE="text-align: justify"><B><U>Contribution</U></B>. In the event that a court of competent
jurisdiction makes a finding, final beyond right of review, that indemnity is unavailable to an Indemnified Person, the Company shall
contribute to the Liabilities and Expenses paid or payable by such Indemnified Person in such proportion as is appropriate to reflect
(i) the relative benefits to the Company, on the one hand, and to Revere and any other Indemnified Person, on the other hand, of the
matters contemplated by this Section 13 or (ii) if the allocation provided by the immediately preceding clause is not permitted by applicable
law, not only such relative benefits but also the relative fault of the Company, on the one hand, and Revere and any other Indemnified
Person, on the other hand, in connection with the matters as to which such Liabilities or Expenses relate, as well as any other relevant
equitable considerations; provided that in no event shall the Company contribute less than the amount necessary to ensure that all Indemnified
Persons, in the aggregate, are not liable for any Liabilities and Expenses in excess of the amount of commissions and non-accountable
expense allowance actually received by Revere in the Placement. The relative fault shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates
to information supplied by the Company on the one hand or Revere on the other and the parties&rsquo; relative intent, knowledge, access
to information and opportunity to correct or prevent such statement or omission. The Company and Revere agree that it would not be just
and equitable if contributions pursuant to this subsection 13.3 were determined by pro rata allocation or by any other method of allocation
which does not take account of the equitable considerations referred to above in this subsection 13.3. For purposes of this paragraph,
the relative benefits to the Company, on the one hand, and to Revere on the other hand, of the matters contemplated by this Section 13
shall be deemed to be in the same proportion as: (a) the total value received by the Company in the Placement, whether or not such Placement
is consummated, bears to (b) the commissions paid to Revere under the Placement Agent Agreement. Notwithstanding the above, no person
guilty of fraudulent misrepresentation within the meaning of Section 11(f) of the Securities Act shall be entitled to contribution from
a party who was not guilty of fraudulent misrepresentation.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">13.4.</TD><TD STYLE="text-align: justify"><B><U>Limitation</U></B>. The Company also agrees that no Indemnified
Person shall have any liability (whether direct or indirect, in contract or tort or otherwise) to the Company for or in connection with
advice or services rendered or to be rendered by any Indemnified Person pursuant to this Placement Agent Agreement, the transactions
contemplated thereby or any Indemnified Person&rsquo;s actions or inactions in connection with any such advice, services or transactions,
except to the extent that a court of competent jurisdiction has made a finding that Liabilities (and related Expenses) of the Company
have resulted exclusively from such Indemnified Person&rsquo;s gross negligence or willful misconduct in connection with any such advice,
actions, inactions or services.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.</TD><TD STYLE="text-align: justify"><B><U>Equitable Remedies</U></B>. Each party to this Placement Agent Agreement acknowledges and agrees
that (a) a breach or threatened breach by the Company of any of its obligations under the exclusivity provisions of Section 1 would give
rise to irreparable harm to Revere for which monetary damages would not be an adequate remedy and (b) if a breach or a threatened breach
by the Company of any such obligations occurs, Revere will, in addition to any and all other rights and remedies that may be available
to such party at law, at equity, or otherwise in respect of such breach, be entitled to equitable relief, including a temporary restraining
order, an injunction, specific performance of the terms of the exclusivity provisions of Section 1, as applicable, and any other relief
that may be available from a court of competent jurisdiction, without any requirement to (i) post a bond or other security, or (ii) prove
actual damages or that monetary damages will not afford an adequate remedy. Each party to this Placement Agent Agreement agrees that such
party shall not oppose or otherwise challenge the existence of irreparable harm, the appropriateness of equitable relief or the entry
by a court of competent jurisdiction of an order granting equitable relief, in either case, consistent with the terms of this Section
14.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.</TD><TD STYLE="text-align: justify"><B><U>Governing Law; Venue</U></B>. This Placement Agent Agreement will be deemed to have been made and
delivered in the State of New York, USA, and both the binding provisions of this Placement Agent Agreement and the transactions contemplated
hereby will be governed as to validity, interpretation, construction, effect and in all other respects by the internal laws of the State
of New York, without regard to the conflict of laws principles thereof. Each of Revere and the Company: (i) agrees that any legal suit,
action or proceeding arising out of or relating to this Placement Agent Agreement and/or the transactions contemplated hereby will be
instituted exclusively in the courts located in the Borough of Manhattan, City of New York, County of New York, State of New York (ii)
waives any objection which it may have or hereafter to the venue of any such suit, action or proceeding, and (iii) irrevocably consents
to the jurisdiction of the courts located in the City of New York, County of New York and State of New York, in any such suit, action
or proceeding. Each of Revere and the Company further agrees to accept and acknowledge service of any and all process which may be served
in any such suit, action or proceeding in such courts and agrees that service of process upon the Company mailed by certified mail to
the Company&rsquo;s address will be deemed in every respect effective service of process upon the Company, in any such suit, action or
proceeding, and service of process upon Revere mailed by certified mail to Revere&rsquo;s address will be deemed in every respect effective
service process upon Revere, in any such suit, action or proceeding. Notwithstanding any provision of this Placement Agent Agreement to
the contrary, the Company agrees that neither Revere nor its affiliates, and the respective officers, directors, employees, agents and
representatives of Revere, its affiliates and each other person, if any, controlling Revere or any of its affiliates, will have any liability
(whether direct or indirect, in contract or tort or otherwise) to the Company for or in connection with the engagement and transaction
described herein except for any such liability for losses, claims, damages or liabilities incurred by the Company that are finally judicially
determined to have resulted from the bad faith or gross negligence of such individuals or entities. Revere will act under this Placement
Agent Agreement as an independent contractor with duties to the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.</TD><TD STYLE="text-align: justify"><B><U>Miscellaneous</U></B>. The Company represents and warrants that it has all required power and authority
to enter into and carry out the terms and provisions of this Placement Agent Agreement and the execution, delivery and performance of
this Placement Agent Agreement does not breach or conflict with any agreement, document or instrument to which it is a party or bound.
The binding provisions of this Placement Agent Agreement are legally binding upon and inure to the benefit of both the Company and Revere
and their respective assigns, successors, and legal representatives. If any provision of this Placement Agent Agreement is determined
to be invalid or unenforceable in any respect, such determination will not affect such provision in any other respect, and the remainder
of the Placement Agent Agreement shall remain in full force and effect. This Placement Agent Agreement may be executed in counterparts
(including electronic counterparts), each of which shall be deemed an original but all of which together shall constitute one and the
same instrument. The undersigned hereby consents to receipt of this Placement Agent Agreement in electronic form and understands and agrees
that this Placement Agent Agreement may be signed electronically. Signatures to this Placement Agent Agreement transmitted in electronic
form will have the same effect as physical delivery of a paper document bearing the original signature, and if any signature is delivered
electronically evidencing an intent to sign this Placement Agent Agreement, such electronic mail or other electronic transmission shall
create a valid and binding obligation of the undersigned with the same force and effect as if such signature were an original. Execution
and delivery of this Placement Agent Agreement by electronic mail or other electronic transmission is legal, valid and binding for all
purposes.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.</TD><TD STYLE="text-align: justify"><B><U>Notices</U></B>. All notices, consents, claims, demands, waivers, and other communications hereunder
(&ldquo;<B><U>Notices</U></B>&rdquo;) shall be in writing and sent by certified mail, hand delivery, overnight delivery or email, if sent
to Revere, at the address set forth on the first page hereof, email: [***], and if sent to the Company, to the address set forth on the
first page hereof, email: [***], attention: Lavell Juan Malloy, II, Chief Executive Officer. All Notices shall be deemed to have been
effectively given (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if sent by FedEx
or another nationally recognized overnight courier (receipt requested); (c) on the date sent by email (with confirmation of receipt from
the intended recipient by return email or other written acknowledgment other than an automatic &ldquo;read receipt&rdquo;) if sent during
normal business hours of the recipient, and on the next Business Day if sent after normal business hours of the recipient; or (d) if certified
or registered mail is required by applicable law, the fifth day after the date mailed by certified or registered mail (in each case, return
receipt requested, postage pre-paid).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you are in agreement with
the foregoing, please sign and return to us one copy of this Placement Agent Agreement. This Placement Agent Agreement may be executed
in counterparts (including facsimile or .pdf counterparts), each of which shall be deemed an original but all of which together shall
constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page of Brag House Holdings, Inc.
PIPE Offering Placement Agent Agreement Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page of Brag House Holdings, Inc.
PIPE Offering Placement Agent Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
truly yours,</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%"></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Revere
    Securities LLC</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Bill Moreno</I></FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bill
    Moreno</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>AGREED AND ACCEPTED</B>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The foregoing accurately sets forth our understanding and agreement
with respect to the matters set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-weight: bold">Brag House Holdings, Inc.</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-style: italic; width: 5%"><FONT STYLE="font-style: normal; font-weight: normal">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-style: italic; width: 35%">/s/ Lavell Juan Malloy, II</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Name:</TD>
    <TD>Lavell Juan Malloy, II</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>6
<FILENAME>ea025072601ex10-3_brag.htm
<DESCRIPTION>REGISTRATION RIGHTS AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<P STYLE="font: normal bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: capitalize; text-align: right"></P>

<P STYLE="font: normal bold 10pt Times New Roman, Times, Serif; text-transform: capitalize; margin: 0pt 0; text-align: right"><FONT STYLE="text-transform: capitalize"></FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 10.3</B></P>
<P STYLE="font: normal bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: capitalize; text-align: center"><FONT STYLE="text-transform: capitalize">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">REGISTRATION RIGHTS AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">This Registration Rights Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of July 24, 2025, by and between Brag House Holdings, Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), and each of the several purchasers signatory hereto (each such purchaser, a &ldquo;<U>Purchaser</U>&rdquo;
and, collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">This Agreement is made pursuant
to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the &ldquo;<U>Purchase Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">The Company and each Purchaser
hereby agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">1.</TD><TD STYLE="text-align: justify"><U>Definitions</U>.</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><B>Capitalized terms used
and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.</B>
As used in this Agreement, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Advice</U>&rdquo;
shall have the meaning set forth in Section 6(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effectiveness
Date</U>&rdquo; means, with respect to the Initial Registration Statement required to be filed hereunder, the 60<SUP>th</SUP> calendar
day following the date hereof (or, in the event of a &ldquo;full review&rdquo; by the Commission, the 90<SUP>th</SUP> calendar day following
the date hereof) and with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section
3(c), the 60<SUP>th</SUP> calendar day following the date on which an additional Registration Statement is required to be filed hereunder
(or, in the event of a &ldquo;full review&rdquo; by the Commission, the 90<SUP>th</SUP> calendar day following the date such additional
Registration Statement is required to be filed hereunder); <U>provided</U>, <U>however</U>, that in the event the Company is notified
by the Commission that one or more of the above Registration Statements will not be reviewed or is no longer subject to further review
and comments, the Effectiveness Date as to such Registration Statement shall be the fifth Trading Day following the date on which the
Company is so notified if such date precedes the dates otherwise required above, provided, further, if such Effectiveness Date falls on
a day that is not a Trading Day, then the Effectiveness Date shall be the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effectiveness
Period</U>&rdquo; shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Filing
Date</U>&rdquo; means, with respect to the Initial Registration Statement required hereunder, the 30<SUP>th</SUP> Trading Day following
the date hereof and, with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section
3(c), the earliest practical date on which the Company is permitted by SEC Guidance to file such additional Registration Statement related
to the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Holder</U>&rdquo;
or &ldquo;<U>Holders</U>&rdquo; means the holder or holders, as the case may be, from time to time of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indemnified
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indemnifying
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Initial
Registration Statement</U>&rdquo; means the initial Registration Statement filed pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Losses</U>&rdquo;
shall have the meaning set forth in Section 5(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Plan of
Distribution</U>&rdquo; shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously
omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the Commission
pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of
any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus,
including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registrable
Securities</U>&rdquo; means, as of any date of determination, (a) all Conversion Shares, (b) all Warrant Shares then issued and issuable
upon exercise of the Warrants (assuming on such date the Warrants are exercised in full without regard to any exercise limitations therein)
and (c) any securities issued or then issuable upon any stock split, dividend or other distribution, recapitalization or similar event
with respect to the foregoing; <U>provided, however</U>, that any such Registrable Securities shall cease to be Registrable Securities
(and the Company shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect
thereto) for so long as (a) a Registration Statement with respect to the sale of such Registrable Securities is declared effective by
the Commission under the Securities Act and such Registrable Securities have been disposed of by the Holder in accordance with such effective
Registration Statement, (b) such Registrable Securities have been previously sold in accordance with Rule 144, or (c) such securities
become eligible for resale without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144 as
set forth in a written opinion letter to such effect, addressed, delivered and acceptable to the Transfer Agent and the affected Holders
(assuming that such securities and any securities issuable upon exercise, conversion or exchange of which, or as a dividend upon which,
such securities were issued or are issuable, were at no time held by any Affiliate of the Company, and all Warrants are exercised by &ldquo;cashless
exercise&rdquo; as provided in Section 2(c) of each of the Warrants), as reasonably determined by the Company, upon the advice of counsel
to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration
statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such
registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated
by reference or deemed to be incorporated by reference in any such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 415</U>&rdquo;
means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Selling
Stockholder Questionnaire</U>&rdquo; shall have the meaning set forth in Section 3(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Guidance</U>&rdquo;
means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements or requests of the Commission
staff and (ii) the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">2.</TD><TD STYLE="text-align: justify"><U>Resale Registration</U>.</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) On
or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale of all
of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on a continuous
basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-3 (except if the Company is not then eligible
to register for resale the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate form in
accordance herewith, subject to the provisions of Section 2(e)) and shall contain (unless otherwise directed by at least 85% in interest
of the Holders) substantially the &ldquo;<U>Plan of Distribution</U>&rdquo; attached hereto as <U>Annex A</U> and substantially the &ldquo;<U>Selling
Shareholders</U>&rdquo; section attached hereto as <U>Annex B</U>; <U>provided</U>, <U>however</U>, that no Holder shall be required to
be named as an &ldquo;underwriter&rdquo; without such Holder&rsquo;s express prior written consent. Subject to the terms of this Agreement,
the Company shall use its best efforts to cause a Registration Statement filed under this Agreement (including, without limitation, under
Section 3(c)) to be declared effective under the Securities Act as promptly as possible after the filing thereof, but in any event no
later than the applicable Effectiveness Date, and shall use its best efforts to keep such Registration Statement continuously effective
under the Securities Act until the date that all Registrable Securities covered by such Registration Statement (i) have been sold, thereunder
or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale restrictions pursuant to Rule 144 and without the requirement
for the Company to be in compliance with the current public information requirement under Rule 144, as determined by the counsel to the
Company pursuant to a written opinion letter to such effect, addressed and acceptable to the Transfer Agent and the affected Holders (the
&ldquo;<U>Effectiveness Period</U>&rdquo;). The Company shall telephonically request effectiveness of a Registration Statement as of 5:00
p.m. (New York City time) on a Trading Day. The Company shall immediately notify the Holders via e-mail of the effectiveness of a Registration
Statement on the same Trading Day that the Company telephonically confirms effectiveness with the Commission, which shall be the date
requested for effectiveness of such Registration Statement. The Company shall, by 9:30 a.m. (New York City time) on the Trading Day after
the effective date of such Registration Statement, file a final Prospectus with the Commission as required by Rule 424.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)
Notwithstanding the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the
Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a
single registration statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable
efforts to file amendments to the Initial Registration Statement as required by the Commission, covering the maximum number of
Registrable Securities permitted to be registered by the Commission, on Form S-3 or such other form available to register for resale
the Registrable Securities as a secondary offering, subject to the provisions of Section 2(e); with respect to filing on Form S-3 or
other appropriate form; <U>provided</U>, <U>however</U>, that prior to filing such amendment, the Company shall be obligated to use
diligent efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the
SEC Guidance, including without limitation, Compliance and Disclosure Interpretation 612.09.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)
Notwithstanding any other provision of this Agreement, if the Commission or any SEC Guidance sets forth a limitation on the number
of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and
notwithstanding that the Company used diligent efforts to advocate with the Commission for the registration of all or a greater
portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities, the number of
Registrable Securities to be registered on such Registration Statement will be reduced as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">a.</TD><TD STYLE="text-align: justify">First, the Company shall reduce or eliminate any securities to be included other than Registrable Securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">b.</TD><TD STYLE="text-align: justify">Second, the Company shall reduce Registrable Securities represented by Warrant Shares (applied, in the
case that some Warrant may be registered, to the Holders on a pro rata basis based on the total number of unregistered Warrant Shares
held by such Holders); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">c.</TD><TD STYLE="text-align: justify">Third, the Company shall reduce Registrable Securities represented by Conversion Shares (applied, in the
case that some Conversion Shares may be registered, to the Holders on a pro rata basis based on the total number of unregistered Conversion
Shares held by such Holders).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In the event of a cutback hereunder,
the Company shall give the Holder at least two (2) Trading Days prior written notice along with the calculations as to such Holder&rsquo;s
allotment. In the event the Company amends the Initial Registration Statement in accordance with the foregoing, the Company will use its
best efforts to file with the Commission, as promptly as allowed by the Commission or SEC Guidance provided to the Company or to registrants
of securities in general, one or more registration statements on Form S-3 or such other form available to register for resale those Registrable
Securities that were not registered for resale on the Initial Registration Statement, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify">[RESERVED.]</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) If
Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the resale
of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities on Form S-3 as soon
as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in effect until
such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)  Notwithstanding
anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate of a Holder as any
Underwriter without the prior written consent of such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">3.</TD><TD STYLE="text-align: justify"><U>Registration Procedures</U>.</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">In connection with the Company&rsquo;s
registration obligations hereunder, the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)  Not
less than two (2) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to the filing
of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed to be incorporated
therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed to be filed, which documents
(other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such Holders, and (ii) cause
its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall be necessary,
in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning of the Securities
Act. The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto to which the
Holders of a majority of the Registrable Securities shall reasonably object in good faith, provided that, the Company is notified of such
objection in writing no later than two (2) Trading Days after the Holders have been so furnished copies of a Registration Statement or
one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments or supplements thereto. Each
Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement as <U>Annex C</U> (a &ldquo;<U>Selling
Stockholder Questionnaire</U>&rdquo;) on a date that is not less than two (2) Trading Days from the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)  (i)
Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus
used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable
Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to register
for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented
by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant
to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration
Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies of all correspondence
from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information contained therein
which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply in all material
respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable
Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this Agreement) with
the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus
as so supplemented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)  If
during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock
then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to the
applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of such Registrable
Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)  Notify
the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied by
an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible (and,
in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm such
notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective
amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether there will be a &ldquo;review&rdquo;
of such Registration Statement and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to
a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or
any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional
information, (iii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending
the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for
that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption
from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding
for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration
Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated
or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement,
Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading, and (vi) of the occurrence or existence of any pending
corporate development with respect to the Company that the Company believes may be material and that, in the determination of the Company,
makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus; <U>provided</U>,
<U>however</U>, that in no event shall any such notice contain any information which would constitute material, non-public information
regarding the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)  Use
its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness
of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities
for sale in any jurisdiction, at the earliest practicable moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)  Furnish
to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including
financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested
by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference)
promptly after the filing of such documents with the Commission, provided that any such item which is available on the EDGAR system (or
successor thereto) need not be furnished in physical form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)  Subject
to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by
each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any
amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)
Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate
with the selling Holders in connection with the registration or qualification (or exemption from the Registration or qualification) of
such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United
States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during
the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions
of the Registrable Securities covered by each Registration Statement, provided that the Company shall not be required to qualify generally
to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction
where it is not then so subject or file a general consent to service of process in any such jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)  If
requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing Registrable
Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted
by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered
in such names as any such Holder may request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)  Upon
the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into account
the Company&rsquo;s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure
of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to
the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document
so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading. <FONT STYLE="text-decoration: none double">If the Company notifies the Holders in accordance
with clauses (iii) through (vi) of Section 3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus
have been made, then the Holders shall suspend use of such Prospectus. The Company will use its best efforts to ensure that the use of
the Prospectus may be resumed as promptly as is practicable. The Company shall be entitled to exercise its right under this Section 3(j)
to suspend the availability of a Registration Statement and Prospectus for a period not to exceed 60 calendar days (which need not be
consecutive days) in any 12-month period</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)  Otherwise
use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities Act and
the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement
or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing if, at
any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof,
the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions
as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)  Reserved
.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)  The
Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock beneficially
owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control over the
shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration Expenses</U>. All fees and expenses incident to the performance
of or compliance with, this Agreement by the Company shall be borne by the Company whether or not any Registrable Securities are sold
pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence shall include, without limitation,
(i) all registration and filing fees (including, without limitation, fees and expenses of the Company&rsquo;s counsel and independent
registered public accountants) (A) with respect to filings made with the Commission, (B) with respect to filings required to be made
with any Trading Market on which the Common Stock is then listed for trading, and (C) in compliance with applicable state securities
or Blue Sky laws reasonably agreed to by the Company in writing (including, without limitation, fees and disbursements of counsel for
the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities), (ii) printing expenses (including,
without limitation, expenses of printing certificates for Registrable Securities), (iii) messenger, telephone and delivery expenses,
(iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the Company so desires such insurance,
and (vi) fees and expenses of all other Persons retained by the Company in connection with the consummation of the transactions contemplated
by this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation
of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees
performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing
of the Registrable Securities on any securities exchange as required hereunder. In no event shall the Company be responsible for any
broker or similar commissions of any Holder or, except to the extent provided for in the Transaction Documents, any legal fees or other
costs of the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">5.</TD><TD STYLE="text-align: justify"><U>Indemnification</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)  <U>Indemnification
by the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder, the
officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities as principal as a
result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees (and any other Persons
with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each
of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with a functionally equivalent
role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling Person, to the
fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without
limitation, reasonable attorneys&rsquo; fees) and expenses (collectively, &ldquo;<U>Losses</U>&rdquo;), as incurred, arising out of or
relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement, any Prospectus or any
form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission
or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus
or supplement thereto, in light of the circumstances under which they were made) not misleading or (2) any violation or alleged violation
by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection
with the performance of its obligations under this Agreement, except to the extent, but only to the extent, that (i) such untrue statements
or omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for
use therein, or to the extent that such information relates to such Holder or such Holder&rsquo;s proposed method of distribution of Registrable
Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement, such Prospectus
or in any amendment or supplement thereto (it being understood that the Holder has approved Annex A hereto for this purpose) or (ii) in
the case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi), the use by such Holder of an outdated, defective
or otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated, defective or
otherwise unavailable for use by such Holder and prior to the receipt by such Holder of the Advice contemplated in Section 6(d). The Company
shall notify the Holders promptly of the institution, threat or assertion of any Proceeding arising from or in connection with the transactions
contemplated by this Agreement of which the Company is aware. Such indemnity shall remain in full force and effect regardless of any investigation
made by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities by any of the Holders in
accordance with Section 6(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)  <U>Indemnification
by Holders</U>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents
and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange
Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable law,
from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged untrue statement of
a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto or in any preliminary
prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary
to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were
made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained in any information
so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such Prospectus or (ii)
to the extent, but only to the extent, that such information relates to such Holder&rsquo;s information provided in the Selling Stockholder
Questionnaire or the proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such
Holder expressly for use in a Registration Statement (it being understood that the Holder has approved Annex A hereto for this purpose),
such Prospectus or in any amendment or supplement thereto. In no event shall the liability of a selling Holder be greater in amount than
the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and
the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement or omission) received by such
Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)  <U>Conduct
of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder
(an &ldquo;<U>Indemnified Party</U>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the
&ldquo;<U>Indemnifying Party</U>&rdquo;) in writing, and the Indemnifying Party shall have the right to assume the defense thereof, including
the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection
with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party
of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be finally determined by a
court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have materially
and adversely prejudiced the Indemnifying Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.75in">An Indemnified
Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and
expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in
writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding
and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to any such Proceeding
(including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to the Indemnified Party
shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified
Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to
employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense
thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party).
The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent
shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified Party,
effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes
an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.75in">Subject to the
terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent
incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall
be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party, provided that
the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions
for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject to appeal
or further review) not to be entitled to indemnification hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)  <U>Contribution</U>.
If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party
harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party, in such
proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions,
statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such
Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including
any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by,
or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&rsquo; relative intent, knowledge,
access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party
as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys&rsquo;
or other fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified
for such fees or expenses if the indemnification provided for in this Section was available to such party in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.75in">The parties hereto
agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or
by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding
paragraph. In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the dollar amount
of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of any
damages such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission)
received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The indemnity and
contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified
Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">6.</TD><TD STYLE="text-align: justify"><U>Miscellaneous</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)  <U>Remedies</U>.
In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement, each Holder or the
Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery
of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and each Holder agrees that
monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions
of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of such breach, it shall
not assert or shall waive the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)  <U>No
Piggyback on Registrations; Prohibition on Filing Other Registration Statements</U>. Except as set forth on <U>Schedule 6(b)</U> attached
hereto, neither the Company nor any of its security holders (other than the Holders in such capacity pursuant hereto) may include securities
of the Company in any Registration Statements other than the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)  [RESERVED]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)  <U>Discontinued
Disposition</U>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the Company of the
occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue disposition of
such Registrable Securities under a Registration Statement until it is advised in writing (the &ldquo;<U>Advice</U>&rdquo;) by the Company
that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will use its best
efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)  <U>Amendments
and Waivers</U>. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented,
and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by the
Company and the Holders of 50.1% or more of the then outstanding Registrable Securities (for purposes of clarification, this includes
any Registrable Securities issuable upon exercise or conversion of any Security), provided that, if any amendment, modification or waiver
disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder (or group
of Holders) shall be required. If a Registration Statement does not register all of the Registrable Securities pursuant to a waiver or
amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered for each Holder shall
be reduced pro rata among all Holders and each Holder shall have the right to designate which of its Registrable Securities shall be omitted
from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect
to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly affect the rights
of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver or consent relates;
<U>provided</U>, <U>however</U>, that the provisions of this sentence may not be amended, modified, or supplemented except in accordance
with the provisions of the first sentence of this Section 6(f). No consideration shall be offered or paid to any Person to amend or consent
to a waiver or modification of any provision of this Agreement unless the same consideration also is offered to all of the parties to
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)  <U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as set forth
in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)  <U>Successors
and Assigns</U>. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the
parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations hereunder
without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign their respective
rights hereunder in the manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)  <U>No
Inconsistent Agreements</U>. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company
or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities, that would
have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof. Except
as set forth on <U>Schedule 6(i)</U>, neither the Company nor any of its Subsidiaries has previously entered into any agreement granting
any registration rights with respect to any of its securities to any Person that have not been satisfied in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)  <U>Execution
and Counterparts</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)  <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined in
accordance with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)  <U>Cumulative
Remedies</U>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)  <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)  <U>Headings</U>.
The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be deemed to limit or
affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)  <U>Independent
Nature of Holders&rsquo; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not joint with the obligations
of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder
hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Holder
pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any other kind
of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity with respect to
such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges that the Holders
are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or transactions.
Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out of this Agreement,
and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose. The use of
a single agreement with respect to the obligations of the Company contained was solely in the control of the Company, not the action or
decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested to do so by
any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and a Holder,
solely, and not between the Company and the Holders collectively and not between and among Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">IN WITNESS WHEREOF, the parties
have executed this Registration Rights Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Brag House Holdings, Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 31%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><I><U STYLE="text-decoration: none">/s/ Lavell Juan Malloy, II</U></I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:&nbsp;</TD>
    <TD>&nbsp;Lavell Juan Malloy, II</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGE OF HOLDERS FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">[SIGNATURE
PAGE OF HOLDERS TO REGISTRATION RIGHTS AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Holder: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Signature of Authorized Signatory of Holder</I>: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Authorized Signatory: _________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title of Authorized Signatory: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>Annex A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Plan of Distribution</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each Selling Stockholder (the
&ldquo;<U>Selling Stockholders</U>&rdquo;) of the securities and any of their pledgees, assignees and successors-in-interest may, from
time to time, sell any or all of their securities covered hereby on the principal Trading Market or any other stock exchange, market or
trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. A Selling
Stockholder may use any one or more of the following methods when selling securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">ordinary brokerage transactions and transactions in which
the broker-dealer solicits purchasers;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">block trades in which the broker-dealer will attempt to sell
the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">purchases by a broker-dealer as principal and resale by the
broker-dealer for its account;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">an exchange distribution in accordance with the rules of the
applicable exchange;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">privately negotiated transactions;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">settlement of short sales;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">in transactions through broker-dealers that agree with the
Selling Stockholders to sell a specified number of such securities at a stipulated price per security;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">through the writing or settlement of options or other hedging
transactions, whether through an options exchange or otherwise;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">a combination of any such methods of sale; or</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">any other method permitted pursuant to applicable law.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders may
also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;), if available, rather than under this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Broker-dealers engaged by
the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts
from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts
to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a
customary brokerage commission in compliance with FINRA Rule 2440; and in the case of a principal transaction a markup or markdown in
compliance with FINRA IM-2440.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the sale
of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling
Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities
to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option or other transactions with
broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer
or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution
may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders and
any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo; within the meaning
of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any
profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities
Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding, directly
or indirectly, with any person to distribute the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is required to
pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify
the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We agreed to keep this prospectus
effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders without registration and
without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance
with the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities
have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities
will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in
certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable
state or an exemption from the registration or qualification requirement is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under applicable rules and
regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market
making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement
of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules
and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the common stock by the Selling
Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders and have informed them
of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule
172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><B>Annex B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SELLING SHAREHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The common stock being offered
by the selling shareholders are those previously issued to the selling shareholders, and those issuable to the selling shareholders, upon
conversion of the preferred shares and exercise of the warrants. For additional information regarding the issuances of those preferred
shares and warrants, see &ldquo;Private Placement of Preferred Shares of Common Stock and Warrants&rdquo; above. We are registering the
shares of common stock in order to permit the selling shareholders to offer the shares for resale from time to time. Except for the ownership
of the preferred shares and the warrants issued pursuant to the Purchase Agreement, the selling shareholders have not had any material
relationship with us within the past three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below lists the
selling shareholders and other information regarding the beneficial ownership of the shares of common stock by each of the selling shareholders.
The second column lists the number of shares of common stock beneficially owned by each selling shareholder, based on their respective
ownership of the shares of common stock, preferred shares and warrants, as of ________, 2025, assuming conversion of the preferred shares
and exercise of the warrants held by the selling shareholders on that date, without regard to any limitations on conversions and exercises
set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The third column lists the shares of common stock
being offered by this prospectus by the selling shareholders and does not take in account any limitations on (i) conversion of the preferred
shares set forth therein or (ii) exercise of the warrants set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with the terms
of a registration rights agreement with the selling shareholders, this prospectus generally covers the resale of the sum of (i) the maximum
number of shares of common stock issued or issuable to the selling shareholders in the &ldquo;Private Placement of Preferred Shares of
Common Stock and Warrants&rdquo; described above, pursuant to the Certificate of Designation, including payment of dividends on the preferred
shares through [DATE], and (ii) the maximum number of shares of common stock issuable upon exercise of the related warrants, determined
as if the outstanding warrants were converted or exercised (as the case may be) in full as of the trading day immediately preceding the
date this registration statement was initially filed with the SEC, each as of the trading day immediately preceding the applicable date
of determination and all subject to adjustment as provided in the registration right agreement, without regard to any limitations on the
exercise of the warrants. Because the conversion price of the preferred shares and the exercise price of the warrants may be adjusted,
the number of shares that will actually be issued may be more or less than the number of shares being offered by this prospectus. The
fourth column assumes the sale of all of the shares offered by the selling shareholders pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of the preferred
shares and the warrants, a selling shareholder may not convert the preferred shares or exercise the warrants to the extent such exercise
would cause such selling shareholder, together with its affiliates and attribution parties, to beneficially own a number of shares of
common stock which would exceed [4.99][9.99]% of our then outstanding common stock following such exercise, excluding for purposes of
such determination shares of common stock issuable upon exercise of the warrants which have not been exercised. The number of shares in
the second column does not reflect this limitation. The selling shareholders may sell all, some or none of their shares in this offering.
See &ldquo;Plan of Distribution.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left; width: 22%; font-size: 10pt; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><B>Name
    of Selling Shareholder</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0pt; vertical-align: bottom; width: 25%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Number
    of shares of<BR>
    Common Stock Owned <BR>
    Prior to Offering</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0pt; vertical-align: bottom; width: 25%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Maximum
    Number of <BR>
    shares of Common Stock<BR>
    to be Sold Pursuant to this<BR>
    Prospectus</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0pt; vertical-align: bottom; width: 25%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Number
    of shares of <BR>
    Common Stock Owned <BR>
    After Offering</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0pt; text-align: left; font-size: 10pt; vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0pt; vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0pt; vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0pt; vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0pt; text-align: left; font-size: 10pt; vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0pt; vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0pt; vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0pt; vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0pt; text-align: left; font-size: 10pt; vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0pt; vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0pt; vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0pt; vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>Annex C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BRAG HOUSE HOLDINGS, INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Selling Stockholder Notice and Questionnaire</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned beneficial
owner of common stock (the &ldquo;<U>Registrable Securities</U>&rdquo;) of Brag House Holdings, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
understands that the Company has filed or intends to file with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
a registration statement (the &ldquo;<U>Registration Statement</U>&rdquo;) for the registration and resale under Rule 415 of the Securities
Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), of the Registrable Securities, in accordance with the terms of the
Registration Rights Agreement (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;) to which this document is annexed. A copy of the
Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise
defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain legal consequences
arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial
owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or
not being named as a selling stockholder in the Registration Statement and the related prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTICE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned beneficial
owner (the &ldquo;<U>Selling Stockholder</U>&rdquo;) of Registrable Securities hereby elects to include the Registrable Securities owned
by it in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned hereby provides the following
information to the Company and represents and warrants that such information is accurate:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">QUESTIONNAIRE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1.</B></TD><TD><B>Name.</B></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
                                                                                           </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Full Legal Name of Selling Stockholder</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Full Legal Name of Registered Holder (if not the same as (a) above) through
which Registrable Securities are held:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Full Legal Name of Natural Control Person (which means a natural person
who directly or indirectly alone or with others has power to vote or dispose of the securities covered by this Questionnaire):</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>2. Address for Notices to Selling Stockholder:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; font-size: 10pt">Telephone:&nbsp;</TD>
    <TD STYLE="width: 95%; border-bottom: black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 3%">Email:&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt; width: 97%">&nbsp;</TD></TR>
  </TABLE>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; font-size: 10pt; width: 10%">Contact Person:&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; width: 90%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>3. Broker-Dealer Status:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Are you a broker-dealer?</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Yes &#9744; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">If &ldquo;yes&rdquo; to Section 3(a), did you receive your Registrable Securities
as compensation for investment banking services to the Company?</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">Yes &#9744; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No &#9744;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.35in; text-align: left"><FONT STYLE="font-size: 10pt">Note:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">If &ldquo;no&rdquo; to Section
3(b), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Are you an affiliate of a broker-dealer?</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">Yes &#9744; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
&#9744;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>



<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">If you are an affiliate of a broker-dealer, do you certify that you purchased
the Registrable Securities in the ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold,
you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">Yes &#9744; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
&#9744;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.35in; text-align: left"><FONT STYLE="font-size: 10pt">Note:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">If &ldquo;no&rdquo; to Section
3(d), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>4. Beneficial Ownership of Securities
of the Company Owned by the Selling Stockholder.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Except as set forth below in this
Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than the securities issuable
pursuant to the Purchase Agreement.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Type and Amount of other securities beneficially owned by the Selling Stockholder:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>5. Relationships with the Company:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Except as set forth below, neither
the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities
of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or
affiliates) during the past three years.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">State any exceptions here:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: -0.25in; width: 0.5in">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-indent: -0.125in; padding-right: 5.4pt; padding-left: -0.25in; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: -0.25in">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: -0.25in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned agrees to
promptly notify the Company of any material inaccuracies or changes in the information provided herein that may occur subsequent to the
date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall not be required to notify
the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">By
signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and
the inclusion of such information in the Registration Statement and the related prospectus </FONT>and any amendments or supplements thereto<FONT STYLE="font-size: 10pt">.
The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment of
the Registration Statement and the related prospectus and any amendments or supplements thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF the undersigned,
by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized
agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Date:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Beneficial Owner:&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 31%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PLEASE EMAIL A .PDF COPY OF THE COMPLETED AND
EXECUTED NOTICE AND QUESTIONNAIRE TO:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>ea025072601ex99-1_brag.htm
<DESCRIPTION>PRICING PRESS RELEASE DATED JULY 24, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Brag House Announces $15 Million Private Placement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>July 24, 2025 | NEW YORK, NY</B> &ndash; Brag
House Holdings, Inc. (NASDAQ: TBH) (&ldquo;Brag House&rdquo; or the &ldquo;Company&rdquo;) the Gen Z engagement platform operating at
the intersection of gaming, college sports, and digital media, announces today that it has entered into a securities purchase agreement
with twelve accredited investors (not one as previously reported) for a private investment in public equity (&ldquo;PIPE&rdquo;) financing
that is expected to result in gross proceeds to the Company of approximately $15 million, before deducting placement agent fees and offering
expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company intends to use the net proceeds from
the offering for general corporate purposes, including working capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the terms of the securities purchase
agreement, the Company is selling an aggregate of 15,000 shares of its Series B Convertible Preferred Stock convertible into 15,923,567
shares of common stock, at a conversion price of $0.942 per share of Series B Convertible Stock and an aggregate of 15,923,567 warrants
to acquire up to 15,923,567 shares of common stock. The purchase price for one unit (consisting of one share of Series B Convertible Preferred
Stock convertible into approximately 1,061 shares and the same number of warrants) was $1,000. The warrants issued in the offering are
exercisable immediately upon issuance at an exercise price of $0.817 per share and will expire five years from the date of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revere Securities LLC acted as the sole placement
agent for the PIPE financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities being offered and sold by the Company
in the private placement have not been registered under the Securities Act of 1933, as amended (the &quot;Securities Act&quot;), or state
securities laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission (the
&quot;SEC&quot;) or an applicable exemption from such registration requirements. The securities were offered only to accredited investors.
The Company has agreed to file one or more registration statements with the SEC covering the resale of the unregistered shares issuable
upon the conversion of the Series B Preferred Stock and the shares issuable upon exercise of the unregistered warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release shall not constitute an offer
to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction
in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such
state or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Brag House Holdings, Inc.</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Brag House is a leading media technology platform dedicated to transforming
casual college gaming into a vibrant, community-driven experience. By merging gaming, social interaction, and collegiate culture, Brag
House enables brands to authentically connect with the influential Gen Z demographic through gamified experiences, live-streaming content,
and scalable data insights. For more information, visit www.braghouse.com.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Caution Regarding Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain statements in this announcement are forward-looking
statements. Investors can identify these forward-looking statements by words or phrases such as &ldquo;may,&rdquo; &ldquo;will,&rdquo;
&ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;aim,&rdquo; &ldquo;estimate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;believe,&rdquo;
&ldquo;is/are likely to,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue&rdquo; or other similar expressions. These statements are subject
to uncertainties and risks including, but not limited to, the risk factors discussed in the Risk Factors and in Management&rsquo;s Discussion
and Analysis of Financial Condition and Results of Operations sections of our Forms 10-K, 10-Q and other reports filed with the SEC and
available at www.sec.gov. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable,
it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ
materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company&rsquo;s
registration statement and other filings with the SEC. Additional factors are discussed in the Company&rsquo;s filings with the SEC, which
are available for review at www.sec.gov. The Company undertakes no obligation to update or revise publicly any forward-looking statements
to reflect subsequent occurring events or circumstances, or changes in its expectations that arise after the date hereof, except as may
be required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations Contact<BR>
</B>Adele Carey<BR>
VP, Investor Relations<BR>
ir@thebraghouse.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Media Contact<BR>
</B>Fatema Bhabrawala<BR>
Director of Media Relations<BR>
fbhabrawala@allianceadvisors.com</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>8
<FILENAME>ea025072601ex99-2_brag.htm
<DESCRIPTION>CLOSING PRESS RELEASE DATED JULY 30, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">Brag House Announces Closing $15 Million Private Placement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">NEW YORK,&nbsp;July 30, 2025&nbsp;(GLOBE NEWSWIRE) --&nbsp;Brag House
Holdings, Inc.&nbsp;(NASDAQ: TBH) (&ldquo;Brag House&rdquo; or the &ldquo;Company&rdquo;) the Gen Z engagement platform operating at the
intersection of gaming, college sports, and digital media, announces today that it has closed the previously announced private investment
in public equity (&ldquo;PIPE&rdquo;) financing. The Company received gross proceeds of approximately&nbsp;$15 million, before deducting
placement agent fees and offering expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">The Company intends to use the net proceeds from the offering for
general corporate purposes, including working capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">Pursuant to the terms of the securities purchase agreement, the Company
sold an aggregate of 15,000 shares of its Series B Convertible Preferred Stock convertible into 15,923,567 shares of common stock, at
a conversion price of&nbsp;$0.942&nbsp;per share of Series B Convertible Stock and an aggregate of 15,923,567 warrants to acquire up to
15,923,567 shares of common stock. The purchase price for one unit (consisting of one share of Series B Convertible Preferred Stock convertible
into approximately 1,061 shares and the same number of warrants) was&nbsp;$1,000. The warrants issued in the offering are exercisable
immediately upon issuance at an exercise price of&nbsp;$0.817&nbsp;per share and will expire five years from the date of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">Revere Securities LLC&nbsp;acted as the sole placement agent for
the PIPE financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">The securities being offered and sold by the Company in the private
placement have not been registered under the Securities Act of 1933, as amended (the &quot;Securities Act&quot;), or state securities
laws and may not be offered or sold in&nbsp;the United States&nbsp;absent registration with the&nbsp;Securities and Exchange Commission&nbsp;(the
&quot;SEC&quot;) or an applicable exemption from such registration requirements. The securities were offered only to accredited investors.
The Company has agreed to file one or more registration statements with the&nbsp;SEC&nbsp;covering the resale of the unregistered shares
issuable upon the conversion of the Series B Preferred Stock and the shares issuable upon exercise of the unregistered warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">This press release shall not constitute an offer to sell or the solicitation
of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><B>About&nbsp;Brag House Holdings, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">Brag House&nbsp;is a leading media technology platform dedicated
to transforming casual college gaming into a vibrant, community-driven experience. By merging gaming, social interaction, and collegiate
culture,&nbsp;Brag House&nbsp;enables brands to authentically connect with the influential Gen Z demographic through gamified experiences,
live-streaming content, and scalable data insights. For more information, visit&nbsp;www.braghouse.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><B>Caution Regarding Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">Certain statements in this announcement are forward-looking statements.
Investors can identify these forward-looking statements by words or phrases such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo;
&ldquo;anticipate,&rdquo; &ldquo;aim,&rdquo; &ldquo;estimate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;believe,&rdquo;
&ldquo;is/are likely to,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue&rdquo; or other similar expressions. These statements are subject
to uncertainties and risks including, but not limited to, the risk factors discussed in the Risk Factors and in Management&rsquo;s Discussion
and Analysis of Financial Condition and Results of Operations sections of our Forms 10-K, 10-Q and other reports filed with the&nbsp;SEC&nbsp;and
available at&nbsp;www.sec.gov. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable,
it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ
materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company&rsquo;s
registration statement and other filings with the&nbsp;SEC. Additional factors are discussed in the Company&rsquo;s filings with the&nbsp;SEC,
which are available for review at&nbsp;www.sec.gov. The Company undertakes no obligation to update or revise publicly any forward-looking
statements to reflect subsequent occurring events or circumstances, or changes in its expectations that arise after the date hereof, except
as may be required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><B>Investor Relations Contact</B><BR>
Adele Carey<BR>
VP, Investor Relations<BR>
ir@thebraghouse.com<BR>
<BR>
<B>Media Contact</B><BR>
Fatema Bhabrawala<BR>
Director of Media Relations<BR>
fbhabrawala@allianceadvisors.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>tbh-20250724.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qA5s7xRiXgen8uKa3EsWaeB+aPtzply2ZlBtmd0bYmKvyAtM7WaniqBUcvGUT0A -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:TBH="http://braghouse.com/20250724" elementFormDefault="qualified" targetNamespace="http://braghouse.com/20250724">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://braghouse.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="tbh-20250724_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="tbh-20250724_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>tbh-20250724_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>tbh-20250724_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="tbh-20250724.xsd#Cover" roleURI="http://braghouse.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://braghouse.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 24, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 24,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Brag House Holdings, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001903595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-4032622<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">45 Park Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Montclair<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">398-2845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TBH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea0250726-8k_brag.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://braghouse.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0250726-8k_brag.htm">ea0250726-8k_brag.htm</File>
    <File>tbh-20250724.xsd</File>
    <File>tbh-20250724_lab.xml</File>
    <File>tbh-20250724_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0250726-8k_brag.htm": {
   "nsprefix": "TBH",
   "nsuri": "http://braghouse.com/20250724",
   "dts": {
    "inline": {
     "local": [
      "ea0250726-8k_brag.htm"
     ]
    },
    "schema": {
     "local": [
      "tbh-20250724.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "tbh-20250724_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tbh-20250724_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 24
   },
   "report": {
    "R1": {
     "role": "http://braghouse.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-07-24",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0250726-8k_brag.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-07-24",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0250726-8k_brag.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://braghouse.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001213900-25-069378-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-069378-xbrl.zip
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M5)10;3;0'>R=N5@VQ\]:LT]K4V=8+GW>?;XW55;+MS#N9.7$I@/R 1LV\-/
M%B[PVC#5S,^:H)WZ',CG=*-IV#Z]A#K$&3,5JR>-Z"!>UR$J)+CPVKO7TQF7
M]@P&CPP#Y*%BRSL)00O_'E--\_Y^,AF!;-1/,E7+,.C8@532^Q<O3(Y<VX,_
M9;:KJ]3P*(:<5=8N1ZX6R6>]E+4G4M9,:9FTKC+M$U10_HK5Z'Q(HT%A+!N<
M%N\#=UPP]YIHE-8L;8V"E_NMKFO0?7UT_URWA"UJK'==-K:M*6K,BE\JK%K
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MKJA]SUQR>5DC;RXF-TP-TQ9&>@NB\H;1"%>!9D/&5VO#W9R$[A"8<\AY$/"
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M)Q'5/^H"$L*_<*M :^06Z$.0OBMJW$&'$=P<134DQ N&O/KEIS@1+T<CKD^
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MC8P@68!C"!_*1+8=O'K6P6!6N4Q@ZKZ[RDL0"+ $#]9E-A]\#R;$ U@ #('
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M$ !?$.G+,H@9&V^7*ZM1.1("HK$D?2"JR]:K2.*6(4)>2V1N'NU:F>BS,7G
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M@)KG'X1SA2[/Y6)SI81_8]J:>.K->'<VWKTBAE_O(H82,?QZ%S'\'#8]]K8
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MYES)@F:P,+GS".OZ0VM &<:5A'7Z>4-]'$*&<T[%61(5?OTEDRUQ];WCVM(
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M_0U,3\/.6E'?NJG.^ZMQ&T9')*C@O'PA>8_%I:.K%VF$YA-PL&>'8+(F6.7
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MO$D1DBD_+TE:HZC?&5?WR[!]L<NP:8;MBUV&[7/8]LADAYTG#"86P277W)'
MV?8_U475:4$VBII>GQXJ(*:H6K^_9Q*C&B D"%%SAZW!7#**3$9#41-$FN^.
MN%HFA1[KN$%..%EM;YAJ:YE?\M6:C30*?C-)&.?%,*H3H$[(^< @=0C8BB?^
MR!*Y=12X]+N1O-JZS'H,\S@>'Y7I-.Q "+,!I5LD<!IQ<LB0FMM@3NC'!R2%
M[MG2R39$0E./90S+S)D@=CT2EW!M?.6*H@UI-78]N,8K]J@'UVON5DH4^+"R
M?;:_G3HG4"MZOYQ]-=%U_--SH&!\HZJMUW13M7;/*R^T31EQK1*8TFBRAB$5
M3'Q5= W1R#%3 EY!Q)Q!*=? _&3;3(_3X2-T/>'Q\(_+J?[@^!<89P6:2Z"1
MBA@M,:J C9+1HV0>/>J/VVK1L"<>,"W2Z">&]-G(R<LFFZO-.Q5?F5D:K:T.
M\@OOX>*V+L7BW&7+&FZD(R]+\#;8)[ ?<Y!$'&$/3""&)1DYER"A8OK WGDG
M3<:ER6.4)B=@65TV7GR$.0B/I$&-G3*]9>*P%;XS*'_#),N;V[!_1I5?UAV!
M1?U>5%BCP[KT0((N??8HKN6YMZD@;@EZP:]ANXSS8-U88T4YF4 E[-UL76H3
M5#".PRF%GRG^G+KY!(-=&EIU1YK0;+2]%0QT4YIJR6H0^.=4IK"]AF]*80=&
M:WJL<L"@I$ZT.IBTN'".#8N$-%",W@O;S,^$>8$=@.A=L42*G(D@4K8[PN-'
M^ D>81L*?X,MPUXY_IUGH-UF=$!OAZUD^7"CMA0)[G]' TQ=XI\246BYY1B$
M$'H?QYL>D'?)U@WV1I30(W4A5M)$6?)24%+,"(QQC==8B/W5@_]C37H7VA\V
M$6P=\S ;QUV=2IEZ")NP6H^L@3X:(5 @R6L*&*.1[12;Y=MD@+R=H- J\*T=
MAJE,3[]LZJ 9)5:Z9O,(R2E+-\VI(2(-H&1!1-P$F<S3^/VP-75(V\9DG^=P
M_(I%D35%KJZ0WJ1H# (I3CKE^*3HE\PH-=(;VFX-K-^_9Q='8DO0!%AJH9'J
M:WS,NFQG"M+R#*&'"5FN//^2+5)7/KI;7YN3(H2*'-D>A5X*8K"[0:)7,Z14
M"'J&J_'1B\'SWUL40^8J\X5(DRON$" $N(,]0WF*X-F1V] K\HUX(Z,H*"JX
MIH>^P;!ET O8,/ @_3UM$;J"[PD;"->4?!W3NLRN:AM-:=]/^E@F7!VC,N#V
MAZA9+XWMAC*Q"BP>!]G@*_FL>I"<196RFL7WSSV"P6V(_JM17L4^F+9+,-R4
MV[QO>4+>Z\9\YT.&P^(>R')+*1Q"*]$P;A-Z#V]]E9<+9H0NL]M\X;IX*N[.
ML\7UBZVI^]Z@Y;+5/UP&)+EL 9X1@)-Y0]S>Y.OH17DZM)'"<F2)ZEYOA3OI
MIP:Y=9Z0@3#G7%BVRI/HPK&BVW*5-G"0ZJ"8>G/,8&02UI0&N,06I_A-:!6F
MD9VBHLKLF$'S5NG#FA% P"Y9G.@FRAVCW>9'D*0QM;"U;"C$R/GJ*:Q=+.,:
M)6X>J%WBTH,=[?([]^IP>JU9'MO)+[7QL]O!;M\:K3V^;<UPUBAQ.]N:R:1Y
M9I\PR_.Y&='W&61_>-OR1%_N\D2:)_IRER?ZC _.DX.GY'UZA]]Q/)V6F;2>
M@9T 0JA8N92'MG60!MF#Z&&M!@D%"$;,HC[7=.J-=E/'$52F4XL<;;G*OS)8
M8&.\4X?KNN1 !G=_:,7C<&W&P#28H7E+GZ[K NFNU_B"DS#W%.9NY!F.Y,K7
MNQJ/ @$O#SJP'PELP4F@)NCL:]"9W#^0_=)L4:^[P7RF+OK4FYRY!J.D70XJ
M.QC8I4=X:&MOC=1Q(?A@/"D^\;IHN@WI)0_2B;*3C:CANC$K( !&I]<CKI)O
MY.'4Y$[#C1_4+_"@OJVK!Z?2OV30(NJ8+;J8*]6+[\3['HW[6]L\>HS/<(<4
MQ8/[F(=-I_HTXY.QE,M8/YU"&/\']/2>\I]:50GO/XDIM<-"P[OF%N82VB '
M@2MDHHUU:!">6+9-M5;"QX6,HU06^36S];KK]_?<Q,<#/JF&7"52RR&O?KK=
M!)9$FGK())W5M;?P@\92.I^+T$C6<L</>;X>_LJ&2D+7WS:UERVT+' _<4E"
M+"A 3!3EK0<Y454G.UQNY;TX)*>L1Y<[VC$!!A=8]P-DFD33N']M+/86-@'J
MH5S5JQJ!:,M*A'M9F@6,;^GHRH)'L+_'C8JH#P2S8O1#5GTRRD\6]1L$FDB6
M6Q9Y@I+2N.XYB$\2[-K?,V$J2B.B?B/;@Q7)+&LQ*[$4NIB[HJNIZ<BD6Z6_
M%$V^XAYFEOC%U0J"@QC==%+9@VZ=>T2_[TB4K;LO7*36G?JV;7^9?J/(7C@X
MW!&#P ::*IL23G)>;UK-/3,"E%\CYE.'X)B76C,^C/5_>JF1?(S0(&C+N-38
MV1BC-L:7:&.\EXCD:5//076T8TFGC0;"<BH8I6L]JGLD!>K+QS 9JOU 82K6
M-;=.T:[35!1?-Q\H;#S/UH6@M_VW/J^-(Y%X+@_C&PIK.41V'W$_!+;W 4Z+
M?-8E$\/4/"FFV!&$0;A,OPMR"#Y P>!8W6L\CUBP!69%,XBYNKL'K8Y9\Z\;
M'-]<7HTB8/*TM']SLOOE[K[G([X7X>*%Z4'X"C!J*84>,EAJ^(X=.;CT&M\T
M7]!HZALV*P@AW5"5\RRK/A!]P\Q/9Y,O'+1.9C-$83?AW\?@?5W#;B#YCHP@
M;EU\O9S<!]2MB\V"SI.T#&%X%E.<A^NB+AT Y_7+TR/\[MWKHY<D#C5,MSOB
MXT?\*P:,P!)6KJ\Z'W?GA6G#V0"N$SJ3/>#@5Q&BL$*>P7X>!A?ZLEZ[G'HS
M  >BQH$!(: ZS+$PP?;%,:8"&UEDTD]<$LSX":V6)2XW%0V9L+&YVY=)4VN5
M#/\ K#%XL"L'!@U=L@D29 ^RA )ZCM4;KPK[;]!'<'SXQ=EGN;FJ-3[1]LW!
MB<EJ8X&IX@,=INSI"$,!OK5>].AA#$0U5?!K;LVNL>E6<VPP[60:^IG_--.=
M?/QL[^^-3K=;$)EERB&L963_?WO7VMLVDF6_"]!_(#+;@QA0.^D\ICM)3P#9
M5A+-.+8AV9-I+!8+6J)L3DNB0%+V>'[]UGU5W2H69>?A=+I7B\&V(XEDL9[W
M<>XY#V$HS/NID)+K_A/(,.GJ<N-SE0OTSZCB3"64YRA<"^I,>7J>SYEL3N62
M>Q0T@_\6B,2%HA/X#===PN<5>PBJJL=38?[7>GK!J&;9W%=I/B6O2#9/O-.Z
MK.%<D!LJ,KZT-D.]S&XJ/GZ2F2P9^GEAA8LOE-=KHT5![V#U"D@'BYZ F8:!
M^#E.$6.^I4(YCRDFJ.HK*2L\TUGJ0/NFIX1O>LJ/*E0PR5<YLU##4%T'VY'K
M['8<<P*GRSFUD+\3?DQ ;5R .1[Z"B?$(REY/&.>I #/"5RO!8<+\A).)^O_
M:,>J$3BECG?,>X$)@;L'@RI#J8?8<('L/+%)@"<;&1LU$I\6_DD>"F@,*36Y
M Z&\<PZ@5JH,1G!'ZJ)0-!,BJG/4ZC9I)3TYR%N2Z7%+<%(Z5DTAB5;*_E(U
MRKW<?$?7W$:(".:FAXAN;FV3*E+,>2)<EZ0G8BYID1.Q6 V(SZW-UMYV+PJZ
MY202#ANL4-. R9<1>$/L.2M]-BO3];277)1F]P),I]FM,)U34$W';#U/C+?'
MC][9[7:&,[TPK'=V7A9KT,:2Y>%'V:B!/E"4FTM& ?<K5D_@?7RJS=SCU:3M
M/KR[CQ= MW76V!!8]\(=?;X'XTM6D"A]M5XP0B&;L<(X@9^)"DSQN:)TW[6Q
MM"\+ C)L5"<)VK^;]"-=UM8L.G"MP*1K!F] >NV1J5]*R:WL@,'K0"*$=C5[
M',@AI,Y/%F614>>8B6BOPW82G9H,+:B;@9*'G-FG%R*V*>Y?D"9$V6R8,FB:
M8@'3NKXLROP_S223&EZHI^4;VT"<N1L4O&<"^4OUF<BEH+#Q,6LS#SQ77E)7
M,3R?.]^.?"ED=DNOW_$](&%E'3;U0,4+S/?IZ?T00B+SG+@Z=*R2 4LZ>8)T
M)TW/U<YP^;YU<]V 8=#1E\ILV170\"F_S[Y.=,XLBV1!J&#(+RTS7KA6%95?
MW \EH*O ;,M@2=&"B6TG4<&8AUQX33!TZTX&A$=X@VZ'HD6*,B'FFT?Q,X*6
M<B&'\\S'245 4J]PJOPGP*"8R0HK#]6G(@LD1<.2;4>Q%>%&8F9B386QZ3 E
MN:&_7+#A+E97M_,Q9E=TT4?5#6\WOV@ZY*%#ND&OXR<W3:5!M)[SB<1,;,R/
MJ0)DCU'5X'Z$QK> <0QQ#^@1>S7$HB"H8D9@3M6"5F49$ZD9&<*FO=[KU)[%
MT2)<2)R3FA.&3,HURQ8[I@E)+].QT "5T3!H@U69E3@"E86(*J?%^Z6<RL[W
MUR<SA+^WH97/*4#_:0LL$F#13UM@T:=-M-]"HE>BAR\@>C@R)T=YY2*'.MI+
ML<.^W8!5^6"O8:"5>"/2H8W8(10W66=$S(\_Q5]BVMIQ8\&I"5#=FMY12#)7
ML/&NB.<4P3I@<4'DPAC&<#K=RF4C=@\G'1!U#8=]F'&SY)I"BMCNS"01HNLP
M3]C&<[K=>3>HH#Z&>7E(28V6.:FM3D[32V*^2(0P]1S89HR=B(6R004P"B2P
M'+ QK83'L97HS''\,9"X$+L[1U9)EZ&!&V=<P&$FO?O"96$)*Q_+Y$)^&B<A
MZ3=0VS(E!-/MM+.L%^S#!"UE,EMRK4FNP^^!F2<T<]?;=SMT?W\P9B1CPJ/1
M"TN(,?].HV0=8Y]S"E)Q3K=-3$T/(<_$K90:8WP^I8G1@Z,4/[G/=W@O&BFZ
M(52)N')*ZX2CZ-PR U*JE(1$R:*+WK[;"3F6"O*'*F9YQB&=VNZ,O2.R_%G:
MW@K\0'3?(NX6=@(V'.?/A$DYG :JWVZ["ZL)@!LV/Y]#(0TFIMBDPN<C4P8Z
M#$SA!C&B)O.(H^ZRI>(]*0E0]%B-ZBU$AMQ + VZCLIKN<O]%L59A8-%3VST
MZ'G9DMW&,8&JM66Q-!Z(E:*I+S%&AA>TLI2BZTHO8G8>.%RJ2S/0DWF6E@1V
MH,0XHE>TDHVXL'/C$]3\/;A*1"6@$M4S?JG;FJ$FUFTMB5:"X/61?M@>6QN.
M+53O'@"/'1P665K+J(7)V".*XN80,L8A"$#*"^/]BO.L:L<;[O:.<SJQ6)VV
M%\PID?F![-(5^Z$H#:3JSA#W<YTBNYOY./;0A@!1/![/.0-"9RRRX.5RX .=
M5X5MHY 2LH@69U\T26@SK/ &&F[<9==$08_TR"IS354H++ 1)6"%9F.W@\)K
MU(@@@1V29F U(O,D3.U]YLAG&1;LI41 #C0"RRD3F@9690TSP@\>5ZRF95ZL
M"E$P' N^)A<>WZD$2E[FGM.:J1,&?Z"UD95H-N!]+\R>M8HBB(6\L,>"Z;D-
M2UP58A/X? FVE'*[!6S8 IXXCRH#DN2S;[: ZEOHK:?;WOJM:N)>;$-7$KIZ
ML0U=_8$7CMEFD)(%]!&,%X!NO -&P)F[[R/SN?HF.. _B811T8\%!3!0BDYY
M+@?Z\,I?$JY^(8XA+Z3D 1WH\>(0.SG/&T5[S11&'AYI? DH[S%^;(&?+0!7
MA6G82,!K>X*:8<W&1LR,>7(]-1?BFKX#<L6_6PEUY:8W7%E_NB35GFE#\3-?
MYDB;[S,I(,M5-2GS\X#GZMGNLUV:OO<R&Q0;O,C9;'Q[9%*.O'Z$G":P9#^K
M'ZC"R\\1@I.(_#?*LVY0LLQX*D#8 _93##(X/B+0L%.FOL2,=04/1W:L1*DB
M0QI/C#L+L0 >H6YG(QF$#),/05S> #SS0J7RFEE/8=L"\&%:WO@A.]8#F=^F
M,-V@-00VDHJI%G3JUD*B;C0@2@*<EBI,LNS9\@*V_LVE$Y1,;RF?4 Q*CH7Q
M7A:AI5KZA-F'>!"O S6T 1E4V?4M"Z2;RIA'U74+.F$?US7P@PGH^3@66,7(
M& "]!%(Z_?@>;5O8][.O08]*54+0JT)Z<6OM&F34X2NOBHL7:7M_-H6J&G5F
MV'=T"FCBJ$]Z2=F[;V&)">3J4MT=5DV=".V_-V9)>F&%U'&@KK)+,SHHS(=K
MU(8;(,8Y,R8P!"#AJK+B/_R?" 2_I2PQK:JLYAV%\$"-N^)HF6$D''AB]R$?
M#(&-->89@_XUY+:MI6B,X"DF#8V@D(*6]GBWY(W+<2.GY^8S7K:(EJ%$1S0V
MX8IYZ*:)]'O88"C(Q1;3*L.7:GEE!C^06D3M0^Y1'C&VLVU#'1NL:J2:@!K!
M;N?@E?'\(&7ZZXUQ2B"D'RDS<Q%YS9";4IGA070F^&37H3"KK1 R5V/:!898
MZL3-H*YN'#S2YE(0NRPZ]"'H)E87YU)"+AG43-OI?(N%Z_I)HQR02%,2GF!.
M8$UL#NN$*M*+!$+(@G_U"4=[5(G79"V46FEFX6)YSOAY91["]1(R:L*Y06D6
MIDZMB5"._G6VQ%,5:=,Y8^8S)+$4M,.NRU'G2, V]_UVK;6OM;]L V4?T5M8
M]]JW%CE7C\R,_S!?.WX-;V^*DO6')HA:BH"LXQ(9LXZG?&/YH2Y\#.$HW0X+
M.A%XP%[JL'IP*9HZM,]-*' A@E6.Z*,E[]YX%42VAWE5,K+B%" J-9G$,I/^
M#1UB9C-Z(+1:U;/-">(>#J:OL7/E-=,Y6=7G53&GT 8YW+JF'_PH05&"R5',
M9EA%!6$V@=X"BA<SR-F4!#E!P1E*[N>L-(78"J'Q400[;G"YD@/)DT*8)=G,
MT?H))H/V'\6W!>)ZD=65<(A,.[!N^,;"ZGD-17N7^<I.-!QR5;WRM<KC)83I
MKT#<)/;L'K!W7QO QJ=[S]T0 G_Z>!L"YQ#XT\?;$/CO<:KW1Z?#_<-!\H]=
M;,'>R+3 ?/Q^.-X?'![VCP;'9^-[;-OOWUAXOHN8C5/F1A;;0&**IWY0AH]H
MRZ2,'J.WUY.8;KL.K#J%E5CZDN/(6C*13X5K<RI414:*V'P(J)MLXF%K!J!-
M:Z42AGEA^"AVC+RYANRQ+P'87BJ2X1*:]6)!<2LZ%)5\P"R? 8WL\Y_'9R>O
MZ\N?'\%_?=GT0-3< 8I?P4@(WPX,0P\^N"RNX>WIWY1%X>ZMW:!Q/#I5 O6Z
MJ(*HAG%8,EM?Q(4T/(*:D_AA8?MB2]*Z8>F0]%$F >\!%X]Y['6H "!!\D"_
MO U-U BYXT!YO-(I^<:-PC5+U9Y.KW+)NDB!'DF26QXO1L>9*\O:"G#V+".
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MHZD@5-7QP4]\ZH >ZD$DKF[4Y^/'.*,PU-6XQY KK\&,R@LG#PX/ST564OI
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M)>9I _AX;WQ\>'8Z@-N<'>T?'QT,W7V'H]'@'\=PT2_=#CQW\,^3T6 \-JW
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M'ZKOI?M?);S<GWX7GR]WO/RYN1S/ST^Z^ND3<WE;C\;N9_>HSVPU7/_>["G
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M!ER-5.C+,D+:/VEKT'AK4'W5HF;50$T!EU#D)6:!@UPA?\>LP.%J4&VKR[)
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M A.L4]@7 Q6RK0FZ]+K>&]>(@T2G 4>Y## A+Z;5 N^?FLPD/WZ"K SMC'=
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MOE@!"P%]U]XS#$C$,![8K20'8L<7CEV\T^K [UP@^GZ]RLU8 < 3A5[FIBQ
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M#MX?_HM*H_QX^O;-B_\'4$L#!!0    (  &*_EH,+XL9G%(  " % @ :
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M.DM1P+26QS\N\@1/<%Z 9!'E-3XN@"EU4D<*.X>2BH@#-Q F#6^@P:*LR$]
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M=59T%=B?1+HHD-.$@J[*8^)Z KAN >%?1OX/=>X99VBI)D@NJX15_X[DK.'
M.92:\(/&(^$V)%A0YA=.6!4DA2T614,76IC:JMTWO^P<1-5%A8]MH44)OT)=
MM2C-Z8U >TVFID^76Q#L\^+THJ)&X$@KW\>5.H$K)6B9MM=/%URFIYWA9AY?
MF&H"2USBC6RF@@4N4SCQ$?V=&B^HXCP?ZX=-PRFS%EF#;IX4&_48ZDU0R,94
MJ9QBQ53'D>#D.@H_2<^4&2_:<JB1R>.MZ36BK=]F^CH%^D(S61R_;%NOJ 93
M:"+C5>!06IFP]5LP%DMA,B(F1;%(2D(@M/2R)EGYB=?E:N&O22[XHQ%!GO0U
MGW.%=.U0CLKJJ3SWVBLP!Z+#3Q=1%I\[,$6M150Z"?2W/"610=*ND@(B,X;R
M_UO<>><"'MML*KJFE]DANCBX32.-O4C10/9!=J9.P9!3)IY&_]5)+=Y%<B&J
MF7L>BH1)I9EU87(,O&U:55:H.$=/\OCJPK] GTA#LU+6C.U\>>''RRJE+0EH
MA^@?QZS*V@/HKLS;")+ YGLT' O:\5/'G[U^/WH,3,\)#V+>;/M7FLG;,C-T
M,R6E:2NW0->F6TAKI.^#*:82"?<C7I;E68:ENEK*W<2$VWB"KA_3ZA6]NQ1M
MQN1"ID+*9N=.C:3J3K @B.ZD1K) ]M=9S2[HTZ;;(SE!:X'C39(&W&_7%1!D
M=SVZS8&?P6O&#8W45C^2+DN.T&4)ZCQ( *6$2*Z415 &'I(E)XB&,#:\0NY[
M'Y>UB,FLBR9Y89QVK &XO "*>K+[*YX[9JE/!;V"<I;?&@'_"3?43QLWE.^&
M^NG[=$/=9D[[!SJ?%BC!^N)E76T"44UO09N$TB.<6N:'-^KX$[+9-$<^R:5"
M'M2,[6?@BE1@B HDI(W>4*=#Q/%)6*0R457-D 65*F'(R95#V Q58/@@YA%N
M<FJ1)UUF &W!V&6G-U(=5"1>U:3UQ.M71,2]]V-F0$>&>5\4\/)>D['+NG?!
M<ZM[F4% ,3<1NUB26-FXLY)P#(IERJIGUQIS$['U,,)58Y$X7Q&G&PXZ G77
M':8SSZZ(TIE>#.N$Z1Y$+]Y^V#_RBH"GR:3@;4+>G0,9%DNX-?=>[OFQ+B_=
M15EF+G59++B>-"H%:XNW-XJ/B[.D(V6JD>+3ES)E<I9T.K*?1J52!,W46=DQ
M X<](W[!G49?:OG*DYP@8ZT]P2_D"Z2686'%JJ5T6='<BW*0K/<X5.X'OT7M
ML,Z8L$PK:II2232BNIRXO?YC1-:*WN:U Y5X-]4**$W&I*Z3M5%(BF?TXT-$
MT4H03A4SN"J;<N=<>ACPS=$Z%FC_BVIDS(U'V_?G< E/Y=TO?D!2?7EGHXD=
M,O$3R,0/M<"Y4C75.LX5J9;@&BL,"KN<56P+:;5F"W#6[G;779*43\4!H(HF
ME+P)]\WA5B4_;7>^=^P8?K-K@R?,2)LW,HF;7OHN?PQ)A8JUV@VXMI_TS*:)
MB]Y@<R;'+IUA\((3.BAW9ZV$:7.)IT7")GH%VU3-3-N6G+/.@"G!!G"5*PQI
MM] 46%D\>;-N/PLV+GV/A<A%/WDRX$NCB?GU+EUIW<@[4%(I?+;8>&9BQ=W"
MGIZ&<1P"HUH%0?6M67!78P(9,(&#!#TS:.'>8<RF.2ST2+<J,L8ZUB)S$-#S
M!??7-+,O XC?J6ZN2'15R0$0;I[,4F:SP&?.\Z2)QLD749*AN]H5T%BHT -+
M6U#,SE5<D79 FLE949N B+UZ9P)/5611(1F_H//29+\ULO\3CHN_;1P7ON/B
M;QO'Q1<G5![EYOY\\F XN-HOFQA-NY\Q!480FJ(=K'I*1%(G\A5J4^DT<7W(
M@2U1?A_9;,"6* SGM:8;-Z++S<1N:XS -<N3YK>F" *-W(+3 [H4BI*+<X:#
M=9S6;!"UUT>.!%%Z'( % ^A&A N=FXH?DT8=5%J' TI9(O^U&E^<$_@R&GM5
MR\CV!/VT4>M7ZD"R,9!2'5 VHXC*8H(-82I.YP[F;% =2\>O&LX*?(E8\WAX
MID[GU[C\E!! I74V^"(TK=C.SE+;2*XN=8+PZU&H#Z*R5MB74JGDJU;\5&F7
M!'3"D_8I4"GL:Y\6R.%C($(#2#RSQR.U#][;FSJTG:(78JV\RH46:&BKG0=E
MMBW GJ"96_)12^!3::Y!$YK]N1?:P:/H&Q9;9&*W1S#O$+=(^@LF?K3*#$,7
MY6RTWM9Y.=94']&P+X$2Q N1H@]%6O;XSJ<*K9F*"@ $NLD\B9:89)X'[YT+
M1W\490S[^>BNF3VG*M99M9S//2N%@FUB^'C^:8F-:=9),.&FKJBCAQ(#/U2V
M;$.*=E**[0,?0/-8<_-E6;9 5H(3MO'RSAE'K0FOO#'D-XNSN$P#^]U"[L*!
MBHL$K[+('23.+#GAPBAA;/C9="GTR%%'>J?ULN?YDFJF8!\MBD-0TO7N#3(F
M@P'78VX6>;/=26)\'[I9F;-*\8S[P6-;1XQ)3,=E\8GE9 7[BZV*)I9A6TPH
M"S!K<YH:@5F3R\ %/_35D3ONZ(U)Y1O3ZWCG:>M,40PZY:K:LB?Q)WQIFV.#
MUBEHG4_71NO< ^*;YU;<]*)T?B,*^=6!)MO[83,5Y!ZRCMQRJE.4I-7IK%4I
MU.AR)D-Q< ]C>F#8EW,JL?8Q $])R6:..-9 AO,$/1+P%VQ5EC,.X@E?5&8,
M6O+;C\Y/"TZHY&S*).OLK4W!!=3]%\@Y*^P8Z?I1QM$B2Z8GB0GES>(THP!&
M8<P#\97&<C[HVL^:3A/LGDE8ANQLF9ZE5='D^U2>K@)[(H>-?AG-EOF$:VX1
MW@M8ZQG&$.JH+#*IQY/49]QDVY:08B!5X.@BLO1-+(<>\ZMRZ:.1R3(WHF ^
MYF.3L7"7Q1G3SBC9"B,VFG#+HZ<=Z$/87<-T=7QHGC%>=4)X'%G9UD\Q.I#<
MII^U]C_JWWZ@E2^R__R8;#796"9#WN!OS)991L&V1AX2I64YRP%L@W%D0;/B
MDQA1&;RLQ*S X/T8 Y3I'#<VGL-^P5^,!DKP:BP* SK0<*"5(!6'B4&0@!5\
M48EA1\)UY"LF6Q-8'0<',E"#'53B>YJ4AD,D5[]19. ?95H1@2WIWJ(MHO&_
M$$=!%9>R\IB<P/:L4V[JL+YZ\54:L5BCOA"7X+Q!]96$\U;EDKLG%Z5TF2LO
MU*NHU*>U>!_[#&E*U"6.#,G2"UN.WU[RM<7ED498X8Y#$6N:4"@Q_:HUMZ-&
M,)]*H;;Y],_2(K-9OF87[(=-.1AF3V./'1F&98O%M39,=TV^Q/@B'XR)+O)2
M!?G:4\15CK?R05FS06%GJRBV$KHA_9?A>XH\NVA^3MYV].@0BVE>!SZ@PFK;
MZ(KB]ET5,#YXVW)1F$[0<0/.3@L#KT;%.!T:L8E&& &X @ABJMC!ZRQ(CISK
MX>"JA=]QDS(V>O5<,K+K_2Y5MG62W[3* 9LP0)S@P]5E"EO7COAYR::$04)&
M#R*7)%/#UF0!U+SEK-5OM'.UG#_1QVM:F1SKLY2M%%,,< I$/B D"Y7A+=-!
MC!([:T:PW8GD!>RNP"P,QG,8V7+#5)+4W%UOY:NY)F9D<%\L$C^<JS-?R.-R
M'[T68YLMTM@V&619([XMR(%I8@%MC-U&'5^7N:NSTH4RMN[%U@3%"D19CZ3I
MUFR6CAA7H5FX=M.M69AC;@?/?#QV!1K26#A^NS,],^7LUE>A=O%'+-+1NCR%
MRCAU/YWY"%LVM&_P6Z3Z71PR"/%!W PDL6VYZT-]6$%$"@939,B_H-TLE.K2
MYV>!43P_JD&ZCL^!%SV(#OG.DYE1NT:(V),(AT>U"+=:VE9+IR'F49E!B2&W
MEL(:1XR#*9T,TE .MP7>.K/:FC%JD$(X=LE&AJ1*E6>FZY[)-C>#]-0*.7'C
MLBF&@V;3.W>LI]=8>W7+4G[6"X#^O F ^@'0G[_/ .@M(]X>"/(.SXO<=_:Z
M[*I6%>)UJ1#;A,Q.T\SCCR+-:[2/^KPK7CP!]49E(#NKF2UAC@Y84[C'QM<\
M^*KV/8ZURL ?6PN_9]H4-K+VN^'.;2.YLD4ZES"2%;2TM9*!O;\7Z]@S/GU5
MM&V-M13F9^L;HP@[UV>-*K'2;X^._ZS5207Q5S,[HVNW.BE1]^IF9U<Y]!6L
M3E866F8G6E27L<""UE>D;"_4>5I'[T$0>1TSNBV-AM7E&QX."FT%VG6@0D"L
M %N#O_ZZ5]MLUDC3C]J8CIRU--2(5#^-X<!KJ&'0R2YGZC63.Z]FZ=G&(Y<R
M]6[ 7!M+\?;'*SBDNF)X+CQ-U[J1CPAW^80@ GF8.<8R<0UB+DZ!7<>E^=Q6
M_!2,B+R5)[6)45M/X2).6WF''4F[Y,CT6).7]O_4I6Z["5"R+SL^O2%PGYTY
M1X43FF<MX@LNV4&OIY5(?;=ZY/HQ-,F$/"O$W59C06C80_U8@Y8$W*'$R;O^
M3IY.HOQ+=];"Z 'W!B7M-?>BHI!'0V'38)^LL.VU;&"7]$4E/<IF3GR'N^A7
MNE#%V;'6-S@<;,6Y\H3O*>/S8US6%[Y3G(ZT]8Q,REKXROJ769"R ZK>7,TA
M1?1'6L(6A1C:D[@@):LY"P]IP>AQ[9_(I"C1EQP=)'A1<ZBP[(>UOV1&^0VU
M*6%0J$4D2DC],WX"DT^C<I^X@B!&#=+*G_;VF$G"_;4Q@*X<P4#FA#AL6Y-M
MXR>8^*&PF/9,8(HGZ#[06(4.;*%D#,>.#26*;;J(@?I4X,8K]^CP&U,@#.7U
M*.1C36M5 )]R/,P 1HHBC2Z=92DG,E\D]&,/[T$JGGR@28%E4(T]0*(EG/\"
M>DW-Y8XH=4=*=3 [JHC)Z)39!1LV4GO*" -_ /5,DBZ:_-8RR"_+Z+AGYTZN
M*6\XZ+^.?,= I!,X@VOCI_$OM \P%U&(.2'I G]A<44;]^-8FCN;>S8<Z!PI
ML>9X,$MS!D?.)3YUL#Q$#L4YD-Z.)O$SB@)V\")2H#A/DEKYN @%RG2FM"8W
M&%-@:35S0Q)-IH[[AEF<JJNTR,D&"X)/8 WVUK$7X:-BF,#'O 0$AICRJ;'R
M'?@!)C1Z)6<I]FB*I^Z'(Z.)1,>%@?WH9K?M;6-YH1I%!OFU<6*KC3BVG!&1
MUIQ9B:!Y8-83,[+XM,!ILO13PD=!H+LFDY+PV<WP%%,D3":!&VFMQUR='B&'
M=JB B,05IVQV[(I7.AQX4S,  9PXR:C)$Y:@=]W2]GWIVOE>0D;.O(ZD%M1D
MDF]3B5_8%(!@ZBD8$_.":X*YYT%K"3UW/SSGT8/AX&C5:H[9:'&)AMCIJ<Y<
M$D" MW'X $[,)'RBM&TTI;>8,?Q/%7#!(9>Y(EI\RVF2"19 %E\DTP?1?M$Y
M;Y=HR@821HD:HS<WQ9(7&'T2_ @OU2"-JM6FN0,8-T&8L-:"X1AB 4!&S&QY
MZ]0PPA?(UPC/V&I.0C%'D,L^7LZN.$Q.<69F+ADJ<N5+\02)]@ ,H%:=8=RJ
MOC4)_R=")(\>;F(D?HSDT</O,TARFY710Z^1'\B/+N1.3^)W").P>:>TEMX7
M>.8.8F9UI\FK>#'G&#'VC.B,) RG+?%!;C[8Q3PI!3P?N39A_M<F.NX\4R-F
M^L/!<<+NKBYUJ!&-,&$9$ I>*V#DX2(LQ+ THKKQ8JT4>"8LV]PKO0MEDLZI
MT*5+I9B9?A6+PF82A%5L'94QZJU-',#7L%3J4GNK+A,UNE8+E7)-FB:J@'XT
MH$B:WK;OK&1_:EULUM=.?K3A8,\DG?C[PR$7ZZO%%';8ZZ<84$TK+Y^&3):P
M'8AU4!@[3*6ZDR*EH8<1$$?BIT8I- &_&BOV*"[:J55.S*HLP+4XE.GV4D.;
M"YJJ\5L';K)$72C69FX'0]Z0>Q]TOK@6HV26&3Q,]FV3I2EYZQT7#Z]6T#H,
M9>G(/<-H@0NO><F TG,&D^692]*J>,=PUN>8=B]8@P:N*DO.T/V$3O.:-H-8
M(': HM$X6:F](-Z4M9=D30;_WFL$\C&>#O+NFCN1H4]W;(MR*10R,1"KION[
MYW^\>CZQCNJM%QD=2],P1&>*/R7T,\E1&A/W45$S'2&C  [WX&OXAM46PL]#
M,L7Z1,FR-UG;]FBHG2Y,[%->G%.-Q)CRE2CWP)\$^1,72,U+\BL3$D]9"N8J
M(K-;VSJ6;@'!6 G31O>=$A.$,%8L"(R8-T*4BBX,])HM=6YT%'9I[)7? [BE
ME^0>WE SS]TE(MIRLK8[V7"$1=>%; 09?,>L^BEWKG&P7BI7337B:D\DS'W;
M17,J<(914(_]^BMHYJX1>C_J=G==TK%:>^2NC@1B@2Z1:*SSAH]*_ +X,M9\
M+&-,9TZB-)&:_ @FBE5R5OG<#DXO K8:4_<EVR/.=K9GFG0!</443=&B,!&6
MD<9_9-KKX. AG(%T#I<-)1?[X"?B340_STD9+TZ[HLK>^EU4@QFD2X3MRJOL
MBCI'K:"S+77]HE%GK2,PGQH.KCOJW"N:^N70"&MH7' :2/8R(>E0K+GC/+^S
M0/.1X[2LP' .M-V8V,B61L*/1T#H\$I=R;SQV#L'F8TYMB0^G@XB2+$_MV54
MLE/[6EN4W7Y7V:.-JZSA*GNT<95MJO!75N'_N'85_J]I-0%[,,Z38EG=A1K\
M*U3>'Z#1D0H,%9JSK$F=63L1KP_(R68A8JF;*QB3AL5O6IH@#94;K2X.5!GF
MA:#GV3SQ8*-67\AP*F(079<<M!@:!.%?@J+*:D,6GY.N$YZ.]LQ26Q+.8K%%
MQT$\7RD8FX3*(V4"H=$DO=Z'F8IL6R=3@(6/5^+OG!>@!F*1JU'+G-(NMA%L
M#K!&#E?.44UD#=6XC[B:VC/TG)ZFSSNM_7/E]U>I:^?B5451PC^WKS*.1S5Q
MV\K5D9;S9Y 5&-I!/]Y'"AO/;VRS?JAKO:2S48(H'<]Y;"J>7(H'A>%+I/<+
M:F,'5,![=^RV[$XH&/T5'_M@]GU,3TXNCJG>/_<R,ZOG:--39SM2B',0:90V
M2]#&'4F<IE)$&G=IYP0\!D,>2M.^Z$>8!#Z,+HD8/QP.3)Z[08#7%R$W^ -\
MD:20^2(R2/Q;QE,6^Q#AQN\WB1?Q!']@#573K Y9B<D+\4#+_)O86\Y018WA
MPV;'728IS$_]Y\'NX>[!?^^^^=<=7JA$"=Z QF Z1@\';QSV,M^ 5Q=$I_&$
M@>Y[T_;'72Q^S#:M*;(EIBS1,=L,S<<# ++M:EG/Y/PI)32X:@(&74=-<Z3Q
M_L>>K4_P^72=.:?4[4$#?;J_ YM!I>E(!.<^ =P+B_!H_(H%S/=5.<=<9.RE
M^/H:"@8&/41_]FRXV)TJ-=B*J7FX-4#)G>$*#;@S!E4A)--1HQ/ BDX#E.+2
MWVJ <YZOV&G@#E^YA*_<CJG^D)K WU&RF^+$(T\K"<,]N:ZKP6<-S.B8-EY\
MGW+8\%DQY1"$5WH"W_!DSGDR#,3J6G9.,?".K6$J=V75T!+C5N-A@G5N$Y5L
MVI]5-=5%H+INV#Z+@^@PN(W_SHA!&./IPP>/_D*AF:*TQ$:!PV)96^R?CAN[
MA7J9E.@P.B1B!QI7O$#-ZBRJSGIR:D--+7V0M5GUG+<-=U 5[\O/+D:-4#\E
M*GKU0.9XK"-9SF,X0+YDHY7LY/73KE/8,<Q3M!8,]E0\ 0ZXP&G(!@K&@\IC
MX[9F[9?SZV"BS;>11F%>IW$CV5?*U1I=+-&ZNVT+3D'RZO%Q^G"\O!_D8G=5
M5%-,:0R@N3*5<E-B=2UJTX#% ;'W=G]3&+A(/TFS?IBR1^#;Y80SD"4@0)%/
M7)_MBM"P@KJ2P1%?]"2GOGZ4("'*8L<<[1$4IBD>W=">ND+,?_2ALBA!W. 4
MC_4VZ_Z,S 3Z&( &]:42Q=@D"4H8FP.HR6<J@#Q+7+VBF)1>T %VJ)@GWO;Y
M01.N6\XD_\#^*^8<3/=:AI8FU=:\3&02L2DNG&QB?Y2:ZZPF4UB'RI-I[Y^L
M_3G(G-]>&C: /'^,,N&T.,<2=/ZW%:<]S+V7MX^;S-V4G82:)(4&PK*3LJK=
M:&9X!XXQ&U$:K1>74K2(L(")!(\YK4J58^&_<,YJ?X1:W+[YC%#R9\TTVW*Q
M)6G\B<5951!\C,P+!W-'ZC+R4<GRW!EW01U9TSV_O7'/-]SSVQOW_.W0G&?&
MT8-&H_'L[BA 138G'8XPH1<O<PU^+MCA>,]M8!?9D\6G8&%O-32;-:@36DRC
M6^T2HL:O9/*TNM#>"?;1<28G?":'2\I'*DJQ9G8J5%ZL->/Q:-/W0-!=<<^X
MU8VX3\EQ>9RR3N+BX'8$!NZR!Q;S4!:_T_@.##MW@%%=0RIMS#=[C73E(:(M
MD9^@(\R3\B0I1]H/CD2G8@*JK'BM4A(EB)3&<0FSQH>TP:G+M)NAB^% 9NQH
MVV#+<,*TU,+5MF:9H7OMCC<R11_\9*W][XKT3YW?>4^GE]O%"_GOK_8 'RZ/
M04U)&<$><U!(J"7<94TV%P'O(E//F=N(@.<;ZG[K.)+,$PO#1^\+>!9H:$E"
MRB]<BD2K5X=R7:><MQM+JI5TNZ2P"&OA.".88VI;TS6B5T)NRM'=Q*;3$(.F
MU+"*0KHK[Y'QVU..8H_C/AVQNKV&G[YU2L:J1*!B/K#0OM$:;1ZKU\E%=J&Y
ML^W8@*H4-=JS;=W%^C^Z]JA$5= =$8#I+M^^E&_?[F?JW8G( ,BV7F.&5U(B
M[P\+'['X$OJ9)/N<%]:3-%&_'QN>S!;=^:E-":Z+$\Y=MCJ!L3/0\#9M2JP1
M$GNQ1/.;"5JUKB<RO5X/KWVVUB]&HFIAT[&=*B(7B-6>A90A=N+94,FP$9"V
M&ZJ1%JXV5^9"28,NR,DA1ZQM) <%"E788S<7G.?]>9QFME,+F=ZQ\7,_6$QG
MXMZ..'<9F5%,_3?%1>_>+ G_E%T(KS@#XF D(*,A^,F*QI"[D",F'SMC2YZ?
M%E@U*Q"3C6'2RM+$R'$5VH@6IF5<V=KBP(K<.U'IYVQ1K+>%NTYM1:44Z"[?
MS3_X;OZ"608Y<;[W\;EK"&9R_"GI;L*/6(]D72XE,YV..L4$^22G,[!7B,K+
M%]@W)]P-(5B4$$+Y#'L]OB\UYI,4"BWG2ZXW& Z\Y!DI$^%/?,,HY>3(B?VI
M!4ZTOCV;:B%%*<W7<-K*G=C?-1TLCS<.EH:#Y?'&P7([6$$FQCSAH')RLZL9
M-#UHQHYC8G,*T ABUL\1\*.4HLXV2TY1,<_6K EE)TR:DP@81VE&3:) HSDK
MN!9IF8M,0".8PUF,1*T NZD$1LVV<M,U_<?MA+6)()RM&]]:0%P-QH-S+V!A
MQ3DKF+'@5XS%[F$WDZR(H<L;95\&1)!?)AC\:;FJVSJYS&=I+O"(C$T2HZ^;
M^K015T;,6+8?)J<6U8IT&XH0'*-GH>8![#=2U!5+[6$3.IR;J33( ;/K@_0
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M]Q"T:-+'HCXE*X^K\PO;/K[/CHU/8F3$=I[<('',4!/P7]-H$:=NFAF3E>@
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M!];1GHI\HV>#;7L[PHX=.T9/'9JGO!TS26?-BB@3,5=%1D\>/36>]T:MYN6
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MWJ_'K/?VH]_WCO9W#P^CW]_M'NQ^>-MDQV,"*8J7]6E1HA4Z78(><0(2&.:
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M-^]NS-9JD<0/KSZ\^0=E2;T[^O7]R_\/4$L#!!0    (  &*_EIZ<P7:]"H
M %+A   9    96$P,C4P-S(V,#%E>#,M,5]B<F%G+FAT;>T]:U/;6++?7>7_
M<&[N[!94"0)Y32;)4,7#F7AO!E+ )+5UZWZ0[6.L&5GR2C+$^^MO/\Y;DFT(
MA&3)SB8!6SJ/[C[][CYOWIW__GZOVWGSKK=_A/^>]\_?]_;>/.9_X8/'^IN#
MDZ-_PK_XWYL/XNS\G^][OSX:YUGU2NSNS"IQGDQE*8[EE3C-IW$6\0>1.)-%
M,GXMIG%QD62O!#ZZ\UI4\G.U%:?)!7Q4)!>3ZM'>FX.]WN=),D@J\71[]\WC
M UC&ASU_/O>UH<PJ6;P6UUW#5I7/:!WF@T%>5?F4/J-E_#T;E+/7S2NXU=E\
M./"&: 4'I_N_B7<G?YSUX._W1_WCW\XBT3\^W+[/1=T_6 Y[I^?]M_W#_?.>
M.'DK]G_O'1_!GW-Q?B)^0,:!S%'OK/_;\?YY_^3X8</EY.V7SM[$<KX?1G+6
M.^WWSL2!.#PY_H@T<O"^)SZ<]M[V3D][1["6D\/_N:6CHWC[([/K6QK0W]N?
M\[)*Q@OU89*-) ZZL_T\R1[M'13QA7B7STL)?Z>C)+N ,?O9<#OJ=F)Q)-/X
M*BZD&.;%+"_B*LDSL5%-I/A[.OK7/'_]YH^]0_O5F\=_[/V]H"\V(S'*8<$3
M6<C! N!;X!HBD60B'L)HHS@;2G&55!/8P9#&W7V^*_(Q[*M*I7B)/^)$>@G=
MSF\RDT6<"F="\3Z^BN"QN*)GQWF:YE>P!U'(,D_G^$@IKF )8C1/%R(>Y;-*
MCL1L7I3S.(.7<GHOGE>3O$BJA9[T((^+$?YRE!2PNKPHPUW3$^Y^NQWUKKN\
M.0"[X$\) ,DPKB2."Q!V'JN_&8FX%/%4PONC&L"7#.6N:/NVSK AH%NGVM6S
M!%2[BS0+A_33N]YI;_\,CV$D (+_0/0^>1:))SM/GD<.#F>%O$R O-,%T#.C
M^=\ TCB#/[-9D5_*420VDDUZ)2F1+(8$UEB4L$98//P,@XQE4<![994/_Q(C
M6<*28R0E0)/"S!D_#GPCSRX110,@XP_FS3-\4Z$&E@+S;R1J6CT<X3V;3P=
M,S!K.0&R!UC-<J!@_)?&DK ^^(4T0/CW7W, 'Q$#TGHDTF2:5/P+;1)&J(ID
MR!]4>!IAY T\A:-1@I]V.W (XFPA$!A)2<^5LH*S5,#9A =74B\=/V02 - 4
MGL%]JX,5 @[AFJ9BF,9E*7F!#.5-ALG7IZ5OA89C(C0BXZ<[FHRS7!$!?-?M
MK$-@8A)?2C&0,B-BEJ,[9@+?&$B/3SZ)<P3KVY/3'@,6*'@(-)T (_:8[71>
MP='I=H#LIXDFQGP DZK3 V]5<9(!9/'4)%E4Y]$)* T9RDRD]X$4J;P \EZ(
M00Z,/Z(1$WM4\#$8 00*G-#4/65J@FY'2<OXHI"P(G6(X!EYD;-44Z\2^RJ5
MO"M??8\XOK;"HG%\VCL[>?^Q=\3H=42Y8? @Q^5G8#TE</WK\3)7<FA<L)0H
M-=U8'8/$,_PQ:H0S,FD#1Y:OZ[?7.L/+Y;TSJBOM[Y@([@_E;_NG9^>OC);X
MK$%;^GM1(@S*;J<=5M?"0&(45ZV# 8H+&>-Y%DE5"E@>:(9 :+%[C@<22.,_
M%A&*(L\!B!,P%4 GT3 U0LI"UT 4Y!83M8R'$]"J+%V_HT&0AB-%Q,37AG#
M$->7,EWP>0Q?*5VZQ\E!I<CR"CDPX@7,!\(7*C67.?%=I2W!J405"#663'^-
M#/E?\P1Q#^@&6T/DJS7V;3"6KB203X281R)(<^0()8VZ#!Q,8,"J0%_*YU59
MQ21 :L+%;BLB*PF>95-E/$Z*:8S@X=4K%+RS&(D!OW]ZY@S\R=S97*W".Q/!
M,EDSCM,*%=)"# %L%["$$6R\!.RPBE?73O%9AKBX@'5FFC^V30// T#T+'3B
MX'DX@^VG.6+MF9_% SGT'TU\^PH&)L3##@J<9I0/Y\BY2[)' 65P2#(FC J6
M8C8(T 929*RJ'=7AW0X]F!>6">LD[P*J"TR5)-])<I !#*B8P32:9GF&;L?(
M_6U%Z_?BW+TO;G/6.SPY/GHESCT-R,C<;N<*3IMGU=_8M2!:/ M?I#O?D,?>
M);2UD^M_W_3WSN@DS6'SL_A":S7 6/M[_W=G?BT5"OFOK2WQ-I'IZ)7X '._
MAG?_-4?& 5.(K2UX5,#_WASU/^KY74+=?=) J2_PLP&@7A;FLX,T!M:RN_T<
MEE+F:3("[?&#/V*-Q-\\AED;%C  V?_7UD B(;XBB/FGYT7#FG"AUYW2 <UC
MA V#XS^& )?,VS\6G_KGQ[VS,T%V\<G;2%C?9+?C.R?!S 66'\,WS9)BWU7-
M!\K[)S_+X5PQ"A(9ZK1+D0%;X7&>[KPY^^/#7C5Y\QC_%:-XH>UR-LIOCR?4
M8'V^CY[FP][[]V<?]@_[Q[_]^FCG$?W^8?_H2/]^[4FODE$UP4=W_F;.".I8
M\:P$6M8_/2(2?'-^JB<@W7@8IQIW0.>/-)F>'YFUGQ_9#\7A"2[]^-='3X#P
MWYX<G[NKW;J,BR3&59=34&VVAC#M.I$['&>/)H*_3J^W3/V4@L&+G;\]:EZY
M_]SS]1Y[&CQW_?4MG:7AY#S:.UB\:GXZX'Z#D/LUGD2 ?W_O<?D8I!VHVRG0
M.2C&OP-V\H7H]U$:W.;&]H[AG+VZ]I9;UG:+ZR*]H 6NC4LZG"1R+'K$4% 3
M/P&M?(BVC+>HQW2BOXL84;-J0"((.&B['M[M&%9[N[I#\_(:]8F[F<KL9(FZ
M\N2U.)F1M_ 5SJ6TS=?B8YS.\>NOI<WPQK,<#,/TCB.T#C0T'%Z+\\4,MKM?
MQ(-D^%K0*2=8'><(@2>>6J/?PF\>D,K51L'?1JQ7+ WU_O?+)T]VFD*]^,7N
MZ\VHV[G=6&^;0;8JU M&X2W&>LVV;:Q7;;C!!=D<ZB4W\ UBO1;BJV*]:D5W
M;*K>9X:"]O<[R'> 9V(F)B;+T9$AL _ZV0GC.O%?ZZ(+0Y0! AR?#KVR@@SP
M*'C!X77<S=%MQ7)N"N+[0ZYR[B-F(PW.)\^CG9T=_-/MA."/,,!)CB 0"86X
M1$&+[^69W*I@X D[0)';BHV?=K9AD-U-,8.321@7&XV8121XB'4HA0S(;H>C
MJ>@BKIW>75JO)BF<)21)3A,P,Z]#$[B<;;4>\H$9%[;K:$5*=R/^%P5P.NW]
M!D-W.LO11)[/\FS]X >%\F\WK/']$:815-L",'8DQTE&Z1+$ +:[G;<J2@#B
M!6',PB\?1X%P ID_+94OGT+S_M=3&6<HAA\8<%V-8CH%*(<GL-M!R)2U.!]\
MN_OS:W3=T&LE<T_+"=2)MP?^Z[IPORG X@$O?36AVPDH4=&?'R37I/_B!_ R
M<03L^^80W(CO6C/[+H#X <;,1]T.GG847.29#2 K^,1S(M_SVW:V?K^PJZF=
MBC=&#8%RJ]6Z?)73&E'2DQXPM&/7PO=+H[1U<XZCQRSC6/X]6(P=YU7"B:.W
MP7D?,M]0'K4&;<!&X2-Q%1>HZU*N03Y3Z:VY*.>#<E@D XH9XW>@GPTG<2DI
MD\$[%1R<W_1484# O  ]3Y8/'/SLPFS1R(S5%6?*_RD&,=H9RLI@7R4:(&?#
M29[">M53'XIDB$3_>SZ2J<@'*K]R7.13X9C=)Q^U3!C/,SX1\/^#-,\Q-?H"
M36SD.?0NY\UN[',F]7D14W[+48SYS GJZ"H1>3Y(DR&L*<OG6@ I?N<F?9.#
MR&8Q\[(CD=2?+.=#8']J7TFI)D"_DYIB1 1V4%]7 C)PE(#P@X<=0V&=E:RS
M$$R$JB^&\Y1F"O[&:.$,\3&)$?B<LGW@B)5_;8T+*2F_%1/(!45)@?5CIDIN
M,EYQ*7]LGVW#]F1<SHM%MT,/4DH4ZN @](7$#'7]="&G@')M&+7O,RX;OALI
M)YC&OI<(E&'*)VP#X'Z9I_!5FE2P'F_V"_()46X]1D-I]_@Y_$*!7OMB VV^
M^WC>3(Y+2-!!-:;SN+A>0I!KHUW<@/RZG3N@/[&:_#@/"E\F1VFZ@$G1EX%"
MT[IG** /@I &'<;I<)ZZV7 #EIT3D %(E1\_[7^P/CB'M8^ B6LX,Q4.)+!%
M(CS%H]HX!9 ,1_58/1HIPQ^DMLX9XP45,E4IW?F:L$-J4]GBZ%F_%7(A..FI
M6_G43>ADV6+NEDXND0?]6Q8Y,)R2=CD QI-?(0"[G0WZ^ND+/K'P(M:__)MQ
M,H[1?7];XO/%R^V7*$7AS[-G8;U@BU]\>;CPZ8_(H!\9?/H@(X/K$=9]:($/
M5N<%JP+TB53TT<M?]_E8U5?K(.3&30K@3U[-H)?\O=28MN%"-I_5\[W/*LEZ
M7Z<(/UA#I+64H.XT:G,3KQ=\^^$^;@!^16&K959@R8\88W#=^!+8[I,$= &C
MTOVT2_$S _0(K?@_=4+\"%=,^@Z:%1RC+4'?H%C8*+E,8 <C\H9-!\HFT'9-
M2@NL"EAQK"I@XWK9W7\ CAV)<D-TL]MDQA'U9L]LR/ZLKT1\T$Z6A\JUM./N
MB8H6.OEQ2(K[4U!O*XH<@D8QKK \]WR2STLJ ^?X\:8C.6KU,?5TDU5AYJ:3
MZ(73<6 =8'Z8R'I*R )-]$AS$17;U;4]AD.Y566%'$HP!R/C/:@7;<WB120,
M:Q+\^8J*,.4GV2!#$?"XE8RWV%,/> 6]=HL-W"U5/C:(RZ3<-'%^MFE+3&,'
MUC9%.K#S ^^;4UGR+$Y&_FIJEO/51*I\)!Q666W.4%0OXH[BM+VPPVP+@"I7
M7-EW#33KRV@#RATFV]\#O3TC>OO(%8FGY,=6! =:GX1! >Q!+2*'==*DY"K&
M>:H2F;*%:W1+I31&NG3Q8 'ON@B>P1N16[797IA(=9J8$&BE@UNHJ41"2Z%F
M\(J?+=5XG(9QR3E=MN\%EC66@>O.?GN%'N762!=6V+%ZL:HNU4EV&3K*BG(/
MT?FB^LC8#9BQOPK& TWQEV? [2WFJ'W&Z$LPIW*+^-PXW3@(C<G2XN;(JTED
M0%-U:)5?2!J/LB\KOW2W!8@Q9<W!LF&!U*G#KW8%D%RWW%7<4;4K,9_KE+LN
MM<EN7NW:[5RSW%7<8;4K .4ZY:[BCJI=NYUKE;O:&L\'JCH^)^GP/@'^/S+I
MO2 ;_ICEC+/4?H7:1:FSGA'N5PD1^M9\UIA?#%*=Z.$27LFJN%C@.TEF?]UP
MV7VP!B?+&P?FS@=.) =;^52L,(SGI._4M57=&"6^C).4.!\:<[")JD@&<Q-D
M(REEQ(3Y&A7;::Z<SQ/GZ/ML2^ECR_(7@*O"FKAK4;XL98)8R$2F.N-S:H8/
M7]#]#8S46:B7=:2?3A(1^Y!D^^HLC-8=U%;U0,_*"SHK?J+%FX,]*ABTZOLR
M2+9F9"J^%S(J?,A!V493JDZ0&KZ\M0*K*LW4]U"R0:GP=R/>])$)K*12@2(Z
MY%;[W!9GCF.([9XA*+=I8@M,2$C7=">;61/99.A:@IJHY:=% K5A2MXIY%*"
MFJ+-I\H3.!_%EYT1<C1CT#'VQW-CE>%N,C#OJ"]:21RRF38B4K^"ID8-&\PX
M'\EC["MRE#9-'R.WT<EY3;&4I"9T.T,'90/5/VZD8X0N]R?$Q*)I>E9!>%P\
M;$ D-=R@SAT%5D!36[0:M\P]F+<.L411N\(4 "^1Q&$",3O_>6W=S@U&QFPE
M"GHU\1@]O)$\['S+M/N40N3V\:14&V;TX'[IP6Z'W@/ZU#URO/W0EY9,Q4BF
MR27A&L=O1EF-2NIU8FWYLYN@T?3'V-@N> ;7SP20J%8>C9-'(770NUYV@-H1
MDM62+3!W=O< "QBAFCK2,%"=WRA2 ^<@5Y!U@%Z2JX3PAMY/A/% 1NN1 )K8
M#'.=&ZC08UP E,X&+YA(D:/U;Y2;\"#V.$-]#$V<.;O45ZH0=>3-,S!.2VS,
M:)PY:PQD9J<6#*I9%C#),G>/7*+)E0#DT!EO64$ZW!W84S?9&[;RFU6UM):0
M6O3!8MY6MT+YU#G+*8/U!(-RAJZ9'3@]6*\)LF !1C.<[2F8-H)Z3HW1D-UX
MO@F/@(&-4!_%B])9KT4X@E,#2V'%QW_#HJQ\N1DE;+"[SQR@AB/B4J?"'M O
M\2)O=:%#Z(B?7=09PGTWV5F>L_'L1\Z&G[/Q[$'F;+25Q=XW\7Y%/7T0Z.FL
MF+UV."'H8LAVR!KK[U$S*>:QS44A^+H;9ER5,F$#QMKY&FNYL+SUH'G1=?2R
M_86,RRIN=:9.;!!^F*=@%%(N* 4T-,-UP^2V-M3?XKTSN*]((\--=F+9BM2:
ML0$*(*AD:!(8]VR<+<"&L;F4V'FW0+=4<PO>E?AB/4S[6TS1KA*F@?O%Z#RM
M=+>A_:E728ET8_P"7/+B!#:H%)=E([G*/F-)LLCD$&TZV ]\+K-RSMI %7ER
M'S5UU\-@G+@ZP4B)U"JO0"PT&1MU!]9 9A(D<D*^-S8Y !9$] H8L7(HHZ,]
M373U/$:M%SH0 0NB+OJ3O)3.B#1>44Z266WNJWR.+BK P,5%(2_HB!CCG"<V
M*3ICKM'@='0ZQ:KN]NG&:-/!C<DUP!7;+*DA)8CN_O+TV;(N"N[SGDN3[RA
MQ5M^'DIX\=GV+[_\S<01'%#34E01.'6*;@PO>&#82+)A.J<G*'4%P:ZVNLSU
MZ%=K!68>@"1L3F$Q<F(P8D^@OUUJN(XC+CDYEM27GR&M]BVE67LVR&V)=MU
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M)X,B_\LMGCV2L[Q,JASV=5X "'5M-6HR[*O&!:BGQ"=X;53$5\!:]VDIJ$$
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ML8#4HEJ^I&NLD9^H*9'-S^^]4C4&NL0$?M0,PW%O.AOBE@0V5]F_+,-?KV.
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M[8LUNWN!FVM<[AHO/UWQ[M4DJ>16.8O16Y+E5T4,[X8#LDEOQ_S9']3=VA=
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M,IMF226T %PZQ2G M";"T<DW&947!1\ ^#NIT5,"$TNB\1)V-*WA09?P.RY
M-NGWB$!Q1_7/GI0@US'-35; 8YH@&]A/G*!OKX"=@['B"^5K=7D&YTB\E/"&
M&7!#F 6Z6^GA_1X>?38NP?ZT*14?QFMCOS5CVL?96\<!CBA(=!#+Q-+$*T+\
M']Y9)4C3L%KLBY*#!XM$=B':R7!AO\?/N#0+@J^BP>/-Z)/2[WOPJMPYG>M5
M7I95OT>^YK:N]:?-C:=_W4+.(6[M0=C/CM15I2@8.& "GR]0K;$Y?8P.!>7V
ME$ +':8,YI!4#C-&4S'/RXM,?'M&V*4!)^;7<H0_Z/6?1V/B1[#(J]\S7@B6
M5I8BZ&KQ;J@)Q9C:_T$V;*G_@XR^-'K;\==F3@_TL"8]]'N_8;2WS73PD',@
MF&4V7QZ-$XR0B$[-_@QD'\<3T!Y@('(5,C+D&F_+:0HB;8QQ!;1_,"IIA3H.
M?].4"**7Y2K\WPYP0U273T'E:B@NRHH:#&2P/:0'G%0)*?=[R:6)P;)D!6-K
M F,J2GABJB0[R7JE%,EG4#7A4C(U>-AQOY>U+R6%2N:5U?("M#[E%5.B^)WV
MN++Y/ 7-J$E)\-N,],J1K#,05$W:@^$(_D+67_0,9O%5.LM1BX3O\= F<.;K
M#X]FP+XCI51'J)-C0!@^+$JRGW1$]/T&)K"BE;($/80NI+ SRJ6LG'+\5&U#
ME<YARVF^8C<$YRF[ZOVFY(S:_40VA]@*:D8?%RGIZ>=E#K_EJ"8Y;P>1E#2L
M;6+ZEPY&P0=X^*5]7YLV7_]V$H6ID08+PPC08/=>KR#(]G*L3WY@Q-P@_:TQ
M$)O\K,'$R/PS'@SY%O)+(D2R4HT&0W%6U%KQH9,DGRQSL7M4.)ZB(2"4D"I_
M^WW[G64!&%DS!:FBUIFHL-\;@Q55%);AW\DJP,R>+!OQD$PE-@SF_K2<4,!'
MS+@T9W-&60Q7KAU0&YA4VOEP+>3B6'7Q/:&3<V1"_Y-6)7"<FJ8Y!LY37K!+
M@7Y]\C.?6+AOJ376:):@V?]@YMSA"6HUY)@U2Q%[7NJ3I8NL-C[NGUK97G]^
MQJV<BYUO\UCGVZ@<*OKBWFV0O#Q/9S>T0=_D8"9#>^<H[&&EC6Z8O#@YBMH.
M%'=GE2Y =\2@)+EPG52[>4)>R'DR11&&_K.2W?[P]R*I&B]YLZ)_,0\4AB%I
MG/3.8(*FE93)04R6<UY:)8X)3!(0\Y@!Y;H,R>])@276#& &[_9>@6Q:H%=U
M3)$>5##@]T>@W>;D0I4_DZ9))F?D!E$K<U VXIG7X\Q8(X'1S5&BP6LX" ,#
M\3+ VC?;&6 ;_=[O&2RM1(&2*L]8VT6]'K,?!UM#1\230%5JF8E%6)?4Y*ZM
MV!>)5QUC_ 2]1\=IT^2LB+QC3=]RAF/2BY4-.1WB"#A+;AB%O4<FIQ?,$MRH
M.LFFG!G*"<2B \HVL>)Q"HS^%!_@YF4JARJLAU,I$=5@(6!:\U2MN:6Z!#8&
M]O0"_?/D_9JE''=*ZC-85IUY.CE+4>.LD@LR"Y+H/9 AO. 8/?4U&,;%AWYO
M6>3HG*549;B?/ECAG!(TGR6\QQF>6;[)$&@7E@SUID^;P09\!Q=^> 0CSX"/
M8"9K8)Y:NY: !*Q[4:H%QS, FB#\B:,Y72:XH& <#G3@KKE<T//,;_ 3*'A)
M)9K94,4R]+NMJ@+KM3C<!IW\.DH'-R%!GZH42SF;$^!/55)=!NB#HW+ZD7C'
MXNRRQMJ=' ]LQ?%4"<TI^O#._+( .]!^-O RS=.F$05/^#A[!):<P[&GS=!1
M5&UFJDOQ610W5!3 QV6VS//8Q ^ 3M+ ]-P)1!WCGQ&A@D*=B_V$2=@E_XNF
M>EG &-'N09<N$0^%-V@<11FEYWBL\Z11<<+F#-T!@R<.^ZCCX%&V R S)+D@
MRZO506X%MH&+O0.NCYQ<+5"M([1JOK#6RUS%.-3&2(QJ45;*?*,(98GQ$\/=
MUM@QB?+H3-YT-D.W.MP,LTVU;6F'DSN?+X/SWH Q)PP<@]73N$X*ZSSS,VUA
MZST43\R)H1!%:(H*F&+0XT()O%4Z*:LI$,*9V;*KABV!<^*EBE.K5 5><QZ!
M^TK%HTE\4DA"8FL.#S#4<,%2*R2B,!2&J8X+;>]2] V> +KDSDMO]A3BHRJ4
M5-(])I-TT1ACU9 0:!63#T5YD:?34]82$K0:(JYW&5_*.=$*#<83:XY2J[@^
M*"=P3[(X\P^"UGY"].@MM%<%L0:=SFP_N[X=C&C6DDYAZ0O6E42S$MF3B,!@
MHJ-(LG;9@NG,SRIGJRM+OY9ZZVFRUY8.Z S\LX>S3H;@X^<J1_,9CDK$^?.(
M'.OP\WU*(+2602W \^@$U()GT7:5C+/)\^@@F:>\2*"2P-0?.XE_ZB[\Y=ZE
M(UX3S7WE4OG[:<B./4-6Q]99CKDY5I9G^E-*QOZTN?&WK;_&5Y6]^<9=8%#:
MLOOFN_2M?)KWDPHG1(6[8@H:8\@0HJZ'R8"FL%03,Y7&&/4 9104"@J_:]4.
MHU^DHV*@HB-AS#A*1NI2RAC:,Q[4?D_Y4)QBKV/UC(UH?Q9;#ZJSCQ$<B>8,
MW1:H\=68BR1Z#I7_T]/)@4.J.#EP+%M?U;/@OQP5,//H]SHFPE^3&AY'*G.J
M*M$R;I8UV88<NVO$:)1P@ZM!<3BR3O*T0S$C-Q6,@M5+TLZ*MN,JR>N2RD25
M+=?MPB*]F99@?"D>;-(/A0.T' /*V:U,0DZM=:S!L:X3FEI%0?#,3C72L37@
M\4U&H205[D0_6':>D?K]7X/M1SO#:/#/X7_C]X/M80P#@25]]N"TO1-<!G:L
MW_L[.=2T4?F,G(&X^1P];0=#[;C? BEJ&DKT6NTXR\1*#/E[X "AD0>+<V8\
MJFA_&8> G3%NW&#)4/$+\K-A_$_5WM'Q=NU&$*^/ V\!,_;37M,9)RX7:2%I
MNCI5^'0IR7)TRUD)+PBG"O=[E"O\\^;F8#P<_/PW\I =T?TTC(.WQ\C3YLO\
ME,PTI6X [TKA+SC"5B)IGES4A"5 :VX-.#;>W8[=[O=N9+L=1X]>?@G+AU>K
MWW.6J[7V2"&.UTB<!LU%23M-=S/+9P$UT-6?RIWG7&FDV"27G%MW8,!N0_OH
M#VQX-1E55O*#O0]K+[#.^W%<,.'5;J_:BHL_\1#V>_:\KES!\$$(T.FW9\SW
M7;V].1FS0S*&U$HW!M/VM]5B!MDU1L^1ZN[O\MR2[?_*>L<_-4UTZJ$DN;G,
M?RR)0LC[J(8M=8+)EL*-ELX$G=CDT-75((S1T;I8N8OUXR[0RG!U;U2ZS?O
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M,+,@G:"9&I*S)@_0Y"TT%/&DI&C.?E<*XXGD22/D36JR4B5D"1=-JA2!-B3
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M=$GI<J]P.JUZ86=WD0<(N-&P1&?;4)JBLD<>JV]!+)ZC,TKST_"B.L;&E2<
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MCOO-Y-"I5'^G3FY[PE*/?TPL;%NZT<$DJ*(QEHC6'R[92XDQ^0S&!%K!::8
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ML>"RJJ4I5Y)S9JY@J^4):9X6%ILF:1.C,U@?I6XY19X-I\@?2^09^ XQ#WE
M.@M"6L94%N06*#!_+*?2R%H>]9>JQJRS6F.*+K#75<T.9K3V<3$*#RJ!7!+)
MI#'GENXF3UD8>$RU(4MU7\43JS$9%@(&?"'& =5&7;:2/,(ZE&G:;GM+V#^+
M>X;<!UZ"\&RP%;4N\;PTA2.=;XW%%&)CBEW&Y)5@=+EHFLR3TU35)?9[W6Y#
MA!=Q<3?9%"*?#/FDM&[IXI*@-UZ!G=:-UWG-\CRB-PW9(BTJ.S-C)Z AM:ZU
M$ +U<;-\ES T5?BU6%#2#:FP$K_E*[FIB5M42[4X.7;!T\:HS&F*?=-TUJ*
MMK#A:$B5%7!-!#/R4W23J#DP#_SV?O';LZ$!JM8=5#0&9$SQKK0VC Z$_(0Q
M:'0V*SNAYUA7KC GN25)65DPN"U<]O9AM6%SR='I%TF3!\4"I[QK9MX#K7X9
MJCJGR.H8#T4&WF0V(ADJ!T:L*)^6.-^H#-:$21+@]U1_=Z[CSBZ/[9:VI8F*
MZOIC.V,5T\ +."828%)(KS,GIQW%;G:>Y>FI@;I5DHP/Q"F5.F:U!D_,U63=
MZUL0/"  5!MFOQ$VXU.MS/I'\<N@$20LS4LS DYB#&\_DYC.] 1.;H:XC#8(
M\&I<QH>C>!>/XA]B@;)ZT+(^Z<@E4RE()9F@^TW[ +H6!)_*EAM?<K6;T9*P
M9I^@D5'E9^TOUDTI'5QNADV;P EP Z-&P;DR1X4Z-(O1#.<F921YT3G9S:]2
M^*;88+:AJ!7JAGS<%:XI)JM3V% K<*P8<CG+F-M!P[<FO=Z7:EZ43,#UU?A*
MMDET 2-GR*1<>4@PTT6=BO*,B"-Z<&J1G. Q)YVPRD<(L)@'P[.U9OIPD._7
M0?Y !_D8,T;KNF2PN6FT3:AP=0M8N!O/,X"M:<DZ:AEG14%5T8DF:4$O+,1D
M)]$Q3HMTEDE:#1&ATSN[(:P"-6Y./=)J*,/:M9ISJ&&M<Q]S,F%KJPYFE5+\
MHIAJ]5>)8V<&EUI8^U C*S%Z5*R$$0M:<)M&@+NNO8=S>K_.:4[G=!MSFG13
M6B3--K;8O)PR;BA*H3F3I5(/#15+":?D8VGK2L&#20BXW0"&SQT(Q>B,"O43
M[&YMDZ3OR5%WD#Z)]SQ0YOVBS#E+D/3<QX;^'6D,O6@+T(,R0D,FC:?;V:AY
MGHX'6XAN#*XB<&1CNU\)LDN*+;<@7DB-!*ZY;*2)Z3HOATO.LG$FBB@W%.I^
M.@_./-::@QFA[N_ B9#*AZS>)$F(\AZ*D*N,1ODN,171U(MB:GFB;=E46=?@
M'=URZ^$8WJ]C6- Q?)U2*KIMD9W)5YA=U^[E@MJ+4E>H05>1*1])E2(L$'TH
MQ*FO<W%CT[R!4<8X?ULZ-^APB@/X]-""^R8FR-D-USF7_QOXW[W+TKI3._)B
M_^7@F$#^EYB!2*D<KTK$^*J'+W[<?WEO9JDVK36E*W*1GC[D(JE<I*??3R[2
M5P-K6D&8'OZ4+W5N4F_:NEX1MG\ DGK_Y&!T?!S]_GIT-#I\Y4;4L6\"M;CT
MNB:(.FYU!+$J$#G/=UFHQB%VS:;; F&6577#=1/H-)U2L<X*:_$.+6U8%IUL
M[[P91;NC-V^.WVWO[A_\^O<?-G^@S^^V]_;4YT^>[44V;<[PTLT_:XZ&J0+)
MHH8!J;]^H'/YXN1(O0!;LR(0M")A6*T?U-D]V;NYQ8!GZ[=$NX>X%@=__^'Q
MM6;N'VW_&KT^?'\\@O^^P94]CJ/]@]T->Q#PGZ-/6Q-UE2SXSYM_OE:FLZ-7
M:N=E>+7<]_]TK:]?M4ON>Y_<](L_?6>^SCI<)X5>/ENYU&LH)M<I[7ZL?XS>
M).<IV'K_6"9%]!:LOO(2SLR^(P&_C[TA#8M?%=WTN[H6_;M:\!,,YCZ[\;7>
M/<O2&>(O@MJ"/KI#5EC"B_TC">NP(XGUBK96T2KK6&7!_'2?[);OR= (6\77
M5M#S30WRG9<'AR?[NZ-^[_!5-/KGZ&AW_WCDZ"-WQAT45J=:FKBM>?N:^9=-
ML0LIR5+7890KF7K0LXF<OJV4;7(9%_*P]F]M9 CTA5\K^L^AH\]88PC.X%JW
M&;7]?B^L[ON:-#'X,'._FY3\I</OHE(W9M+"L-OJ@!JYSGD/MH8<T* PG'2:
MDO21%!/AZU!>IL8&=@+9LFP.N*\'F9&:QJ?J40.*@V0SC.,IW#7IL"BPGY0%
M4M4:U4:#X:A.[BKIC=,S5;_)R.O2A> <)LKHMD:-)9*Y\2W"*+??07^;"?CQ
M$'WW3! <22/D#@$@P<[JT0 (#D'+S.Z/RX_#9]%_1?^-U)(G%T PW]&:?4LB
M"6!U?HTI8\;II4;?>E]0(L(QUD'6SZ.R^J[6XAMN_U8(JO5K3/E___+7IT^?
M4Y->4U5SEH;QHSOQ1!+$$#1H'7$4+J?I]Y#S+//$Q57";N :S'\RC+M+(>A!
M"@!-I.@\^9C-E_/NP8F0=EH&4G%C<Q:H&>9ZN"FFAJX:Y/U#$OGJ:1'7'/;
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MME?;>?^=)HX?=P[W_D5%HJ]/WKYY^?\!4$L#!!0    (  &*_EK+9*6JJ@D
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M%\^>)>0#9 Z6Y>(Q,REP@' P7AW'GB3$MGR :"#8:D$I%S$-*]">J$1_%=I
M-VDU_[MA*G-%9V!/ZDGYJ"XQ,>16)#]C?>GLL\_ &S-C8U1($5I+^DXGK<)G
M)ZV6)).PKZ[!<SB!D:!5S:=SLODFFX^%.L402*;T$20&UULH-[B/ 0@P:-[E
M93O3R;"B$_'C@L.DJ=!0A* 0VE5$?$8*L%%9_,  9R< PML(2C0 M).EZ@I<
M8P9N;K&0H0,WGDX8IVC9H)BT&WL(7J]8/9*.#XN8UX/<)O$=I'XWR:F96(/;
M.E4J*G.P"=";@IN*6]"A"83J,2ZXC!*#Z+H1A+S.P+2Z-J);2(&0-IS4?AAC
M"4YVK0S,(3I2.GTI!@X?;:!\XOG 1<-!=Z=]KKEQ89Q8S#6BG$.=12=K2KEX
M]L(VA#/D3Z1QT90$+M9%FC\(4 Q]:F"G BG% RM@64<"ON^210,F-BEX[V'R
MT WO46J;( ;-_[B9W:S%AL,.Q/^HVI<SX]M*&5P1*2(%DH,;#"9(,$\V-[:T
ML^6JQT9=H9")((AH,IZ&N9O+) "F['OKV&MW/?*M3@E2$N:>1"N7VSG*GC+<
MB@+!B"&)XR5$DX:SOE7W-M,XE3MYR>$6V_4HAFB<R-"^-DXEH_<'90CL4(HA
M-O9ALD%XFP#U2X ^\MZ@!5[ALS9%V= \I,4WAEQ5=N9DC=3#"F>;V9S5*C2N
MOU(;UBUQDVTDEXIWQMF!NA)0'RK]$,C "T8H(<;36QKJTNNN=$ R;"CCW6ZU
M!^=>+!8[T'PVI[OLP&8;<NQA NZ;)]<)_$"(<XE.QG&TP1"H./GVN;7<UE[U
MU?,A\OUA+GZ"_D?J$3-@#D5IU[XTQ;<2Q]T7VZ.,]FA1MV4S;_MGHPQE2.<4
ML457@M9V#J6!>RZL0R8@ZNJY0Q'TL9R UK2/1N![2?<.UPY1D].-@9K%P?AX
MM+Y44FKI&@+OS.AJ?0A7X.YO?3P^FZR/ GW,^EBJ2HU6Y(YRVN^2#4M]HYC:
MW3G+AICDZQ.4M-HTPY=(2\5;>%WI4CK*>.(0B-U(*JF"K^Q+0GV3_@'+,'\@
MC[++>\J+@GGC5Z\X":A#8 I20D!$U/B.00M% ; C+^?:9XWWJ\;VDF9?M[-T
M+L;?2=.^AFXY3]I[<1KW,7^@54=&EDNT\53/7\?N"T"'MAVLE]*1UESR2R O
M^1#?4G%7T;Z?\K!M'*5KY9$8V[\E]/OW^*C'IHI/EI[9<3ZFOE@$16ZECE@H
M(\;A[)V9O=T11V68,\ .'W):'_OX^$HS,?1:Q5J']*;Y>@)()NG26RX,P&;
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MT1.7:C592>=@/':\3!$(.+"N\#0<_$]]8TAT=HVZ A;"&AQB$)LO<!6O/5,
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M^+;R[24']($H?C&B#TO_!5!+ P04    "  !BOY:J_%\62D#  #B"P  $
M '1B:"TR,#(U,#<R-"YX<V2U5MMRVC 0?>],_T'U:\>6#4W2$$B&)$W*A+29
M$)*T+QUA"]!$EAQ)YM*OK^0;%P,!VO(D[YYS=M>[*U,_FX04C+"0A+.&Y3FN
M!3#S>4#8H&%U.W:S<]%J6>#L]/T[H'_U#[8-K@BF00U<<M]NL3X_ =]0B&O@
M&C,LD.+B!#PB&AL+OR(4"W#!PXABA;4CC50#AXZ'@&UO(?N(6<!%][Y5R Z5
MBF0-PO%X[# ^0F,N7J3C\W [P8Y"*I:%FCMQL]]V]%LB_8(,7YL'\FAR3YX'
MF'V.;U#UBWQ"^/PCNE._(SJM_*3G*@S<WH_P9C1MJMNC)\3(ZWG7'UUW']QF
M&K(N_2$.$="]8+)AF?JR\L95AXL!K+BN!Y]OVYT$9Z7 VH02]K(*[AT?'\/$
MFT-+R$E/T%RZ"HV[AR0NE+67;, 3)A5B_@(^4 5A'GP 4^<"E*R$'J90DD,#
MO(23V'<&? 2U0^,K!SDPEO8 H:@ ]Y'L):*98P$LA2H#M7$99*MIA.5*:.I:
M(#R<?RV@/8$&0QY+;&8R0;E'E4]ZL2@.,5-77(27N(]BJA-YC1$E?8(#"R@D
M!EB9(9,1\O%;<OFH(L:XGFB]59G%V**(Z)$M#-ID6EP3G.('G3LP![U2:V(8
M+[S@^EJP  D:5GJ<4\OU MPGC"2QLQWR@&TV)C:%ZF/"K,-E<%E)APZ^L]/D
M' DL-3VIJ:T-&3^#;.;ZB/HQW8LZRV\3,[/G;[+TBO-5NL=]D*Q@S0Q+PY+$
MW(%69AL*W&]8JC>T\W[^TE4[>I9RA FP80.3%BV_J"QN+H&$7U(IW1!:A$=8
M**('>NX:2#,GRM#OYL( $T=: /Z[PBGJ[5JXIF#Z'RMN&_URJ76XN%CZ>7GY
MZKI:+A1@I37>=(NF]W^;^XG4!HIYLG.>;4RV5[&KGC.1P2S379*8O8'=DLAY
M>R2QYBY?%5^N@YM#,D+;!EWS3=@8="4'8JID;MD[A?DOR%_DD,CLE,1".P,E
MH)$PHA5;]['JK4_G+6;R+/<: I_'3(GI+H,P3\D?]NO&[-N_72-R?-H$\W=@
MW[![3$$Y^*H1J,-431__ %!+ P04    "  !BOY:\/395OT*  !_A@  %
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MZF*K+=7'K<(@.MGF2._E6H.DR%<W?R%9Q)-GN9SO:D=+YKS3+2:-OF]HPD+
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M4$L! A0#%     @  8K^6DE+:V>H,0  :P$! !H              ( !L+4
M &5A,#(U,#<R-C Q97@Q,"TR7V)R86<N:'1M4$L! A0#%     @  8K^6@PO
MBQF<4@  ( 4" !H              ( !D.<  &5A,#(U,#<R-C Q97@Q,"TS
M7V)R86<N:'1M4$L! A0#%     @  8K^6GIS!=KT*@  4N$  !D
M     ( !9#H! &5A,#(U,#<R-C Q97@S+3%?8G)A9RYH=&U02P$"% ,4
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M:"TR,#(U,#<R-%]L86(N>&UL4$L! A0#%     @  8K^6C/8I(1:!P  U5<
M !0              ( !%-H! '1B:"TR,#(U,#<R-%]P<F4N>&UL4$L%!@
0   +  L ^P(  *#A 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>ea0250726-8k_brag_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tbh-20250724.xsd" xlink:type="simple"/>
    <context id="AsOf2025-07-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903595</identifier>
        </entity>
        <period>
            <startDate>2025-07-24</startDate>
            <endDate>2025-07-24</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-07-24" id="Fact000003">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="AsOf2025-07-24" id="Fact000004">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-07-24" id="Fact000005">0001903595</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-07-24" id="Fact000010">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-07-24" id="Fact000011">2025-07-24</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-07-24" id="Fact000012">Brag House Holdings, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-07-24" id="Fact000013">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-07-24" id="Fact000014">001-42525</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-07-24" id="Fact000015">87-4032622</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-07-24" id="Fact000016">45 Park Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-07-24" id="Fact000017">Montclair</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-07-24" id="Fact000018">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-07-24" id="Fact000019">07042</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-07-24" id="Fact000020">413</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-07-24" id="Fact000021">398-2845</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-07-24" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-07-24" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-07-24" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-07-24" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-07-24" id="Fact000026">Common Stock, $0.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-07-24" id="Fact000027">TBH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-07-24" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-07-24" id="Fact000029">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-07-24" id="Fact000030">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
